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Cellular reprogramming is an emerging research field in which a somatic cell is 
reprogrammed into a different cell type by forcing the expression of lineage-specific 
transcription factors (TFs). Cellular identities can be manipulated using experimental 
techniques with the attainment of pluripotency properties and the generation of induced 
Pluripotent Stem (iPS) cells, or the direct conversion of one somatic cell into another 
somatic cell type. These pioneering discoveries offer new unprecedented opportunities 
for the establishment of novel cell-based therapies and disease models, as well as 
serving as valuable tools for the study of molecular mechanisms governing cell fate 
establishment and developmental processes.  
Several retinal degenerative disorders, inherited and acquired, lead to visual impairment 
due to an underlying dysfunction of the support cells of the retina, the retinal pigment 
epithelium (RPE). Choroideremia (CHM), an X-linked monogenic disease caused by a 
loss of function mutation in a key regulator of intracellular trafficking, is characterized by 
a progressive degeneration of the RPE and other components of the retina, such as the 
photoreceptors and the choroid. Evidence suggest that RPE plays an important role in 
CHM pathogenesis, thus implying that regenerative approaches aiming at rescuing RPE 
function may be of great benefit for CHM patients. Additionally, lack of appropriate in 
vitro models has contributed to the still poorly-characterized molecular events in the base 
of CHM degenerative process. Therefore, the main focus of this work was to explore the 
potential applications of cellular reprogramming technology in the context of RPE-related 
retinal degenerations.  
The generation of mouse iPS cells was established and optimized using an inducible 
lentiviral system to force the expression of the classic set of TFs, namely Oct4, Sox2, 
Klf4 and c-Myc. Wild-type cells, as well as cells derived from a conditional knockout (KO) 
mouse model of Chm, were successfully converted into a pluripotent state, that 
displayed morphology, molecular and functional equivalence to Embryonic Stem (ES) 
cells. Generated iPS cells were then subjected to differentiation protocols towards the 
attainment of a RPE cell fate, with promising results highlighting the possibility of 
generating a valuable Chm-RPE in vitro model. In alternative, direct lineage conversion 
of fibroblasts into RPE-like cells was also tackled. A TF-mediated approach was 
implemented after the generation of a panoply of molecular tools needed for such 
studies. After transduction with pools of 10 or less TFs, selected for their key role on 
RPE developmental process and specification, fibroblasts acquired a pigmented 




regions of RPE-specific genes were activated indicating that the transcriptional identity of 
the cells was being altered into the pursued cell fate. 
In conclusion, highly significant progress was made towards the implementation of 
already established cellular reprogramming technologies, as well as the designing of 
new innovative ones. Reprogramming into pluripotency and lineage conversion 
methodologies were applied to ultimately generate RPE cells. These studies open new 
avenues for the establishment of cell replacement therapies and, more straightforwardly, 
raise the possibility of modelling retinal degenerations with underlying RPE defects in a 






A reprogramação celular permite que uma célula somática seja reprogramada para 
outra célula diferente através da expressão forçada de factores de transcrição (FTs) 
específicos de determinada linhagem celular, e constitui uma área de investigação 
emergente nos últimos anos. As células somáticas podem ser experimentalmente 
manipuladas de modo a obter células estaminais pluripotentes induzidas (CEPi), ou 
convertidas directamente noutro tipo de célula somática. Estas descobertas inovadoras 
oferecem oportunidades promissoras para o desenvolvimento de novas terapias de 
substituição celular e modelos de doença, funcionando também como ferramentas 
valiosas para o estudo dos mecanismos moleculares que estabelecem a identidade 
celular e regulam os processos de desenvolvimento. 
Existem várias doenças degenerativas hereditárias e adquiridas da retina que causam 
deficiência visual devido a uma disfunção no tecido de suporte da retina, o epitélio 
pigmentar da retina (EPR). Uma destas doenças é a Coroideremia (CHM), uma doença 
hereditária monogénica ligada ao cromossoma X causada por mutações que implicam a 
perda de função duma proteína com funções importantes na regulação do tráfico 
intracelular. A CHM é caracterizada pela degenerescência progressiva do EPR, assim 
como dos foto-receptores e da coróide. Resultados experimentais sugerem que o EPR 
desempenha um papel importante na patogénese da CHM, o que parece indicar uma 
possível vantagem terapêutica na substituição do EPR nos doentes com CHM. Por outro 
lado, existe uma lacuna em termos de modelos in vitro de EPR para estudar a CHM, o 
que pode explicar o ainda desconhecimento dos mecanismos moleculares que explicam 
a patogénese desta doença. Assim, este trabalho focou-se principalmente na 
exploração das potencialidades das técnicas de reprogramação celular no contexto das 
doenças de degenerescência da retina, em particular no caso da CHM. 
Células de murganho de estirpe selvagem, bem como células derivadas de um ratinho 
modelo de knockout condicional de Chm, foram convertidos com sucesso em CEPi 
recorrendo a um sistema lentiviral induzido que permite a expressão forçada dos 4 
factores clássicos de reprogramação, a saber Oct4, Sox2, Klf4 e c-Myc. Estas células 
mostraram ter equivalência morfológica, molecular e funcional a células estaminais 
embrionárias (CES). As CEPi obtidas foram seguidamente submetidas a protocolos de 
diferenciação com o objectivo final de obter células do EPR. Os resultados promissores 
obtidos revelam a possibilidade de gerar um valioso modelo de EPR-CHM para estudos 
in vitro. Em alternativa, a conversão directa de linhagens partindo de fibroblastos para 
obter células do EPR foi também abordada. Uma vasta gama de ferramentas 




seleccionados devido ao seu papel fundamental no desenvolvimento embrionário e 
especificação do EPR. Conjuntos de 10 ou menos FTs foram usados para transduzir 
fibroblastos, que adquiriram morfologia pigmentada e expressão de alguns marcadores 
específicos do EPR. Adicionalmente, observou-se a activação de regiões promotoras de 
genes específicos de EPR, indicando que a identidade transcricional das células foi 
alterada no sentido pretendido. 
Em conclusão, avanços significativos foram atingidos no sentido da implementação de 
tecnologias de reprogramação celular já estabelecidas, bem como na concepção de 
novas estratégias inovadoras. Metodologias de reprogramação, quer para pluripotência, 
quer via conversão directa, foram aplicadas com o objectivo final de gerar células do 
EPR. O trabalho aqui descrito abre novos caminhos para o estabelecimento de terapias 
de substituição celular e, de uma maneira mais directa, levanta a possibilidade de 
modelar doenças degenerativas da retina com disfunção do EPR numa placa de petri, 
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Chapter 1 : Introduction 
Cellular Reprogramming 
Reprogramming concepts 
Multicellular organisms are composed of an assortment of differentiated cells responsible 
for different functions and whose stability is essential for the growth, survival and 
perpetuation of the whole organism. During development, uncommitted stem cells 
differentiate into various tissue-specific cell types, in a process established and 
maintained by a complex interplay of endogenous and exogenous factors. For a long 
time, lineage commitment and differentiation was believed to be unidirectional and 
irreversible, as Conrad Waddington represented in his model in 1957 (Figure 1.1). In this 
classic view of cell fate hierarchy, the undifferentiated cell resides above the different 
committed and differentiated states. Furthermore, it was long thought that along with the 
differentiation process, there was a concomitant loss of chromosomes or permanent 




For instance, in a mammalian organism, the unicellular totipotent zygote lies in the 
beginning of the developmental process given its ability to give rise to all cells of an 
organism, including embryonic and extra-embryonic tissues (such as the placenta). At 
the blastocyst stage of the early embryo, the cells from the inner mass are pluripotent: 
they are able to generate all the cells of the embryo, and so they form each of the three 
Figure 1.1: Waddington’s “epigenetic landscape” model.  
In this model, a cell moving towards terminal differentiation is represented as a marble 
rolling down the landscape that segregates into different grooves on the slope, thereby 




germ layers – endoderm, mesoderm and ectoderm. As differentiation follows, cells 
become progressively more committed to their cell fate and more restricted in terms of 
developmental potency. Cells that are committed to each of the germ layers specialize to 
give rise to the tissues of the adult body, which still contains multipotent and unipotent 
cells. The former retain the ability to differentiate into multiple cell types within the same 
lineage (such as hematopoietic stem cells and neural stem cells), whilst the later only 
have the capacity to differentiate into one type of cell as spermatogonial stem cells 
(Jaenisch and Young, 2008). 
Contrarily to this unidirectional developmental process, studies suggesting cellular 
plasticity in the animal kingdom go back to 1895 when Wolff reported that, after surgical 
removal of lens from the adult eye of newts, a structurally and functionally complete lens 
regenerated from the dorsal, pigmented epithelial cells (Wolff, 1895). This example 
constituted the first experimental evidence of in vivo adult cellular reprogramming (or 
transdifferentiation). Cellular reprogramming (or nuclear reprogramming) refers to the 
concept of “rewiring the epigenetic and transcriptional network of one cell state to that of 
a different cell type” (Hanna et al., 2008). Three different experimental approaches have 
definitively confirmed that, although the differentiated state of a cell is generally stable, 
cellular identity is dynamically controlled and subjected to perturbations in the 
stoichiometry of the transcriptional and epigenetic regulators present in the cell in any 
given time. Nuclear transfer, cell fusion and transcription factor (TF)-transduction have 
provided means to induce in vitro reprogramming of defined and specialized cells either 
into a different somatic cell type (lineage conversion) or into an embryonic pluripotent 
state (Figure 1.2) (Yamanaka and Blau, 2010). On 2012, the Nobel Prize in Physiology 
or Medicine was jointly attributed to John B. Gurdon and Shinya Yamanaka “for the 
discovery that mature cells can be reprogrammed to become pluripotent”. 
 
1. Nuclear transfer 
Gurdon efficiently transferred nuclei from highly specialized tadpole intestinal cells 
into irradiated oocytes, obtaining normal adult frogs. Despite it was a low frequency 
event, Gurdon interpreted his results as evidence supporting that the process of 
cell specialization did not require irreversible nuclear changes with permanent 
gene loss or silencing (Gurdon, 1962). Contrarily, when a nucleus from a 
differentiated somatic cell is transplanted into an enucleated oocyte, cellular 
reprogramming is initiated, giving rise to the generation of an entire adult organism, 




somatic-cell nuclear transfer (SCNT), or cloning, provided definite evidence that 
cell specialization involves changes in gene expression rather than gene content. 
Thus, it is a reversible process, once genes that are required to create an entire 
organism are still present in the nucleus of the specialized cell (despite silenced) 





The first successfully cloned mammal was Dolly the sheep by Wilmut and 
colleagues, mice followed as a wide range of different species. Relevantly, the 
hypothesis that the reprogramming was only due to contaminating cells was put to 
rest when a mouse clone was produced from the nuclei of B cells in which the 
immunoglobulin had been rearranged (Hochedlinger and Jaenisch, 2002; 
Wakayama et al., 1998; Wilmut et al., 1997). Instrumental contributes to allow 
Figure 1.2: Experimental approaches for cellular reprogramming to pluripotency.  
In the first approach (top schematic), the nucleus of a somatic cell (diploid) is transplanted 
into an enucleated oocyte. The somatic cell nucleus now integrated in the environment of 
the occyte is reprogrammed into a pluripotent state. From this oocyte, a blastocyst is 
generated and, if development is allowed to occur until completion, an entire cloned 
organism is generated (reproductive cloning). By cell fusion (middle schematic), two distinct 
cell types are combined to form a single entity. The resultant fused cell can become a 
heterokaryon where the nuclei from the original cells are maintained and the genotype of 
one cell influences the other. Alternatively, if the fused cells proliferate, on cell division the 
nuclei fuse given rise to hybrids. The third approach (bottom panel), transduction of somatic 
cells with pluripotency TFs, can be used to generate induced Pluripotent Stem cells (iPSC), 





reprogramming of somatic cell into pluripotency was the derivation and stable 
maintenance of pluripotent cell lines in vitro, specifically the derivation of embryonic 
stem (ES) cells from the blastocyst inner cell mass (Evans and Kaufman, 1981). 
The efficiency of generating cloned mice is usually low (1-2%), but increases 
substantially (20%) when the cell source for nuclei is nuclear-transfer-derived ES 
cells suggesting that the process of nuclear reprogramming is enhanced by a 
passage through an ES cell state (Hochedlinger and Jaenisch, 2002). Additionally, 
developmental defects in cloned animals are common and believed to stem from 
incomplete erasure of “epigenetic memory”, meaning that epigenetic factors, such 
as regulators of DNA methylation, histone modifications and replacements and 
ATP-dependent chromatin remodelers, have not been completely reprogrammed 
into a pluripotent state (Simonsson and Gurdon, 2004). Recently, optimized 
nuclear transfer approach, designed to circumvent early embryonic arrest on prior 
attempts, allowed the derivation of human nuclear-transfer-derived ES cells 
(Tachibana et al., 2013). 
 
2. Cell fusion 
Cell fusion involves fusing two or more cell types to form a single entity, which can 
result in heterokaryons (that do not proliferate and thus contain more than one 
nucleus) or in hybrids (that proliferate, with fusion of the nuclei of the original cell 
occurring due to cell division). In the 1960s, the existence of trans-acting 
repressors acting on DNA to regulate gene expression was uncovered by cell 
fusion experiments of a fibroblast with a melanocyte given rise to a hybrid with no 
melanin synthesis (Davidson et al., 1966). Moreover, in 1983, heterokaryons of 
mouse muscle cells and human amniotic cells have been shown to express human 
muscle proteins (such as human myosin light chains 1 and 2) indicating that 
previously silenced genes were activated (Blau et al., 1983). Equivalent 
experiments for other cell types were rapidly performed, with the relative ratio of 
the nuclei, or the gene dosage, of the two cell types dictating the outcome of the 
reprogramming, and therefore confirming that the differentiated state was 
continuously controlled by the balance of regulators present at any given time 
(Yamanaka and Blau, 2010). 
Fusion experiments involving pluripotent cells were also performed and Tada and 
colleagues showed that thymocytes could acquire a pluripotent state after fusion 




mouse Oct4 (Tada et al., 2001). Fusion-based nuclear reprogramming was also 
shown to be strongly enhanced (up to 200-fold) after overexpression of the 
pluripotency TF Nanog (Silva et al., 2006). Moreover, experiments with 
heterokaryons are well suited for elucidating the molecular mechanisms required 
for the initiation of reprogramming into a pluripotent state, given their rapid rate of 
reprogramming. Loss-of-function and gain-of-function approaches have allowed to 
uncover essential molecular players, namely Oct4 and enzymes responsible for 
DNA demethylation (Bhutani et al., 2010; Pereira et al., 2008). 
 
3. Trancription factor transduction 
In the previously described molecularly undefined reprogramming methods, a 
milieu of components or elements (e.g., transcription factors, histone-modifying 
and chromatin-remodelling enzymes, and DNA demethylases) that are largely 
unknown contribute to achieve cellular reprogramming. Conversely, direct 
reprogramming methods use defined genetic or nongenetic elements to induce 
rewiring of the cell state (Hanna et al., 2008). Overexpression of a single tissue-
specific TF in somatic cells was surprisingly able to activate genes typical of other 
somatic cell types and alter the cell fate. First report was by Gehring and co-
workers using Drosophila melanogaster in 1987, followed by another work showing 
that ectopic expression of eyeless (Pax6 in mice), a master regulator of eye 
morphogenesis, lead to induction of ectopic eye structures on the wings, the legs 
and the antennae (Halder et al., 1995; Schneuwly et al., 1987). Davis and 
colleagues have demonstrated reprogramming of mouse fibroblasts into myoblast-
like cells upon ectopic expression of the MyoD transcription factor (Davis et al., 
1987). More recent work has shown that overexpression of  a myeloid transcription 
factor CCAAT/ enhancer-binding protein α (C/EBPα) promotes conversion of 
lineage-committed B and T cells into macrophage-like cells (Xie et al., 2004). 
More surprisingly, Takahashi and Yamanaka reported in 2006 that forced 
expression of a combination of only 4 TF-encoding genes could generate ES cell-
like pluripotent cells from mouse fibroblasts (Takahashi and Yamanaka, 2006). The 
authors first selected 24 genes expressed by ES cells as candidates for factors 
that would induce pluripotency in somatic cells. Retroviral-mediated transduction of 
mouse fibroblasts with the 24 genes followed by drug selection for reactivation of 
the Fbx15 gene was used to test their ability to induce pluripotency. Fbx15 gene is 




expression of neomycin resistance cassette was used. Drug-resistant clones were 
isolated and demonstrated morphology, proliferation and gene expression similar 
to ES cells. To confirm pluripotency, cells were injected into immunodeficient mice, 
forming teratomas, tumours including all three germ layers, endoderm, mesoderm 
and ectoderm. To further determine which of the 24 candidates were critical for the 
reprogramming process, the effect of withdrawal of individual factors from the pool 
of transduced candidate genes on the formation of drug-resistant colonies was 
assessed. Four TFs were identified as being essential for the reprogramming of 
fibroblasts into pluripotent cells, Oct4, Sox2, Klf4 and c-Myc, and resulting cells 
were named induced Pluripotent Stem cells (iPS cells). After Yamanaka’s 
seminal discovery, a panoply of subsequent works followed, demonstrating 
optimized ways of generating iPS cells or providing mechanistic insights of the 
reprogramming process. Importantly, human iPS cells were generated and proof-
of-principle experiments demonstrated its therapeutic potential, as such cells can 
be used as a cell source for tissue repair or replacement while avoiding ethical and 
immunological concerns associated with the use of ES cells (Takahashi et al., 
2007a; Yu et al., 2007). Besides patient-specific, disease-specific pluripotent cell 
lines derived from human patients with specific diseases were obtained, 
constituting invaluable tools and an unlimited source for biological material that can 
be used to study these complex diseases in the Petri dish (Park et al., 2008; Raya 
et al., 2009). 
Furthermore, the unexpected finding that somatic cells can revert all the way back 
to the embryonic state by a handful of transcription factors soon inspired the 
discovery of TF-mediated conversion of pancreatic exocrine cells to β cells and 
fibroblasts into other cell lineages, namely neurons, hepatocytes, and 
cardiomyocytes (Huang et al., 2011; Ieda et al., 2010; Vierbuchen et al., 2010; 
Zhou et al., 2008). Both TF-mediated approaches to directly reprogram somatic 
cells into pluripotency or into another cell type, and their applications, will be 





All the three mentioned approaches to cellular reprogramming display common 
features, such that in each case if the balance of regulators is tilted to favour 
pluripotency (or other somatic cell fate), the epigenome is altered and the 
expression of pluripotency/cell-specific factors that otherwise would be silenced in 
a stably differentiated cells. In order to maintain the new phenotypic identity of the 
reprogrammed cell, there must be activation of feedback and auto-regulatory 
mechanisms to attain critical threshold levels of endogenous cell-specific 
transcriptional regulators. Nevertheless, when comparing the 3 approaches, there 
are differences in terms of technical feasibility, time required for reprogramming, 
efficiency of the process, cell yield and probably also in the underlying molecular 
mechanism. In terms of cell yield, TF-transduction provides the abundant and 
easily reproducible across the world generation of iPS cells, which concurs to their 
advantageous prospective use in therapeutic settings, as well as usefulness for 
disease-modelling and drug testing (Hanna et al., 2008; Yamanaka and Blau, 
2010). Additionally, the advent of these technological breakthroughs has put to 
argue the paradigm of unidirectional development. A non-hierarchical “epigenetic 
disc” model to explain interconversion of somatic and pluripotent cell fates has 
been recently proposed as an alternative to Waddington’s classical view (Ladewig 
et al., 2013). 
 
Somatic to pluripotent TF-mediated reprogramming 
Pluripotent stem cell lines can be obtained through the reprogramming of somatic cells, 
by ectopic expression of defined factors known to be important for the maintenance 
pluripotent stem cells identity. Generated iPS cell lines are characterized and compared 
with their biological counterparts (ES cells) in order to assess reprogramming efficiency 
and fidelity. Moreover, several studies of the molecular basis, both genetic or epigenetic, 
of these natural and induced pluripotent states, as well as investigations into how 
pluripotency is maintained and the mechanisms of lineage commitment have provided 
insights for improving the understanding of mammalian embryogenesis and cellular 
differentiation, but also for developing successful stem cell-based therapies for 
regenerative medicine. 
 
Pluripotency regulation: transcriptional network and signalling pathways 
Pluripotent stem cells have two remarkable properties: immortality, or the faculty of 




the adult body. ES cells were first isolated from the inner cell mass (ICM) of pre-
implantation mouse blastocyst embryos at embryonic day 3.5 (E3.5). Mouse ES 
cells are rapidly proliferating cells that form tight, dome-shaped colonies (Evans 
and Kaufman, 1981). To maintain their self-renewal capacity in an undifferentiated 
state, they require the growth factors leukaemia inhibitory factor (LIF) and bone 
morphogenetic protein 4 (BMP4) in mouse embryonic fibroblast (MEF)- and serum-
free conditions, respectively (Figure 1.3) (Williams et al., 1988a; Ying et al., 2003). 
The pluripotent cells in the pre-implantation embryo are considered naïve because 
they have unbiased developmental potential and can give rise to germline-
competent chimeras when reintroduced into a blastocyst.  Contrarily, another stem 
cell population derived from post-implantation embryo, epiblast stem (EpiS) cells, 
exhibits a “primed” state of pluripotency (Nichols and Smith, 2009; Tesar et al., 
2007). Human ES cells are derived from human blastocysts but, in contrast to 
murine ES cells, form flat 2D colonies dependent on basic fibroblast growth factor 
(bFGF) and activin/transforming grothw factor-β (TGFβ) signalling (Figure 1.3) 
(Thomson et al., 1998). Human ES cells share several molecular features with 
naïve mouse ES cells but they also share a variety of epigenetic properties with 
primed murine EpiS cells, displaying a “primed” pluripotency. Very recently 
however, derivation conditions for the establishment of human naïve pluripotent 
cells was also reported (Gafni et al., 2013). 
There is a core regulatory circuitry composed of a set of TF that functions to 
maintain the pluripotent state in pluripotent stem cells, natural or induced and in 
humans and mice. OCT4 (also known as POU5F1), NANOG and SOX2 function 
together to positively regulate their own promoters, forming an interconnected 
autoregulatory loop. Additionally, they co-occupy promoter regions of genes that 
are involved in pluripotency maintenance (keeping them in an active state) and 
early lineage differentiation (repressing them) (Figure 1.3) (Masui et al., 2007; Silva 
and Smith, 2008; Young, 2011).  
POU family TF Oct4 was found to be required for the formation of the naïve 
epiblast, from which pluripotent cells emerge during pre-implantation. In Oct4-null 
embryos, the inner cell mass lacks pluripotent characteristics. In addition, Oct4 is 
also critical for maintaining mouse ES cells since abrogation of Oct4 expression 
leads to their differentiation along the trophoblast lineage (Nichols et al., 1998; 






Figure 1.3: Pluripotency maintenance circuitry in mouse and human ES cells.  
In both cell types, Nanog, Oct4, and Sox2 form a positive autoregulatory loop that regulates 
self-renewal and pluripotency. (A) Mouse ES cells require LIF and BMP4 for maintenance. 
LIF promotes self-renewal by activating the Janus kinase/signal transducers and activators 
of transcription (JAK/STAT3) and phosphatidylinositol 3' –kinase (PI3K)/AKT signalling 
pathways. There’s an upregulation of Klf4 and Tbx3, which then activate Sox2 and Nanog, 
respectively. BMP4 upregulates transcription of inhibitor of differentiation (Id) genes 
through activation of SMAD (Small Body Size / Mothers Against Decapentaplegic) proteins 
1, 5, and 8. (B) Human ES cells and mouse EpiS cells require insulin-like growth factor 
IGF/insulin and bFGF for maintenance. bFGF activates the mitogen-activated protein 
kinase (MAPK) as well as the Activin/Nodal signalling pathways, and IGF activates the Ras 
and PI3K pathways. MEFs are also stimulated by bFGF in culture to secrete IGF (dashed 
arrows). SMADs 2 and 3 propagate Activin/Nodal signalling as well as directly bind and 




Sox2, a SRY-related TF containing the high-mobility group-box DNA-binding 
domain, has also been shown to possess a loss-of-function phenotype similar to 
that of Oct4 in both embryos and ES cells.  Ectopic expression of wild-type levels 
of Oct4 can rescue the Sox2-null phenotype in ES cells, which, in addition to the 
similarity of phenotypes, suggests a synergistic action of the two TFs in regulating 
the expression of themselves and other ES cells-specific genes (Avilion et al., 
2003; Masui et al., 2007). 
 Nanog is a homeodomain protein that was discovered in a screen for self-renewal 
factors that could sustain mouse ES cells in the absence of LIF signalling. Nanog is 
critical for mammalian development and is required for specification of the ICM in 
the pre-implantation embryo. Although ES cells can be propagated in the absence 
of Nanog, it promotes a stable undifferentiated ES cell state. Overexpression of 
Nanog leads to enhanced self-renewal of ES cells, illustrating a positive effect on 
the pluripotent network (Chambers et al., 2007; Saunders et al., 2013). 
The interconnected regulatory loop of Oct4, Sox2 and Nanog promotes a bistable 
state for ES cells: residence in a positive-feedback-controlled gene expression 
program when the factors are expressed at appropriate levels, versus entrance into 
a differentiation program when any one of the master transcription factors is no 
longer functionally available. The core TFs collaboratively activate a substantial 
fraction of the actively transcribed protein-coding and microRNAs (miRNAs) genes 
in ES cells. A large proportion of these actively transcribed genes are bound and 
regulated by both the core transcription factors and also c-Myc, which plays 
important roles in ES cells proliferation and self-renewal. While Oct4, Sox2, and 
Nanog core regulators are involved in RNA polymerase II recruitment, c-Myc is 
believed to stimulate the transcriptional pause release of RNA polymerase II. 
Consequently, Oct4/Sox2/Nanog apparently play dominant roles in selecting the 
set of ES cell genes that will be actively transcribed and recruiting RNA 
polymerase II to these genes, while c-Myc regulates the efficiency with which these 
selected genes are fully transcribed (Rahl et al., 2010; Young, 2011). 
Simultaneously, the core regulators repress the expression of a wide spectrum of 
cell-lineage-specific regulatory genes, through a process mediated by SetDB1 and 
Polycomb group (PcG) chromatin regulators. Once their repressive signal is lost, a 
rapid induction of expression occurs indicating that these genes are poised for 
activation. Interestingly, the chromatin conformation associated with many of these 
key developmental genes is composed of ‘bivalent domains’ consisting of both 




4 methylation marks. These bivalent domains are lost in differentiated cells. Thus, 
the core regulatory circuitry, and additional collaborative regulators of gene 
expression, are responsible for maintaining ES cells in a stable pluripotent state 
whilst remaining poised to differentiation (Bernstein et al., 2006). 
In addition to Oct4, Sox2, Nanog, and c-Myc, the transcription factors Tcf3, Smad1, 
Stat3, Esrrb, Sall4, Tbx3, Zfx, Ronin, Klf2, Klf4, Klf5, and PRDM14 have been 
shown to play important roles in control of ES cell state. Transcriptional regulation 
of pluripotency state is also dependent on cofactors, protein complexes that 
contribute to activation (coactivators) and repression (corepressors) of expression 
but do not have DNA-binding properties of their own. Chromatin regulators, such 
as cohesin/condensin protein complexes, histone-modifying enzymes, ATP-
dependent chromatin-remodeling complexes and DNA methyltransferases, also 
play a role in maintaining the ES cell viability and stability. A variety of non-coding 
RNA species have also been implicated in control of ES cell state, including 
miRNAs, which can regulate the stability and translatability of mRNAs, and longer 
non-coding RNAs, which have been implicated in recruitment of chromatin 
regulators (Yeo and Ng, 2013; Young, 2011). 
As mentioned earlier, signal transduction pathways are involved in cells’ 
response to their surrounding cellular and biochemical environment. For ES cells, 
maintenance of the pluripotent state is dependent on the absence or inhibition of 
signals that stimulate differentiation. Traditionally, mouse ES cells were cultured 
and kept pluripotent on a layer of mitotically inactivated feeder cells in serum-
supplemented media. The combinatorial use of LIF and BMP4 allowed the 
establishment of a defined feeder- and serum-free culture sufficient to derive and 
maintain germ-line transmittable mouse ES cells. LIF and BMP4 induce 
phosphorylation and activation of their downstream TFs Stat3 and Smad1, 
respectively, which in turn co-bind at Oct4, Sox2 and Nanog  regions and thus 
sustain the core ES cell transcriptional network (Niwa et al., 1998; Pera and Tam, 
2010; Ying et al., 2003). 
FGF - MEK (mitogen activated protein kinase) - ERK (extracellular signal regulated 
kinases 1 and 2) signalling has a pro-differentiation effect. Explicitly, stimulation of 
mouse ES cells by Fgf4, working through the Mek/Erk signalling pathway, is known 
to induce mouse ES cells to exit self-renewal and initiate differentiation (Kunath et 
al., 2007). Additionally, mouse ES cells are also responsive to Wnt/β-catenin 
signalling, which contributes to maintenance of pluripotency. Active canonical Wnt-




Tcf3, the most abundantly expressed member of TCF/LEF family of TFs in mouse 
ES cells. This nuclear effector of Wnt/β-catenin signalling, Tcf3, is bound to the 
same regulatory regions as Oct4 and Nanog, and has been known to negatively 
balance their effects in the maintenance of the pluripotent state (Wray et al., 2011). 
Recently, β-catenin was also shown to contribute to pluripotency acting through an 
Oct4 complex, on a transcriptional-independent manner (Faunes et al., 2013). 
Hallmarks of naïve pluripotency include driving Oct4 transcription by its distal 
enhancer, retaining a pre-inactivation X chromosome state, and global reduction in 
DNA methylation and in H3K27me3 repressive chromatin mark deposition on 
developmental regulatory gene promoters. In recent years a combination of small-
molecule inhibitors has been identified that greatly facilitates murine ES cells 
derivation and maintenance in a naïve pluripotent state. This so-called 2i inhibitor 
cocktail consists of a MEK/ERK inhibitor (PD0325901) and a GSK3 inhibitor 
(CHIR99021). 2i culture conditions promotes the achievement of a “ground state” 
pluripotency by blocking the pro-differentiation effect of the FGF–MEK–ERK 
signalling pathway and simultaneously inhibiting glycogen synthase kinase GSK3b, 
thereby promoting the self-renewal positive effect of Wnt/β-catenin signalling. 
Moreover, factors associated with lineage-specification are repressed under 2i 
culture conditions, at an epigenetic level. A more homogeneous expression of key 
pluripotency regulators is also induced in 2i culture conditions. Particularly, biallelic 
expression of the key pluripotency regulator Nanog is achieved (whilst in serum 
conditions Nanog is only expressed by one allele), which has been shown to be 
important for the survival of the peri-implantation inner cell mass (Marks et al., 
2012; Miyanari and Torres-Padilla, 2012; Silva et al., 2008; Ying et al., 2008). 
 
Mechanistic insights into the reprogramming process 
The precise molecular mechanisms that underlie the reprogramming of 
differentiated cells to iPS cells remain largely unknown. However, systematic 
studies addressing this issue have been demonstrating that the cells transit 
through distinct intermediate states, which can be simplified in two major phases, 







Figure 1.4: Selected molecular events occurring during reprogramming.  
(A) The reprogramming process involves intermediate cell states, defining two general 
phases. In the first, removal of exogenous factors results in reversion into the differentiated 
state. During this transgene-dependent phase, a set of morphological alterations is 
observed, with early reprogramming cells rapidly dividing and beginning to form clusters. 
Following this expansion, apoptosis is observed and eventually cells will form tight colonies 
of fully-reprogrammed cells. At this point, a transgene-independent state is achieved with 
the withdrawn of reprogramming factors no longer preventing the final transition to 
pluripotency. (B) Concomitantly, alterations in gene expression are observed along the 
process. First, there is an upregulation of proliferative genes followed by a mesenchymal-
to-epithelial (MET) transition seen at an intermediate state. Silencing of the somatic 
program occurs, whilst the permanent reactivation of the core pluripotency network is 
observed later on the process. (C) Reprogramming factors (OSKM) initially bind to 
accessible chromatin locations, as defined by the epigenetic status of the somatic cell. A 
general loss of repressive histone and DNA modifications is observed. DNA demethylation 
is a crucial barrier for reprogramming and, once overcome, fully reprogrammed cells are 
obtained. X- chromosome reactivation and telomere elongation are also observed. Adapted 




Reprogramming process is initiated by the forced expression of traditional OSKM 
factors. However, in the nucleus, the majority of DNA is packed into nucleosomes, 
occluded by higher order chromatin structure and repressors. Cell proliferation may 
facilitate reprogramming by allowing TF access to otherwise occluded cis-
regulatory regions through nucleosome displacement during DNA replication. In 
the absence of cell division, several models have been proposed to account for the 
access of transcription factors to their relevant binding sites, including the ‘pioneer’ 
TF model. Contrarily to other factors, pioneer factors can access their target sites 
in repressed regions of the genome, through inducing local chromatin opening, 
nucleosome repositioning, and recruitment of chromatin modifiers and co-
regulators. OCT4, SOX2 and KLF4 might act as pioneer factors, facilitated by C-
MYC proliferative action. This initiation is then followed by feed-forward induction of 
additional TFs to execute the reprogramming process (Soufi et al., 2012; Taberlay 
et al., 2011; Vierbuchen and Wernig, 2012). 
In the early stages of reprogramming, gene expression is stochastic with resulting 
differential expression of genes involved in cell-division cycle, DNA replication and 
a process called the mesenchymal-to-epithelial (MET) transition, which also occurs 
during normal development (Li et al., 2010a). In parallel, some cells show reduction 
in the expression of genes associated with cell–cell interaction and cell adhesion, 
and of markers that are typical of the initial differentiated-cell population. MET is 
one of the earliest observable events occurring during fibroblast reprogramming, 
with elongated cells become rounded and aggregated in small clusters. This 
transition correlates with alkaline phosphatase (AP) positivity and stage-specific 
embryonic antigen-1 (SSEA-1) upregulation. There is also an up-regulation of 
epithelial junction components and involvement of the TGFβ signalling pathway. In 
terms of epigenetic modification, histone modifications and structural changes that 
are associated with a more open chromatin conformation are also observed during 
the early phase of reprogramming (Buganim et al., 2012; Polo et al., 2012). 
A progressive increase in the expression of early - albeit not definitive - markers of 
pluripotency is observed. At this point, reprogramming-refractory and 
reprogramming-competent cells coexist, expressing different levels of the 
reprogramming factors and giving rise to heterogeneous cell populations. A second 
“wave” of molecular events follows, with cells hierarchically increasing the 
expression of genes that are involved in the establishment and maintenance of 
pluripotency. DNA demethylation has been proposed to be a crucial barrier for 




locking the defined pluripotent state (Buganim et al., 2012; Cantone and Fisher, 
2013; Polo et al., 2012).  
Oct4 has an established importance in the reprogramming process since it can be 
used alone to obtain iPS cells. Mechanistically, experimental evidence suggests 
that Oct4 participates in the induction of the MET and in the derepression of 
somatic cell chromatin. In addition, Oct4 in cooperation with Sox2 was proposed to 
prevent the acquisition of alternative cell states during reprogramming. 
Furthermore, Oct4 dose and cellular localisation were proposed as important 
parameters of successful reprogramming: an ES cell level of Oct4 must be attained 
at the late stages of reprogramming for cells to enter the pluripotent cell state 
(reviewed by (Radzisheuskaya and Silva, 2013). 
 
Technological overview of reprogramming into pluripotency 
At first, Yamanaka reported the generation of iPS cells through forced expression 
of a set of core pluripotency-related TF (OCT4, SOX2, KLF4 and c-MYC – or 
abbreviated as OSKM) in fibroblasts (Takahashi and Yamanaka, 2006). After TF 
transduction, tightly compacted colonies appeared on the culture dish, which 
resembled ES cells morphologically, molecularly and phenotypically (Okita et al., 
2007). Several protocols for iPS cells generation have been developed in the 
following years. They use, for example, different mouse and human donor 
populations or vary the number, identity and delivery mode of the reprogramming 
factors (Aasen et al., 2008; Aoi et al., 2008; Carey et al., 2009; Kim et al., 2009; 
Nakagawa et al., 2008; Okita et al., 2008; Takahashi et al., 2007a). The multitude 
of the different approaches undertaken over the past few years will not be 
exhaustively mentioned here, but was recently reviewed by (Bayart and Cohen-
Haguenauer, 2013; González et al., 2011). 
Direct reprogramming into pluripotency is conceptually and technically simple. 
Nonetheless it is still an extremely slow and inefficient process influenced by 
several variables that affect its efficiency, reproducibility and the quality of the 
resulting iPS cells. Several parameters must be considered prior to the generation 
of iPS cells, namely the cell type to be reprogrammed, the reprogramming factors 







Different efficiencies and kinetics have been observed depending on the starting 
cell. The reprogramming process requires the delivery of certain factors into a 
specific cell and their adequate expression for a proper period of time, usually 
smaller for mouse than for human cells. Fibroblasts are still the most widely used 
Figure 1.5: Parameters to consider before each reprogramming experiment.  
Any reprogramming experiment is determined by a number of preliminary choices 
regarding the donor cell type to reprogram, the factors to use and the mode of their 
delivery. The choice of the initial cell type depends not only on its availability but also the 
ease of reproducing the reprogramming process. The TFs important for embryonic 
development must be overexpressed, alone or in conjunction with other positive or negative 
regulators of cell cycle, epigenetic markers or signalling pathways. Forced expression of 
the reprogramming factors can be achieved through several available delivery modes with 
variable efficiency and safety. CHD1, chromodomain-helicase-DNA-binding protein 1; 
DNMT1, DNA methyltransferase 1; DPPA4, developmental pluripotency associated 4; E-
cadherin, epithelial cadherin; ERK, extracellular signal-regulated kinase; MAPK, mitogen-
activated protein kinase; MMLV, Moloney murine leukaemia virus; PRC2, Polycomb 
repressive complex 2; SV40LT, SV40 large T antigen; TERT, telomerase reverse 




cells, however reprogramming efficiency may be higher in different cellular 
populations, such as keratinocytes (with the further advantage of their ease to 
obtain from human donors) (Aasen et al., 2008). Moreover, in some certain 
populations, the reprogramming efficiency is higher or the requirement for factors is 
smaller given the high levels of endogenous expression of reprogramming TFs. For 
instance, neural progenitor cells, which express SOX2 endogenously, are 
reprogrammed in the absence of exogenous SOX2 or with OCT4 alone (Kim et al., 
2009). The differentiation status of the donor cell has also shown to influence both 
the efficiency of the process and the quality of the generated cells. 
The factors that induce reprogramming are genes that are normally expressed 
early during development and are involved in the maintenance of the pluripotency 
of cells from the inner cell mass of the pre-implantation embryo. Core regulatory 
TFs Oct4, Sox2 and Nanog are usually included in reprogramming cocktails, such 
as OSKM and also early-described alternative cocktail of Oct4, Sox2, Nanog and 
Lin28 (Yu et al., 2007). Other TFs expressed by ES cells, such as SALL4 and 
UTF1, have been shown to positively affect reprogramming efficiency or kinetics. 
Influence of cell-cycle regulators on reprogramming has also been highlighted once 
some factors such as MYC and KLF4, which directly or indirectly affect cell 
proliferation, have been shown to increase reprogramming efficiency. Contrarily, 
some factors inhibit reprogramming barriers, such as senescence and apoptosis, 
and allow an increase in both the speed and efficiency of reprogramming (for 
instance inhibition of p53) (González et al., 2011; Kawamura et al., 2009). 
Besides improvements in the cocktail of TFs, modulation of the reprogramming 
process has also been achieved by small-molecule compounds, which specifically 
target kinase signalling pathways or epigenetic regulators. MEK and GSK3 
inhibitors used in 2i culture conditions, when in combination with LIF, stabilize iPS 
cells while inhibiting growth of non-pluripotent cells, and promote the conversion of 
pre-iPS cells into “ground-state” pluripotency. TGFβ inhibitors (such as ALK4, 5 
and 7) have also been used. In conjunction with OSK cocktail, these inhibitors 
were responsible for the activation of Nanog in partially reprogrammed cells to 
facilitate transition to fully-reprogrammed iPS cells. Moreover, they also inhibit pro-
EMT signals (Maherali and Hochedlinger, 2009; Silva et al., 2008). Targeting the 
epigenome has also been shown to benefit the reprogramming process and small 
molecules that function as DNA methylation inhibitors (azacytidine), histone 
deacetylase inhibitors (valproic acid) and lysine methyltransferase inhibitors have 




exclusively been used in combination with the exogenous TFs, until very recently. 
Hou and colleagues reported the generation of pluripotent stem cells from mouse 
somatic cells at a frequency up to 0.2% using a combination of seven small-
molecule compounds, bypassing the need of TFs (Hou et al., 2013). 
Additionally, while most factors used as reprogramming transgenes can be 
replaced by other means, Oct4 has remained essential until very recently. Shu and 
colleagues and Montserrat and co-workers reported that mouse and human cells 
could be reprogrammed into iPS cells using nuclear factors that control lineage 
specification and are not considered to be core factors of pluripotent stem cells. A 
‘‘seesaw’’ model was proposed placing in the centre of the reprogramming process 
the balance between counteracting differentiation cues. Accordingly, lineage 
specifiers facilitate reprogramming when they are balanced with other mutually 
exclusive lineage specifier: Gata3, as well as other mesendodermal specifiers, can 
replace Oct4, presumably by counteracting the upregulation of ectodermal genes 
induced by Sox2; Gmnn, an ectodermal specifier, can replace Sox2 in 
reprogramming, as it attenuates the elevation of mesendodermal genes induced by 
Oct4. With simultaneous replacement of Oct4 and Sox2 by the mesendodermal 
and ectodermal specificiers, respectively, the opposing differentiation potentials are 
balanced and pluripotency state is achieved (Montserrat et al., 2013; Shu et al., 
2013). 
Finally, reprogramming methods can be divided in two classes: integrative and 
non-integrative. The former involves the integration of the exogenous factors in the 
host genome whilst the latter is characterized by the absence of genome 
alterations on the initial cells. Additionally, delivery methods can also be classified 
in viral and non-viral vectors. Included on the integrative category, retroviral and 
lentiviral vectors have been used since the early experiments and still provide the 
higher efficiency of reprogramming. Comparing with retroviral-based strategies, 
lentiviral vectors have the advantage of transducing both dividing and non-dividing 
cells. Additionally, the use of inducible promoters has allowed expression of the 
reprogramming factors in a controllable manner. However, concerns have been 
raised given the probability of random transgene integration in the genome which 
could affect the expression of nearby tumour-suppressor genes or oncogenes. 
Even if properly silenced after the reprogramming process, viral transgenes can 
eventually be reactivated during differentiation or during the life of iPS cell-derived 
cells on transplanted animals, leading to tumours. Potential of damage was 




from the same promoter (Carey et al., 2009; Maherali and Hochedlinger, 2008). 
Integration-free viral methods have also been tried, using adenoviral vectors; 
however the efficiency of iPS cell generation using this system in the mouse 
ranges between 0.0001% and 0.0018%, which is approximately three orders of 
magnitude lower than that for retroviruses (Stadtfeld et al., 2008). Viral methods 







Table 1.1: Viral delivery methods of reprogramming factors.  
The main viral delivery methods are summarized, with their advantages and caveats shown 
below. For each of the methods, details for the design of the vector is shown at the top, 
followed by the status of the cell after initial delivery of the vector, then the status of the 
vector in reprogrammed cells (iPS cells). Finally, the status of the transgenes after the 
differentiation of the pluripotent cell is also highlighted. DOX, doxycyclin;  MLV, Moloney 




Alternates to viral delivery systems, non-viral approaches have been attempted 
based on standard DNA transfection using liposomes or electroporation. A 
polycistronic plasmid, in which the OSKM transgene is flanked by loxP sites, and 
thus can be deleted by transient expression of Cre recombinase was developed 
(Kaji et al., 2009). PiggyBac transposon system was also tested, which includes a 
donor plasmid containing the transposon (containing the sequence of interest 
flanked by the 5′ and 3′ terminal repeats required for transposition), co-transfected 
with a helper plasmid expressing the transposase. PBs are, in theory, precisely 
deleted without modifying the sequence of the integration site upon remobilization 
by the transposase, contrarily to Cre-excisable linear transgenes which leave a 
genomic scar (Kaji et al., 2009; Woltjen et al., 2009). Non-integrative approaches 
were also established, taking advantage of non-replicating or replicating episomal 
vectors, the latter being maintained through cell division and possibly being 
removed by culturing the cells in the absence of drug selection (Yu et al., 2009). 
Alternatively, minicircle vectors allow the expression of the reprogramming factors 
as non-integrating, non-replicating episomes, but with higher transfection efficiency 
and longer ectopic expression of the transgene (Jia et al., 2010). In order to 
completely eliminate plasmid or viral vectors, reprogramming of somatic cells into 
pluripotency was also achieved by delivery of synthetic modified mRNAs or 
recombinant proteins. In the first case, the efficiency reached was much higher 
than that achieved with other non-integrative systems, with 2% of neonatal 
fibroblasts being converted into iPS cells in just 17 days (Warren et al., 2010). 
Protein-based strategies, although very promising, are difficult to use routinely due 
to the difficulties in purifying the recombinant protein. Moreover, this approach 
show extremely slow kinetics and poor efficiency (Zhou et al., 2009). Non-viral 









Table 1.2: Non-viral delivery methods of reprogramming factors.  
The main non-viral delivery methods are summarized, with their advantages and caveats 
shown below. DNA-based delivery methods include those that do or do not involve 
integration into the genome. For each of the methods, the status of the cell after initial 
delivery of the vector is shown, followed by the status of the vector in reprogrammed cells 
(iPS cells) and finally the status of the cells after differentiation — in each case the cells 
should be transgene-free. PB, piggyBac; oriP/EBNA1, oriP/Epstein–Barr nuclear antigen-1-




Regardless of the initial cell type, reprogramming factors and delivery mode 
implemented, obtained iPS cell lines must be thoroughly characterized and an array of 
criteria must be attained to confirm the fidelity and efficiency of the reprogramming 
process. Fully reprogrammed iPS cells must demonstrate morphological, molecular and 
functional equivalence with their biological counterparts, ES cells. Morphologically, iPS 
cells must appear identical to ES cells and display unlimited self-renewal. At a molecular 
level, genuine iPS cells must be independent of transgene expression and thus lack 
expression of the delivered factors. Additionally, gene expression profiles of iPS cells 
must be indistinguishable of ES cells, particularly in terms of endogenous expression of 
key pluripotency factors and ES cell-specific surface antigens. Finally, iPS cells must 
demonstrate their functional pluripotency attribute, explicitly the ability to differentiate into 
lineages from all three embryonic germ layers (Bayart and Cohen-Haguenauer, 2013; 
Maherali and Hochedlinger, 2008). 
 
Somatic to somatic TF-mediated reprogramming 
Early experiments from Davis and colleagues describing the conversion of fibroblasts 
into myoblasts through ectopic expression of MyoD TF provided proof-of-principle of 
cellular plasticity, further demonstrating that a somatic cell could be converted into a 
different somatic cell type without reversion to pluripotency (Davis et al., 1987). 
Subsequently, several studies exploiting this direct lineage conversion approach (or 
transdifferentiation) mediated by overexpression of TFs were performed. Cells from 
mesodermal, ectodermal and endodermal lineages were successfully converted into 
distinct somatic cell types of related lineages within the same germ layer, with 
particular attention being dedicated to clinically relevant cell types (Figure 1.6). 
Besides myoblast cells, other cellular conversions within the mesodermal lineages were 
attained. The existing knowledge of the TFs’ instructive roles in lineage specification in 
the haematopoietic system facilitated the conversion of certain haematopoietic lineages 
into different yet related ones. Conversion of fully committed B cell and T cell progenitors 
into functional macrophages was achieved through the ectopic expression of the basic 
Leu zipper transcription factor C/EBPα, the activity of which is required for the formation 
of granulocyte and macrophage precursors (Xie et al., 2004). A stable macrophage 
phenotype could be observed as soon as 48 hours after induction. Further work 
demonstrated that the combination of C/EBPα and another TF important for early lineage 
decisions of haematopoietic progenitors towards a granulocyte and monocyte fate (PU.1) 




exhibiting upregulation of lineage-specific genes and phagocytic functionality in vitro 




The limited regenerative capacity of cardiac muscle inspired the search for alternative 
cell sources for replacement therapies. Mouse cardiac and dermal fibroblasts have been 
converted to cardiomyocyte-like cells. Candidate factors were selected from a suite of 
genes expressed in cardiomyocytes and associated with clear developmental cardiac 
Figure 1.6: Direct lineage conversion of somatic cells.  
a) The schematic illustrates successful intra- and trans-germ layer conversion approaches. 
b) Transdifferentiation within the mesoderm. Different combinations of TFs or miRNAs have 
the potential to convert fibroblasts into immature or fully mature cardiomyocytes. c) 
Transdifferentiation within the endoderm. A combination of 3 TFs can convert exocrine 
pancreatic cells into endocrine insulin-producing pancreatic β-cells. d) Transdifferentiation 
across different germ layers from the mesoderm to the ectoderm. Induced neurons can be 
generated by different sets of TFs or miRNAs. Additional factors or small molecules 




defects in mutants. A initial pool of 14 factors was further refined into 3 TFs GATA4, 
MEF2C and TBX5 capable of inducing the expression of cardiac markers in fibroblasts 
without transitioning through a cardiac-progenitor state (Ieda et al., 2010). The 
conversion occurred very rapidly, with the first induced cells appearing 3 days after 
transduction. Induced cardiomyocytes expressed cardiac-specific markers, had a global 
gene expression profile similar to cardiomyocytes, and contracted spontaneously, after a 
further maturation step. Additionally, fibroblasts transplanted into mouse hearts one day 
after transduction of the 3 factors also differentiated into cardiomyocyte-like cells in situ. 
Using the same cocktail of TF, it was also possible to directly convert in vivo resident 
cardiac fibroblasts into functional cardiomyocytes, with resulting decreased infarct size 
and attenuated cardiac dysfunction (Qian et al., 2012). Alternatively, cardiomyocytes 
could also be obtained from in vitro and in vivo transdifferentiation of fibroblasts when 
adding a fourth TF to the cocktail, HAND2 (Song et al., 2012). Importantly, beside TFs, 
miRNAs known to be involved in cardiac development were shown to mediate 
conversion of fibroblasts into cardiomyocytes both in vitro and in vivo (Figure 1.6b) 
(Jayawardena et al., 2012). 
Cell fate conversion within the endoderm was achieved by overexpression of 3 TFs in 
pancreatic exocrine cells, which was sufficient to induce transdifferentiation into 
functionally insulin-producing β-cells. NGN3 (or NeuroD1), PDX1 and MAFA correspond 
to TFs known to be expressed in mature β-cells and their precursors, and to originate 
disturbed β-cell development when mutated (Zhou et al., 2008) (Figure 1.6c). 
It was assumed for long time that lineage reprogramming was only possible between 
closely related cell types, which likely share some epigenetic features as a result of their 
recent descent from a common progenitor cell. Inspired for increased knowledge in 
cellular reprogramming mechanisms and the generation of iPS cells, several teams 
began to assess combinations of lineage-specific TFs for their capacity to directly 
convert somatic cells into developmentally unrelated cell fates, and so across germ 
layers. 
Pioneering experiments by Wernig and colleagues demonstrated the direct conversion of 
fibroblasts into induced neurons (iN) (Figure 1.6d). A combination of only 3 factors, 
Ascl1, Brn2 and Myt1l was enough to rapidly and efficiently convert mouse embryonic 
and postnatal fibroblasts into functional neurons in vitro. The resulting iN cells expressed 
multiple neuron-specific proteins, generated action potentials and formed functional 
synapses (Vierbuchen et al., 2010). The generation of iNs from human fibroblasts was 
also achieved, with the conversion being facilitated by the addition of the NeuroD1 TF to 




cocktail was attempted in order to enhance the conversion efficiency and to achieve 
direct conversion into disease-relevant specific neuronal types. Dopaminergic neurons 
and spinal cord motor neurons were obtained by combining overexpression of generic 
neurogenic factors with TF that instruct distinct regional subtypes (Caiazzo et al., 2011; 
Son et al., 2011). Similarly to cardiac muscle cells, miRNAs were also found to be potent 
tools for neuronal conversion (Yoo et al., 2011). In an attempt to exploit this approach for 
studying neurodegenerative disease in human neurons, fibroblasts of a patient with 
Alzheimer’s disease were subjected to a TF cocktail. Obtained iN cells were 
characterized, displaying features associated with Alzheimer’s disease, such as the 
accumulation of the beta amyloid peptides, highlighting the potential use of this system in 
disease modelling studies (Qiang et al., 2011). 
Conversion of mesodermal into ectodermal lineage was also demonstrated. Hnf4α, 
Foxa1, Foxa2 and Foxa3 TFs were found to drive the direct conversion of mouse 
embryonic and dermal fibroblasts of mesodermal origin towards the hepatocyte lineage, 
which develops from the endoderm. Obtained cells showed typical epithelial morphology, 
expressed hepatic genes and acquired hepatocyte functions (Huang et al., 2011). 
Contrarily to pluripotency-inducing reprogramming, all the above mentioned direct 
lineage conversion protocols do not involve transition through a de-differentiated state. 
Consequently, transdifferentiation depends on the ability of ectopic TFs to overwhelm 
pre-existent genetic and epigenetic marks and force the establishment of the target cell 
identity gene network. Therefore high expression of the reprogramming factors is 
essential in direct lineage conversion protocols. The direct change in identity-specific 
genetic networks correlates with rapid kinetics of reprogramming, with specific 
phenotypic changes being observed as early as a few hours or days after 
overexpression, contrary to days or weeks in the case of iPS cells. Additionally, direct 
conversion can proceed in the absence of cell proliferation, generating post-mitotic cells 
and not progenitor cells, contrarily to iPS cell generation which occurs by step-wise 
proliferation and de-differentiation (Figure 1.7A and C) (Sancho-Martinez et al., 2012). 
Alternatively, several groups have recently reported another approach to cellular 
conversion exploiting the Yamanaka factors. Transient expression of these factors is 
thought to lead to an “open” epigenetic state, in the form of multipotent, partially 
reprogrammed intermediates. These partially reprogrammed intermediates can be 
differentiated into specific cell types by modulating extracellular developmental cues and 
without reversion into pluripotency, unless left in medium amenable to pluripotent cell 




Lineage conversion by plastic induction was first used to generate functional 
cardiomyocytes by Efe and colleagues. After an initial 4 days-period of transgenic 
expression of OSKM, MEFs could be directly reprogrammed to spontaneously 
contracting patches of differentiated cardiomyocytes over a period of 11-12 days, once 
cultured in media containing developmental cues specifically promoting cardiogenesis. 
The authors further demonstrated that a pluripotent intermediate was not involved in this 




Figure 1.7: Cellular reprogramming strategies allowing the generation of specific cell 
types.  
A) Reprogramming to pluripotency gives rise to iPS cells (iPSC) with unlimited self-renewal 
capacity (albeit with low efficiencies). The generated iPS cells can be further differentiated 
into every major cell lineage comprising an adult individual. B) Lineage conversion by 
induction of cellular plasticity relies on the use of iPS cells reprogramming factors during an 
initial ‘epigenetic activation phase’. Unstable intermediate states can be further 
differentiated into specific lineages when the appropriate developmental cues are provided 
by chemically defined differentiation media. Plastic induction is generally accompanied by 
cell proliferation and allows for the generation of multipotent progenitor cells. C) Direct 
lineage conversion originates specific cell types as defined by the TF cocktail employed for 
reprogramming. Generally it implies the generation of post-mitotic cells with limited 




Also exploiting an early “epigenetic activation phase”, the same group demonstrated the 
conversion of mouse fibroblasts into distantly related ectodermal neural progenitor cells 
(NPCs). Transient induction of the 4 reprogramming factors (OSKM) followed by 
induction with defined media gave rise to neural rosettes expressing typical neuronal and 
NPC markers. An intermediate pluripotent state was not involved in the process and 
generated NPCs could be expandable in vitro, retaining the ability to give rise to multiple 
neuronal subtypes and glial cells (Kim et al., 2011). Other combinations of pluripotency-
related TFs, including Sox2 alone, or in conjunction with neuronal lineage-related TFs 
were also attempted with the successful generation of intermediate progenitor states 
bearing multilineage potential (Han et al., 2012; Lujan et al., 2012; Ring et al., 2012; 
Thier et al., 2012).  
Indirect lineage conversion has also permitted the conversion of human fibroblasts into 
mesodermal progenitor cells. First, an 8 day-period of plastic induction through 
exogenous expression of OSKM mediated by retroviral or non-integrative delivery 
methods generated CD34+ angioblast-like cells with bipotent differentiation potential. 
These progenitor cells could generate endothelial and smooth muscle lineages by 
treatment with mesodermal induction medium for another 8 days. Differentiated 
endothelial cells exhibited neo-angiogenesis and anastomosis in vivo (Kurian et al., 
2013). 
In conclusion, two different reprogramming approaches complementary to iPS cell 
generation (followed by differentiation) have been described to promote somatic to 
somatic cell conversion. First, a direct lineage conversion without going through 
undifferentiated states allows identity switch of cell type A into cell type B in the absence 
of proliferation. Secondly, indirect conversion through a de-differentiation process leads 
to the generation of intermediate proliferative states with multilineage differentiation 
capacity. This plastic state can be subsequently committed into a differentiation state by 
exposure to developmental cues (extracellular signals or late-identity specification TFs) 
(Ladewig et al., 2013; Sancho-Martinez et al., 2012). 
 
Applications 
The discovery that differentiated cells can be reprogrammed to pluripotency or other cell 
fates by treatment with defined factors opened up unprecedented opportunities for 
biomedical sciences. Although the details and mechanisms underlying the 
reprogramming events are still being elucidated, the resulting cells are very promising for 




modelling, drug screening and toxicology studies. Additionally, the ability to induce cell 
fate conversion is also attractive for basic research fields, such as development, cancer, 
epigenetics and ageing (Figure 1.8). 
 
Cell transplantation therapy 
Since human ES cells’ isolation, great expectations were put on these cells to 
provided treatment to incurable disorders, such as Parkinson’s disease or heart 
failure (Thomson et al., 1998).  However, prospective use of human ES cells also 
raised ethical concerns about the usage of human embryos, and medical concerns 





Figure 1.8: Major applications of differentiated cells obtained by reprogramming 
strategies. 
Adult somatic cells (unipotent) from human patients can be subjected to reprogramming 
protocols. Generated iPS cells can be differentiated in vitro into the desired specialized 
cells. Alternatively, lineage conversion strategies can be applied with the direct conversion 
of the original somatic cell into another somatic cell fate. Either way, specialized 
differentiated cells obtained by reprogramming strategies can be used for cell replacement 
therapies. More straightforwardly, obtained cells can be used for disease modelling to 
understand the molecular mechanisms underlying disease phenotypes, for example the 
molecular causes for arrhythmia in cardiomyocytes (a). Another potencial application is in 
drug screening and discovery, to determine the effects of candidate drugs and new 
compounds and identify target pathways (b). Human cells derived from reprogramming 
technologies are also valuable in cardiac, neural and liver toxicity tests to assess cellular 
toxic responses (c). Drug screening and toxicity tests together represent human preclinical 
trials “in a tube” which strongly contribute to the early stages of the drug discovery process. 




Cellular reprogramming into pluripotency with the generation of human iPS cells 
potentially overcame these drawbacks. Proof-of-concept that iPS cells could be 
valuable therapeutic tools was first demonstrated in 2007 for a mouse model of 
sickle-cell anemia. A genetic defect in the β-globin gene is responsible for this 
disorder and mutated iPS cells were corrected for the single gene defect through 
homologous recombination. It was shown that mice could be rescued after 
transplantation with hematopoietic progenitors obtained in vitro from autologous 
corrected iPS cells (Hanna et al., 2007).  iPS cell-based autologous transplantation 
methods have the advantage of minimizing the risk of immunological rejection, 
when compared to the current allografts from other donors. However, there are 
reasons to question this assumption of an immune-privilege, including recent 
studies that have tested iPS cells immunogenicity in various ways with conflicting 
results. This immunogenicity might result from the immaturity of cells differentiated 
from iPS cells, the genetic and epigenetic changes that arise from reprogramming 
or adaptation to culture conditions, the usage of xenogeneic or non-physiological 
culture reagents, and the gene correction strategies applied to restore proper 
expression of missing or dysfunctional proteins (Scheiner et al., 2014). Moreover, 
realistically, an individualized patient-specific iPS cell-based therapy implies high 
medical costs and an experimental timeframe that might be incompatible with the 
disease progression. Thus, at present, a collection of human iPS cell stocks from 
various HLA (human leucocyte antigen)-homozygous donors might be the most 
promising approach and guidelines for the collection of such cells are being 
discussed by the scientific community (Turner et al., 2013). 
Nevertheless, for either an autologous or allogeneic transplantation, and besides 
immunogenicity issues, significant roadblocks to translating iPS cells to the 
bedside still remain. Tumorigenicity is one of such concerns. The current gold 
standard test of pluripotency for human iPS cells is the teratoma formation, which 
is inherently a tumorigenesis assay. Any residual undifferentiated cells present in 
differentiated cell cultures used for transplantation can cause a teratoma, and 
should be removed before use. Hence, effective methods for the removal of 
undifferentiated cell contamination as well as more efficient differentiation protocols 
must be developed. Additionally, much research has focused on removing or 
replacing the potent oncogene c-Myc in the reprogramming cocktail, as well as in 
developing non-integrative reprogramming techniques to minimize the risk of 
insertional mutagenesis and reactivation of transgenes after differentiation. Many 




innovations in an effort to, in the near future, generate clinical-grade iPS cells 
under Good Manufacturing Practice (GMP) compliance (Barrilleaux and Knoepfler, 
2011; Takahashi and Yamanaka, 2013). 
Another concern with human iPS cell-based regenerative medicine is associated 
with the genetic and epigenetic alterations that have been described. Genomic 
changes, such as copy number variations, point mutations and karyotype 
alterations, are acquired by iPS cells as they proliferate and differentiate. 
Strategies to minimize genomic damage based on minimizing reprogramming- and 
propagation-induced oxidative stress are currently being developed, in order to 
avoid the overexpression of oncogenes and inactivation of tumour suppressors that 
might result from the DNA alterations. At the epigenetic level, reprogrammed cells 
can retain a memory of the starting tissue from which they were derived. 
Abnormalities in DNA methylation patterns and aberrant histone modifications can 
occur. Cells can also vary in X chromosome inactivation status (Barrilleaux and 
Knoepfler, 2011; Hong et al., 2013; Peterson and Loring, 2014). 
Besides the described problems related to immune rejection, genetic instability, 
and tumorigenicity that must be solved, early stage preclinical studies have 
highlighted additional challenges that must be addressed before moving to clinical 
trials. These include rigorous quality control and efficient production of required cell 
populations, improvement of cell survival and engraftment, and development of 
technologies to monitor transplanted cell behaviour for extended periods of time. 
Regarding the key step of precisely correcting the gene defect in patient-specific 
iPS cells, a rapid and positive evolution of novel genome editing technologies was 
observed in recent years, with the development zinc finger nucleases, transcription 
activator-like effector nucleases and clustered regularly interspaced short 
palindromic repeat/CAS9 RNA-guided nucleases (Harding and Mirochnitchenko, 
2014; Li et al., 2014). 
 
Disease modelling 
Animal models have contributed tremendously to a better understanding of disease 
mechanisms, but with some limitations due to species-specific differences and the 
non-accurate recapitulation of human disease in some cases. Moreover, the 
majority of drugs that are effective in mice have failed in human clinical trials. Thus, 
a novel and more human-relevant model is in order and human iPS cell-based 




complementary. These human in vitro models are not confounded by species-
specific differences, allow cell-autonomous and non-cell-autonomous functions to 
be distinguished and also permit to study the effect of a genetic variant on the 
cellular phenotype. Furthermore, cultured cells can be produced and cultured 
relatively rapidly and in large quantities, which is compatible with the development 
of large-scale genetic and chemical screens for phenotypic modifiers (Merkle and 
Eggan, 2013). 
Disease-specific iPS cells were generated for the first time in 2008 from patients 
with a variety of disease including Parkinson’s disease, and a year later, iPS cells 
from a type 1 spinal muscle atrophy patient and his unaffected mother were 
generated and differentiated into neural tissue and motor neurons. As these 
differentiated cells displayed the genetic defect and the disease phenotype of 
selective motor neuron death, this report provided the proof-of principle of human 
iPS cell-based disease modelling (Ebert et al., 2009; Park et al., 2008). Following 
this first report, many disease-specific iPS cell lines have been established and 
used for in vitro disease modeling. In essence, it consists of differentiating control 
and disease-bearing human iPS cells into the target cell type affected in disease 
and comparing these target cells for disease-relevant phenotypes. The confluence 
of human iPS cell-based disease models with new gene-editing technologies, 
genome-wide association as well as DNA sequencing studies provide a promising 
workflow for interrogating the contribution of disease-associated candidate genetic 
variants to disease-relevant phenotypes in the attempt to illuminate the molecular 
basis of human disease (Bellin et al., 2012; Merkle and Eggan, 2013).  
 
Drug screening and toxicological assessment 
Our understanding of disease pathology in humans has been limited by a lack of 
appropriate models but also by insufficient research on drug–gene interactions. 
New technologies, such as in vitro differentiated human iPS cell-derived cells, have 
the power to transform the drug discovery process. Recent papers have shown 
that cell-autonomous disease phenotypes can be modelled in vitro. For example, 
the addition of propanolol and nadolol, two β-adrenergic blocking agents, 
attenuated catecholamine-induced tachyarrhythmia in cardiomyocytes. These cells 
were derived from human iPS cells from patients with Long QT syndromes that are 
caused by mutations in ion channel genes (Moretti et al., 2010). These results 




the management of cardiac arrhythmia. Similar studies further suggested a 
paradigm in which biological and physiologically relevant assays in human cells 
can drive drug discovery to deliver potentially safer, more efficacious medicines as 
well as to iteratively relate patient information from the clinic back to the drug 
discovery laboratory (Bellin et al., 2012). 
For the past 20 years, the drug discovery industry has relied heavily upon high-
throughput screening to identify biologically active small drugs for further 
optimization into candidate drugs. Panels of patient-specific human iPS cells 
representing the spectrum of the disease and/or drug response can be generated 
and differentiated into relevant cell type(s) making it possible to investigate the 
genotype-phenotype-drug response relationship in a controlled and systematic 
manner. To date, some handful of drug efficacy screens evaluating from hundreds 
to thousands of small molecules in human iPSC-derived cells (neurons and 
hepatocytes) have already been reported (Engle and Vincent, 2014). Examples 
from neurons, hepatocytes, and cardiomyocytes have demonstrated 
physiologically relevant disease phenotypes as well as drug-induced toxicities, 
demonstrating their prospective use in safety assessment by toxicological studies 
(Kolaja, 2014). Although the current studies have been focused on the very early 
preclinical stages of drug discovery, as the technology progresses and the costs to 
generate patient cells and models decreases, it is likely that the technology will find 
additional applications at the clinical trial stage and in postmarketing surveillance 
(Engle and Puppala, 2013). 
 
Applications in the basic sciences 
The advent of reprogramming technologies has helped to elucidate, although not 
entirely yet, the relationship between epigenetic modification and cellular identity, 
as the identified roadblocks to reprogramming serve as barriers that ensure the 
stability of cellular identity (Vierbuchen and Wernig, 2012). Reprogramming 
techniques can also be used to dissect the role of transcriptional and epigenetic 
changes in cancer development, given the shared features of carcinogenesis with 
the reprogramming process such as MET and involvement of cancer-related 
proteins such as Myc and p53 (Bernhardt et al., 2012). Reprogramming somatic 
cells to iPS cells also allows obtaining ‘rejuvenated’ cells that can provide a tool for 
in vitro ageing studies. Additionally, as in vitro differentiation protocols usually 




our knowledge in this field. Recent reports on three-dimensional complex tissues 
formed by differentiation of iPS cells have been highlighting self-organization of 
tissue development-based studies as an extremely valuable tool. Applications 
range from the next generation of organ transplantation to disease modelling 





Retinal Pigment Epithelium 
Vertebrate eye, retina and RPE 
It is believed that around 500 million years ago, on the Cambrian period, lateral light-
sensing organs with a non-imaging function evolved into a specialized structure which 
included all crucial features that characterize the modern vertebrate eye. As these visual 
systems emerged, several attributes as sight and rapid movement provided evolutionary 
advantages (Lamb et al., 2007). Image-forming eyes developed differently in the various 
phyla, however sharing some common underlying traits in terms of patterning and 
developmental pathways, namely between insects and mammals (Chow and Lang, 
2001).   
The mature eye is a very complex organ that develops through an extremely organized 
process during embryogenesis. It is responsible for the vision sensory capacity, with 
severe handicapping diseases occurring due to its loss of function. Three major tissues, 
the cornea, the lens and the retina, constitute the vertebrate eye (Figure 1.9) (Graw, 
2003). 
The eye works as an optical device that detects and perceives visual information, 
conducting it into the retina. Being a component of the central nervous system located 
peripherally, the retina is responsible for light sensing, imaging processing and 
information delivery into the brain through the optic nerve. Though a very thin tissue 
(around 200 µm in humans), the retina has a profoundly organized structure with several 
layers of cells: the complex neuronal circuitry named neuroretina (NR), and the 
underlying retinal pigment epithelium (RPE). Regarding the NR, five types of neurons 
compose it: photoreceptors (PRs), horizontal cells, amacrine cells, bipolar cells and 
retinal ganglion cells (RGCs) (Sung and Chuang, 2010). 
PRs are light-sensitive neurons located in the outer part of the retina. They capture 
photons and generate electrophysiological signals, being divided in rods that respond to 
single photons, responsible for night vision, and cone PRs, specialized in sensing 
daytime high-intensity light, including colour vision. Both PRs types have an outer-
segment (OS) constituted by membranous discs containing a visual pigment composed 
of a vitamin A-based chromophore (11-cis-retinal) and a seven-transmembrane-helix 
apoprotein, opsin. Phototransduction is initiated by photon absorption by opsin and 
associated isomerization of 11-cis-retinal into all-trans-retinal. A G protein-coupled 
signalling cascade of events is activated leading to alterations in membrane potential, 
with resultant modifications on the level of neurotransmitters’ release on synaptic 







PRs’ electric response is transmitted first to a group of retinal interneurons called bipolar 
cells, and then to RGCs, which long axons form the optic nerve, leaving the eye and 
transmitting the information to the visual centres of the brain. Concomitantly, information 
relayed by the PRs can be altered by other types of interneurons, namely horizontal and 
amacrine cells. The different types of retinal neurons are distributed along 3 distinct 
layers of cell bodies: the outermost containing PRs cell bodies (outer nuclear layer), the 
inner nuclear layer where interneurons’ cell bodies are located, and, on the inner part the 
ganglion cell layer with RGCs’ nuclei. Additionally to neuronal cells, Müller cells are also 
present performing glial-supportive functions, such as maintenance of the homeostasis 
of the retina extracellular milieu, control of angiogenesis and release of neurotrophic 
Figure 1.9: Structure of the adult human eye.  
Schematic representation of a section of the human eye, depicting its composing tissues. 
The vertical red line separates the anterior segment from the posterior segment of the eye. 
Anteriorly, the eye is composed by the cornea, the iris, the lens and the ciliary body. Light 
enters the eye through the cornea, anterior chamber and lens, along the optical axis. Then 
it travels to the posterior segment, composed by the vitreous humour, the retina and the 
choroid. The retina has several components represented on the right close-up panel: 
ganglion cells, bipolar cells, Müller glial cells, photoreceptors (cones and rods) and retinal 
pigment epithelium (RPE). Amacrine and horizontal cells, though not represented, are also 




factors. Müller glia also play important roles in the response to retinal pathological 
conditions (Bringmann et al., 2006; Sung and Chuang, 2010). 
At first sight, the organization of retina’s cell layers might seem counterintuitive, since 
light must travel through a complex organization of non-light-sensing cells located on the 
inner side before reaching the outermost portion of the retina and being captured by 
photo-sensible OS. Contrarily, this spatial arrangement unveils the key supportive role of 
the RPE lying on the apical side of PRs in close relation to them. 
The RPE is an epithelial monolayer of polarized pigmented cells, hexagonally-packed 
and tight junction-connected. It composes the outer blood-retina barrier, separating the 
outer retina from the choroidal capillary bed and regulating the movement of solutes 
between both, therefore maintaining a microenvironment adequate to proper function of 
neuronal layers of the NR (Rizzolo et al., 2011; Sparrrow et al., 2010). Apical microvilli of 
RPE cells surround the light-sensitive OS of PRs. On the basolateral side, RPE displays 
membrane infoldings and is in close contact with a specialized Bruch’s membrane, which 
separates it from the underlying fenestrated endothelium of choroidal capillaries (Figure 
1.10) (Strauss, 2005). 
The Bruch’s membrane is an approximately 2 µm-connective tissue constituted by five 
laminar layers including the basement membrane of the RPE and of the endothelium of 
choriocapillaries, 2 collagen-rich layers and an elastic sheet (Nakaizumi, 1964). Being an 
extracellular matrix, it is composed of collagens, elastin, laminin, fibronectin and 
proteoglycans containing heparin sulphates (Hewirr et al., 1989)  Due to its strategic 
location, the Bruch’s membrane is responsible for flow of nutrients, water, ions, oxygen, 
biomolecules and metabolic byproducts between the metabolically active RPE cells and 
the choriocapillaries (Booij et al., 2010; Sivaprasad et al., 2005). It has also been 
implicated in regulating RPE cell adhesion and attainment of proper epithelial 
polarization (Del Priore et al., 2002; Rizzolo, 1991).  It has been described that aging and 
other pathological conditions contribute to an increased thickness of Bruch’s membrane, 
due to the deposition of noncollagen proteins, lipid deposits, heparin sulfate, laminin, and 
fibronectin. These calcification and fragmentation processes affect Bruch’s membrane 
permeability and the movement of nutritional factors from the choriocapillaries through 
the RPE layer into the outer retina (Ehrlich et al., 2008; Spraul et al., 1999).  
The choroid is the vascular layer of the eye composed of single layer of fenestrated 
blood vessels (choriocapillaris) and large vessels such as feeding arterioles and draining 




composing endothelial cells are fenestrated mostly on the side facing the outer retina, 




In addition to being a component of the outer blood-retina barrier regulating epithelial 
transport, the RPE also plays a crucial role in light absorption, spatial ion buffering, the 
visual cycle, phagocytosis of PRs’ OS and secretion of growth factors and 
immunosuppressive factors. The functional integrity of the retina relies on the 
maintenance of these diverse RPE functions and any alteration affecting them will result 
in retinal degeneration with consequent loss of visual function (Sparrrow et al., 2010; 
Strauss, 2005). 
In average, the human retina absorbs approximately 1012 to 1015 photons each day. Light 
enters the optical device and is focused by the lens in the retina, where photons are 
captured by PRs. Scattered or unabsorbed light is absorbed by the RPE cells lying just 
beneath the PR layer. PRs and RPE cells work in conjunction in order to maximize the 
Figure 1.10: The Retinal Pigment Epithelium, located in the outer retina.  
Schematic diagram of the RPE cell layer and its close relationship with the OS of the PRs 
apically, and with Bruch’s membrane and choriocapillaries on the basal side. Pigmented 
granules and characteristic membrane specializations are also depicted: apical microvilli, 





optical quality of visual imaging whilst keeping the risk of photodamage to its minimum. 
Exposure to bright light leads to two types of photodamage in cells: thermal damage and 
photochemical damage, which occurs as a result of energy transfer from photons to 
irradiated molecules leading to changes in electron orbitals or breakage of bonds (Hunter 
et al., 2012). 
In addition to the high photo-oxidative environment caused by light exposure, RPE cells 
are also exposed to a high oxygen overflow given the high blood perfusion rates of 
choroidal capillaries (probably to avoid the light-induce thermal damage) (Parver, 1991). 
Moreover, photo-oxidative activity in the RPE is increased by the production of reactive 
oxygen species (ROS) during the phagocytosis of daily shed OS of PR cells (see more 
details later on). RPE cells have established three lines of defence against these sources 
of oxidative stress. First, cells contain pigmented light absorbers such as melanin, 
lipofuscin and retinoids. Secondly, antioxidants, either enzymatic (as catalase and 
superoxide dismutase) or non-enzymatic (such as carotenoids, ascorbate, glutathione, α-
tocopherol, and melanin itself) are also accumulated by RPE cells and neutralize ROS 
before they can cause damage to cellular macromolecules. When such damage occurs, 
the third line of defence responds, and damage to lipids, proteins and DNA are 
recognized and repaired (Winkler et al., 1999).  
Before reaching the RPE cells, environmental light passes through other eye layers with 
transmission and absorption capacities, such as cornea, lens and the PRs themselves. 
PRs contain carotenoids, mainly lutein and zeaxanthin, acting as a sink for blue incoming 
light, and as antioxidants due to quenching of ROS and free radicals (Beatty et al., 1999; 
Sliney, 2005). Then, on the RPE cells, light absorption is mainly mediated by melanin 
granules present in lysosome-related organelles named melanosomes. Here the melanin 
is mainly eumelanin, which is a heterogenous macromolecule derived from tyrosine or 
dopa (dihydroxyphenylalanine) with brown/black colour. Melanin synthesis and storage 
occurs in melanosomes. It is formed in a series of oxidation and tautomerization 
reactions catalyzed by several enzymes, being tyrosinase (monophenol 
monooxygenase) the rate-limiting one responsible for the first step (Murisier and 
Beermann, 2006). Besides light absorption, melanin also plays a role as anti-oxidant 
ROS and free radicals-scavenging properties, conferring some cytoprotection to 
apoptosis. Moreover it has been described its ability to bind to metals, such as zinc, and 
drugs (Burke et al., 2011; Schraermeyer and Heimann, 1999; Seagle et al., 2005).  
Along with retinoids and melanin, another pigment involved in light absorption is auto-
fluorescent lipofuscin. Lipofuscin granules are an agglomerate of modified lipids and 




visual cycle and phagocytosis of OS. Lipofuscin is highly susceptible to photochemical 
changes, acting as a photosensitizer and is known to reach a toxic concentration level in 
the elderly eye. Consequently, the oxidative-antioxidative equilibrium may be unbalanced 
with ageing and accounts for the onset of some pathological retinal conditions (Hunter et 
al., 2012; Winkler et al., 1999). 
As abovementioned, RPE forms the outer blood-retinal barrier regulating the movement 
of solutes and molecules between the fenestrated choroidal capillaries and the PR layer 
of the outer retina. Tight junctions contribute to the barrier once they selectively limit 
diffusion through paracellular spaces between RPE cells (Rizzolo et al., 2011). 
Epithelial transport occurring through RPE cells is responsible for supplying nutrients 
from the blood to the PR. Glucose as an energy supply is transported by GLUT1 and 
GLUT3 transporters in a facilitated diffusion manner (Ban and Rizzolo, 2000). Transport 
of retinol to ensure the supply of retinal for the visual cycle also occurs. Also important 
for maintaining the visual function is the delivery of omega-3 fatty acids, used as building 
blocks of the phospholipids present in retinal neurons’ membranes and PRs’ disks 
(Bazan et al., 1992). 
Transport also occurs in the opposite direction, from the PRs into the basolateral side or 
blood stream, mainly of water, ions and metabolic waste products (as lactic acid). 
Relevantly, the RPE regulates the passage of a variety of ions (like Cl-, K+, Na+, HCO3
-) 
which are important in the polarisation/hyperpolarization of cell membranes, in fluid 
transport and the regulation of pH. Ion pumps, such as the Na+/K+-ATPase present in the 
RPE’s apical membrane, provide energy in the form of ATP for transepithelial transport. 
Consequently, electrochemical gradients are generated and drive other solutes 
vectorially through channels, cotransporters, and antiporters (Rizzolo et al., 2011; 
Strauss, 2005). Ca2+-activated Cl- channels, like Bestrophin-1, are also present in the 
RPE cells and are widely regarded as a marker of RPE maturation (Marmorstein et al., 
2009). 
RPE cells along with Müller glial cells are responsible for stabilizing ion homeostasis in 
the subretinal space. RPE cells accomplish this spatial ion buffering task through the 
mentioned ion epithelial transport regulation and also fast-adapting voltage-dependent 
ion channels. Light-dependent alterations on overall excitability of PRs and other retinal 
neurons occur at a very fast rate, requiring a fast compensating mechanism from RPE 
cells. Light-evoked responses of the RPE membrane potentials are secondary to rod PR 
activity, mediated by paracrine signals and can be monitored by electroretinogram 
techniques allowing the diagnose of alterations in RPE functions (Steinberg et al., 1983; 




Phototransduction by the rods PRs begins with photons reaching rhodopsin, which is 
composed of the 7 transmembrane domain G-coupled receptor protein, opsin, and the 
chromophore 11-cis-retinal. Absorption of photonic energy occurs with conformational 
change of 11-cis-retinal into all-trans-retinal. PRs lack cis-trans isomerase function for 
retinal, thus 11-cis-retinal is recycled by a reisomerization pathway occurring in RPE 
cells and named as visual cycle (Figure 1.11). A similar pathway is present for cones, 
notwithstanding an alternative pathway for production of 11-cis-retinal occurring in Müller 
cells (Miyazono et al., 2008; Yau and Hardie, 2009). 
An alternative pathway also occurs depending on the activity of retinal G protein-coupled 
receptor (RGR) of the RPE and Müller cells. RGR is an abundant opsin that after light 
induction generates 11-cis-retinal by stereospecific isomerization of its bound all-trans-
retinal chromophore, an inverted reaction of the one occurring for rhodopsin. This 
pathway is important to maintain constant levels of 11-cis-retinal independently of 
changes in ambient light. Fine tuning of fast adapting demands for 11-cis-retinal in the 
sudden transitions from darkness to light is achieved by several retinal pools of retinal 
binding proteins: rod OS, IRBP in the subretinal space, CRALBP and RPE65 in the RPE 
cells (Chen et al., 2001; Strauss, 2005).  
Another important interaction between RPE and PR crucial for the maintenance of the 
retina’s structure and functionality is the cyclic phagocytosis of PRs’ OS by RPE cells 
(Kevany and Palczewski, 2010). RPE cells extend their apical microvilli sheathing the 
OS, which are constantly subjected to photo-oxidative damage as already described. 
Thus, OS are constantly renewed and invariable length is kept due to daily shedding of 
degraded tips of OS in a circadian regulated process (LaVail, 1976). RPE cells efficiently 
phagocyte OS from subretinal space and recycle some of their components (Young and 
Bok, 1969). Several players have been identified in the regulation of the phagocytosis 
events by the RPE.  Among others, type B scavenger receptor CD36 is required for OS 
internalization, αvβ5 integrin is essential for binding of OS and receptor tyrosine kinase 
c-mer (MertK) is necessary for activation of phagocytosis (D’Cruz et al., 2000; Feng et 








Being a polarized epithelial tissue, RPE cells display polarity traits in the cellular 
localization of some proteins (as apically localized Na+/K+-ATPase pump), but also in the 
secretion of various factors and  signalling molecules. Secretion of numerous growth 
factors occurs in a polarized way allowing the RPE cell to communicate with adjacent 
tissues on either sides, as reviewed by (Kay et al., 2013): adenosine triphosphate (ATP), 
ciliary neurotrophic factor (CNTF), connective tissue growth factor (CTGF), fas-ligand 
(fas-L), fibroblast growth factors (FGF-1, FGF-2, and FGF-5), lens epithelium-derived 
Figure 1.11: Visual cycle of retinal in RPE cells and PRs.  
Phototransduction events begin with photons (hν) being absorbed by 11-cis-retinal (11-cis-
RAL), the chromophore associated with PRs’ opsin. Opsin is converted into its meta form 
for a period of time and all-trans-retinal (All-trans-RAL) is formed. After signal transduction 
has occurred, opsin releases All-trans-RAL and substitutes it for 11-cis-RAL in order to 
permit absorption of another photon. All-trans-retinol (All-trans-ROL), formed by reduction 
of all-trans-RAL catalyzed by a membrane bound retinol-dehydrogenase (RDH), is then 
delivered to the subretinal space where it is loaded to IRBP (interphotoreceptor retinoid-
binding protein). This carrier protein transports it into the RPE cells, where it is first 
transferred to cellular retinol-binding protein (CRBP) and then delivered to an enzymatic 
complex responsible for the recycling of 11-cis-RAL. First, lecithin:retinol acyl transferase 
(LRAT) catalyzes esterification of retinol; RPE65 (RPE specific protein 65kDa) is 
responsible for re-isomerisation to 11-cis using the energy from ester-hydrolysis; finally 11-
cis-RDH promotes oxidation of retinol into 11-cis-RAL. The reaction is accelerated by 
CRALBP (cellular retinaldehyde-binding protein) which is also part of the enzyme complex 
and to which 11-cis-RAL is immediately transferred. Finally, 11-cis-RAL is released to IRBP 




growth factor (LEDGF), insulin-like growth factor-1 (IGF-1), members of the interleukin 
family (such as IL-6 and IL-8), platelet-derived growth factor (PDGF), pigment 
epithelium-derived factor (PEDF),  TGF-β, tissue inhibitor of matrix metalloprotease 
(TIMP) and vascular endothelial growth factor (VEGF), just to mention some. For 
example PDGF is secreted on the apical side and plays a role in retinal neurons’ 
development and integrity due to its neurotrophic properties. It also maintains a non-
angiogenic retinal environment (Barnstable and Tombran-Tink, 2004; Patricia Becerra et 
al., 2004). VEGF, on the other hand, is secreted basolaterally, mediating paracrine 
vascular survival signals for adjacent endothelia (Sonoda et al., 2010; Witmer, 2003). 
Secretory activity of RPE cells is triggered by an increase in intracellular Ca2+ content 
and voltage-dependent Ca2+ channels expressed by these cells act as its regulators 
(Wimmers et al., 2007). 
Finally, RPE cells contribute to the immune privilege of the vertebrate eye. Firstly, 
through the presence of tight junctions in the polarized epithelium, a physical barrier is 
formed separating the inner space eye from the bloodstream. Secondly, RPE cells are 
able to communicate with the immune system either by secretion of immunomodulatory 
molecules (such as interleukins, PEDF, galectin-1) or by sensing immune signalling 
molecules due to their expression of toll-like receptors or tumor-necrosis α-receptor 
(Mochizuki et al., 2013; Strauss, 2005). The fact that RPE functions as an immune-
privileged tissue is extremely relevant for the development of therapeutic strategies for 
several retinal disorders, mainly for gene therapy or cell-based therapy approaches 
(Wenkel and Streilein, 2000). 
 
Eye development: the view from the RPE 
Organogenesis of the eye is a highly organized multistep process taking place during 
embryogenesis. A complex interplay between inductive signals, resulting from tissue-
tissue interactions, and cell intrinsic factors, as the timely action of TFs, is critical to 
ensure the correct development of the different eye components as well as maintenance 
of their fate. Establishing the genetic basis of eye defects in drosophila, zebrafish, 
chicken, xenopus, mouse and human provided a very important tool to identify the 
extrinsic and intrinsic determinants in this complex process. 
The vertebrate eye comprises tissues from different embryonic origins. The surface 
ectoderm gives rise to the lens and the cornea, whilst the anterior neural plate will form 
the retina and epithelial layers of iris and ciliary body. During gastrulation, the developing 




forebrain. After specification of the EF within the neuroplate, the forming eye tissues 
undergo a series of complex morphogenetic movements (Figure 1.12) (Fuhrmann, 2010; 
Graw, 2010). First, the single EF is separated during the establishment of the midline 
and two bilateral optic grooves become apparent as the neuroepithelium of the ventral 
forebrain evaginates forming two bulges at each side (by E8.5 in the mouse). As the 
evagination process occurs, two optic vesicles (OV) are formed contacting at their distal 
part with the overlying surface ectoderm, which is then induced to form the lens placode 
(E9). Secondly, resultant of this interaction an invagination step is now initiated with 
invagination of the lens placode to form the lens, and invagination of the distal OVs 
leading to the formation of a bilayered optic cup (OC) (in the mouse this process is 
initiated at E10). The NR develops from the inner layer of the OC, and RPE is derived 
from the outer layer contacting with the periocular mesenchyme. As morphogenesis 
proceeds, the presumptive RPE spreads ventrally and circumferentially to completely 
surround the NR, allowing the closure of the ventral fissure (Fuhrmann, 2010; Graw, 
2010). Several molecular players and cellular processes have been identified as playing 
a role in controlling the eye development and RPE specification and differentiation, and 
they vary along the multiple steps already mentioned. 
 
1. Eye field 
Although the first morphological signs for eye development only occur with the 
bilateral evagination of the developing forebrain, the early EF is specified earlier 
during gastrulation. Reports supporting the existence of this single eye field go 
back till late 1920s when Adelmann’s embryological manipulations have shown 
that transplanted regions of the anterior neural plate demonstrated an eye-forming 
potential (Adelmann, 1929). Modern genetic evidence showed that the early EF is 
specified at the neural plate stage by the expression of a set of eye field 
transcription factors, EFTFs. The EFTFs in Xenopus are expressed in a dynamic 
and overlapping pattern in the EF and include ET (also known as transcription 
repression factor Tbx3), Rx1, Pax6, Six3, Lhx2, Tll (also known as Nr2e1) and 
Optx2 (also known as Six6). Expression of an EFTF cocktail with Otx2 was shown 
to be sufficient to induce ectopic eyes outside the nervous system at high 
frequency.  Together these TFs are organized in a hierarchical network with self-
regulating feedback interactions that specifies the vertebrate EF, which is very 
close to the previously described network of homologous Drosophila genes (Chow 








The orthodenticle protein homolog Otx2 is a member of the orthodenticle-
related family of TFs, containing a highly conserved bicoid-type homeodomain. In 
Figure 1.12: Embryonic development of the vertebrate eye cup.  
The first signs of the developing eye cup become apparent during neurulation, when the 
neural plate folds upwards and inwards (a and b). Two lateral optic grooves evaginate (c) 
and bulge outwards as the lips of the neural folds approach each other (d). At this point the 
optic grooves have enlarged to form the optic vesicles, which continue to balloon outwards 
and terminate very close to the surface ectoderm (e). As a result of this interaction, the lens 
placode is induced and the neuroectoderm folds inward forming the optic cups by 
invagination. The inner layer of the optic cup gives rise to the retina, whereas the outer 
layer will form the RPE. Developing retinal ganglion cells send axons out across the retinal 
surface, growing toward the optic stalk and forming the optic nerve. Lens placode will also 
invaginate and give rise to the lens (f). The optic cups grow circumferentially, eventually 
sealing over the choroidal fissure and enclosing the axons of the optic nerve (g). Adapted 




Otx2-/- mice mutants, forebrain and midbrain structures are completely missing. 
Heterozygous deletion of Otx2 leads to a variable phenotype and mice can be 
normal, display developmental eye abnormalities including anterior segment 
malformations, severe eye anomalies such as microphthalmia (eyes with reduced 
size) or anophthalmia (absence of both eyes), or head defects. Otx2 is expressed 
throughout the forebrain and midbrain in the developing embryo, specifying the 
anterior neuroectoderm. Its expression precedes that of the other early EFTFs, and 
is subsequently down-regulated and absent in the EF defined by them. As 
mentioned later on, Otx2 also plays a role in subsequent steps of eye 
development, namely in directing the evagination of the OV to contact the surface 
ectoderm and in specifying the presumptive RPE (Hever et al., 2006; Martinez-
Morales et al., 2001). 
An essential role in the early events of eye development has been established for 
the paired-type homeobox gene Rax (retina and anterior neural fold homeobox) 
after analysis of its expression patterns and loss and gain-of-function phenotypes 
in mice (Furukawa et al., 1997; Mathers et al., 1997). Rax is first expressed at the 
anterior neural plate, and following neurulation, it is expressed most abundantly in 
the OV. At later stages, Rax expression is found only in the developing retina. 
Post-natally, the expression of Rax is restricted to proliferating cells within the 
retina, gradually decreasing as proliferation declines. Mouse embryos carrying a 
null allele of this gene do not form OCs and so do not develop eyes. Similarly, 
among other species, in zebrafish the ortholog for Rax gene is rx3 which once 
mutated generates an anophthalmic phenotype. Mutation in the human RAX gene 
also leads to anophthalmia (Voronina et al., 2004). Rax is one of the molecules 
that define the EF during early development: anterior neuroectoderm expresses 
Otx2 that in turn activates transcription of Rax; Rax itself then increases 
transcription of several EFTFs like Pax6, Six3 and Lhx2. Proliferation of the EF is 
controlled by Six6 in a Rax-dependent way. Rax also participates in suppressing 
the canonical Wnt pathway to prevent the induction of posterior fates of the anterior 
neural plate, and it promotes non-canonical Wnt signalling that controls 
morphogenetic movements of eye cells. Additionally, Rax performs several 
functions that are important for the formation of retinal progenitor cells, their 
proliferation and movement from the midline and outward to contribute to 
evaginating OV. At subsequent steps of the eye formation, Rax also plays a role in 
downregulating the transcription of Otx2 in the cells of the presumptive NR. 




necessary for normal PR gene expression, maintenance, and function (Bailey et 
al., 2004; Fuhrmann, 2010; Martinez-Morales and Wittbrodt, 2009; Pan et al., 
2010). 
Pax6, a TF containing paired-box and homeobox motifs, is the paradigm for a 
master control gene in eye development. Loss of Pax6 function leads to the 
eyeless phenotype in Drosophila (Quiring et al., 1994), and the same happens in 
different organisms as frog, mouse and human. Pioneering work in the nuclear 
reprogramming field showed that ectopic expression of the mouse Pax6 induces 
functional eyes in Drosophila antennae or legs (Halder et al., 1995). The small eye 
(Sey) in mouse is a semidominant mutation in which the homozygous animals 
display no eyes and the heterozygous condition results in multiple ocular 
abnormalities, such as microphthalmia, lens cataracts and iris defects (Hill et al., 
1991). Similar mutations in humans cause the ocular syndrome Aniridia, as well as 
multiple lens and corneal defects (Ton et al., 2014). Pax6 is first expressed in the 
early anterior neural plate, followed by expression on the prospective lens field in 
the surface ectoderm and on the neuroectoderm from where OV evaginates. On 
the OV stage, expression becomes restricted dorsodistally and in the presumptive 
lens ectoderm. In the developing OC, Pax6 is initially expressed throughout but 
then expression is lost in the RPE and only kept at NR level in ganglion and 
amacrine cells. Besides these cell types, expression is also maintained in lens and 
cornea on adult eye (Hever et al., 2006). Since Pax6 null mutants fail to develop 
eyes, conditional gene targeting and chimeric studies provided the way to establish 
its role in later stages of the eye development. Tissue-specific deletion of one copy 
of Pax6 using the Cre/loxP system has shown that correct levels of expression in 
the distal OC are essential for normal iris development.  Dosage levels in the 
surface ectoderm were also shown to be critical for development of the lens and 
cornea (Davis-Silberman et al., 2005). Moreover, other studies have shown that 
Pax6 is required for the multipotent state of retinal progenitor cells, once upon 
Pax6 inactivation these progenitors can lead exclusively to the generation of 
amacrine neurons and not the other NR fates (Agathocleous and Harris, 2009; 
Marquardt et al., 2001). Pax6 also participates in the determination of RPE cells as 
mentioned later on. 
Also classified as EFTFs are two closely related members of the Six/sine oculis 
homeodomain family, Six3 and Six6 (also known as Optx2 or Six9). Loss of 
function mutations on both genes lead to disorders in humans with severe brain 




al., 1999; Wallis et al., 1999). Both genes have expression patterns on mice 
embryos suggestive of their role in early eye development. Early on, Six3 
expression is restricted to the anterior neural plate including areas that later will 
give rise to ectodermal and neural derivatives. Later, Six3 is expressed throughout 
the OV and then in the optic stalk, NR and invaginating lens tissues. Six6, when 
compared to Six3, has an expression pattern quite similar, but more restricted. 
Six6 is expressed in the anterior neural plate, not necessarily in the EF, and 
subsequently in the ventral forebrain and ventral portion of the future NR. 
Thereafter, Six6 is detected in the NR and optic stalk but not in the lens (Jean et 
al., 1999; Lee et al., 2012; Oliver et al., 1995). Ectopic Six3 expression promotes 
the formation of ectopic OV-like structures in developing medaka and mouse 
embryos (Lagutin et al., 2001; Loosli et al., 1999) Furthermore, overexpression of 
Six3 in zebrafish embryos induces enlargement of the rostral forebrain (Kobayashi 
et al., 1998). Six3 has been known to play a role in the formation of anterior neural 
plate structures, and thereafter on NR specification, both through inhibition of Wnt 
signaling (Lagutin et al., 2003; Liu et al., 2010). Concerning lens specification, Six3 
also plays a role, namely through direct activation of Pax6 (Liu et al., 2006). 
Similarly, Six6 overexpression leads to an enlargement of the eye tissue and 
transformation of anterior neural plate into retinal tissue in Xenopus. Moreover, 
Six6 has shown to be capable of inducing transdifferentiation of RPE into NR, thus 
suggesting that Six6 role in eye development lies on NR development (Wawersik 
and Maas, 2000; Zuber et al., 1999).  
Another EFTF is Lhx2, a member of the LIM homeobox-containing TFs family. In 
mice embryos, Lhx2 expression has been observed in the anterior neural plate 
prior to OV formation. Subsequently, in the OV Lhx2 expression becomes 
progressively restricted to the NR and its inner nuclear layer. Null embryos display 
severe forebrain defects and anophthalmia, revealing its role in patterning the 
forebrain and particularly in eye development. Lhx2 is essential for progression of 
the OV to the OC stage, since Lhx2-/- embryos have normal OV specification but 
OC and lens placode fails to occur (Porter et al., 1997). Although Lhx2 
overexpression per se did not induce ectopic eye structure formation, 
overexpression of various combinations of EFTFs factors other than Lhx2 only 
induced ectopic eyes when endogenous Lhx2 expression was upregulated (Zuber 
et al., 2003). Expression of important EFTFs, namely, Rax, Pax6, and Six3, at the 
anterior neural plate stage was found to be reduced in Lhx2 mutants, further 




Lhx2 is also required for Six6 expression initiation in the OV, cooperating 
synergistically with Pax6, and thus promoting establishment of definitive retinal 
identity and cellular proliferation (Tétreault et al., 2009). Recent reports also 
highlighted an ongoing role of Lhx2 to maintain optic identity across multiple 
stages, from the formation of the OV to the differentiation of the NR, by 
continuously suppressing alternative fates (Roy et al., 2013). Furthermore Lhx2 
regulates OV patterning and lens formation in part by regulating BMP signaling, 
either in an autocrine or paracrine manner, respectively (Yun et al., 2009). 
Nr2e1 (also known as Tlx, Tll, and Tailless) encodes a highly conserved TF known 
to be a key stem cell fate determinant in both the developing mouse forebrain and 
retina. In the mouse embryo it is detected in the developing forebrain as soon as 
E8 in few adjacent cells of the neural epithelium. Its expression is then intensified 
and spread, including into the evaginating OV. Later on, Nr2e1 expression 
becomes restricted to the innermost surface of the retina and reaches its maximum 
intensity at E15.5, suggesting a role for this gene in an early phase of 
retinogenesis. Notwithstanding brain and behavioural phenotypes, Nr2e1-null mice 
have retinal and optic nerve dystrophy, leading to blindness. The proliferation rate 
of retinal progenitor cells is affected and increased apoptotic levels in the ganglion 
cell layer is observed, which results in a marked reduction in thickness of the 
distinct layers in the adult retina (Monaghan et al., 1995; Schmouth et al., 2012; 
Young et al., 2002). In Xenopus, it has been described that Six3 and Pax6 
expressed early in EF can induce Nr2e1 expression. Conversely Nr2e1 is capable 
of regulating the expression of these TFs and other EFTFs with whom it is not co-
expressed, supporting a role in eye formation and maintenance (Zuber, 2010). 
Finally, T-box 3 (Tbx3) is a member of the T-box gene family, first identified as ET 
(eye T-box) in Xenopus. In this animal model, it is expressed in the early EF with a 
more restricted pattern in the anterior neural plate when compared with the other 
EFTFs. Misexpression of Tbx3 in frog embryos results in abnormal eye 
morphogenesis, loss of ventral retinal markers, and when expressed medially, 
fused retinas. Tbx3 has also been shown to regulate the expression of other 
EFTFs in vivo and in vitro and to be a crucial component of a cocktail of EFTFs 
sufficient to induce ectopic eye formation in Xenopus (Zuber, 2010). However, 
homozygous mutations of Tbx3 are embryonic lethal in mice but with no described 
eye phenotype, which supports its role in regulating early embryo development, but 
questions its requirement for eye field specification. Additionally, Tbx3 has been 




differentiation, regulating its self-renewal. Moreover, knockdown of TBX3 during 
differentiation of ES cells reduced neural rosette formation as well as the 
expression of neuroepithelial and neuroectoderm markers (PAX6, LHX2, and 
RAX), suggesting a role in promoting neuroepithelial differentiation (Esmailpour 
and Huang, 2012). Interestingly, Tbx3 significantly improves the quality of iPS cells 
in reprogramming protocols when it is used along with Oct4, Sox2 and Klf4 (Han et 
al., 2010).   
In summary, in the early embryo several TFs are expressed in the anterior neural 
plate within a single EF which contains the primordial cells that will give rise to the 
vertebrate eye. Splitting of the single EF in two occurs in parallel with the 
introduction of the midline. Sonic hedgehog (Shh) and TGFβ/nodal pathways have 
been described to be involved in this step preceding OV formation (Chow and 
Lang, 2001). 
 
2. Optic vesicle 
When the splitted EF begins to evaginate, it gives rise to two OV that progressively 
become closer to the surface ectoderm. Initially, OV cells are indistinguishable and 
express a common set of TFs. Neuroepithelial cells are bipotential and the 
presumptive retina is able to develop into RPE cells. Conversely, prospective RPE 
can differentiate into the retina (Coulombre and Coulombre, 1965; Pritchard, 1981). 
Due to the evagination process, the distal part of the OV, the prospective NR, is in 
contact with the surface ectoderm, whereas its dorsal part, the presumptive RPE, 
faces the extraocular mesenchyme. Exogenous signals originating from these 
tissues play an instrumental role in influencing the initial patterning of the OV into 






FGF signalling is responsible for the patterning of the retina in the distal OV, as 
well as for initiation of retinal neurogenesis later on. FGF ligands and receptors are 
profusely expressed in ocular and extra-ocular tissues and particularly, FGF1 and 
FGF2 are expressed by the lens ectoderm facing the prospective NR. In chick 
embryos, inhibition of FGF2 signalling blocked neural differentiation in the 
presumptive NR, without affecting pigmented epithelial cell differentiation. 
Figure 1.13: Patterning of the OV in the presumptive NR and RPE.   
(a) At E8-E9, the initial patterning of the OV into distal NR and proximal RPE domains is 
mediated by head surface ectoderm (SE) and surrounding mesenchyme. FGFs secreted 
from the SE (blue arrows) promote NR differentiation while a TGFβ family member 
secreted from the mesenchyme (yellow arrows) promotes RPE cells’ fate. Shh emanating 
from the ventral forebrain (red arrows) promotes formation of the optic stalk from the ventral 
portion of the OV. (b) The external signalling clues instruct the regionalization of the OV, 
and several TFs acquire region-specific expression. Namely, Chx10 (or Vsx2) is 
upregulated in the NR (blue) and Mitf expression is restricted to prospective RPE (in 
yellow). (c) The earliest lens structure, the lens placode (LP), is essential for promoting 





Moreover, addition of FGF to the OV causes the presumptive RPE to undergo 
neuronal differentiation and, as a consequence, a double retina is formed (Pittack 
et al., 1997). In mouse embryos the ectopic expression of FGF molecules in the 
proximal region of the OV also resulted in a duplicate NR (Nguyen and Arnheiter, 
2000). Additionally, FGF signal is transduced through the tyrosine kinase type FGF 
receptors that activate a wide variety of signalling transducing cascades, including 
the MEK – ERK (also known as mitogen-activated protein kinase, MAPK) pathway. 
Ectopic expression of constitutively active Ras was also sufficient to convert the 
RPE into NR, highlighting that activation of MAPK pathway may mediate FGF-
induced repression of RPE (Zhao et al., 2001). This repression of the RPE 
phenotype is mediated by a homeobox gene Vsx2 (also known as Chx10), the 
earliest gene that shows domain-specific expression for the retina. In Vsx2 null 
mutant mice, FGF can no longer induce transdifferentiation of RPE into the retina. 
Consistently, loss of Vsx2 activity mimics FGF loss-of-function resulting in a retina-
into-RPE transdifferentiation (Horsford et al., 2005). This Vxs2 action may be 
mediated by directly suppressing transactivation of Mitf gene in the distal OV, a 
critical TF for RPE identity as discussed later on. 
Midline tissue-derived Shh molecules play critical roles in establishing the bilateral 
EF, as mentioned before, but also in determining the proximal–distal axis of the 
eye primordium. Experiments in chick embryos highlighted Shh role in coordinating 
dorsal-ventral patterning of the eye at OV stage. Shh activity is also required for 
eye morphogenesis during the transition from the OV to the OC, as well as after 
initial formation of the double-layered OC (Zhang and Yang, 2001). 
On the other hand, members of TGFβ family favour the specification of the RPE. In 
explant cultures of chick OV after removal of surrounding extraocular 
mesenchyme, RPE development did not occur. Extraocular mesenchyme was 
shown to be required for the induction and maintenance of expression of the RPE-
specific genes (such as Mitf), inhibition of the expression of NR-specific TF Vsx2 
and downregulation of EFTFs (Pax6 and Six6). Furthermore, TGFβ family member 
Activin A was shown to mimic the effects of the extraocular mesenchyme. Activin 
ligands and receptors are expressed in the surrounding mesenchyme and in the 
OV, respectively (Fuhrmann et al., 2000).  
Also belonging to the TGFβ superfamily are BMPs.  Several BMP ligands and their 
receptors are expressed in the developing chick and mouse eye and surrounding 
tissues. BMP treatment of chick OV converts cells of the presumptive optic stalk 




BMP signalling at OV stages inhibits RPE formation and induces NR-specific gene 
expression in the outer OC (Müller et al., 2007). Thus, TGFβ signalling plays a role 
in establishing RPE identity, with signals originating from both the extraocular 
mesenchyme and the surface ectoderm. 
Moreover, Wnt signals, which are context-dependently transduced via the 
noncanonical or canonical signalling pathways, were recently shown to mediate 
RPE specification by a GSK3β-dependent but β-catenin-independent pathway. 
Wnts (namely Wnt2b) and BMPs are released from the surface ectoderm to specify 
the RPE cooperatively. Surface ectoderm removal at early OV stages or inhibition 
of Wnt, but not Wnt/β-catenin, signalling prevents pigmentation and downregulates 
Mitf expression. This effect is rescued by both activation of BMP or Wnt signaling. 
Thus, Wnt signalling from the overlying surface ectoderm was proposed to be 
involved in restricting BMP-mediated RPE specification to the dorsal OV (Steinfeld 
et al., 2013). 
In addition to signalling molecules, patterning of OV is also specified by TFs, in 
particular Lhx2. As mentioned before, in Lhx2-/- mouse embryos, eye field 
specification and OV morphogenesis occur, but development arrests prior to OC 
formation. This is accompanied by failure to maintain or initiate the expression 
patterns of OV-patterning. Lhx2 is cell-autonomously required for expression of 
TFs determinants of RPE and NR in the OV (namely Mitf and Vsx2). Moreover, 
Lhx2 also influences OV patterning by modulating BMP signalling (Roy et al., 2013; 
Yun et al., 2009). 
Regarding RPE specification, signalling molecules previously mentioned instruct 
the cells of the dorsal OV towards a RPE fate by activating/repressing a network of 
TFs. Contrarily to early EF, only a small number of TFs have been proven to be 
essential to RPE specification: Mitf, Otx1 and Otx2, and Pax6. 
Microphthalmia-associated transcription factor Mitf, which encodes a basic 
helix-loop-helix leucine-zipper (bHLH-LZ) protein at the mouse microphthalmia 
locus, plays important roles in many developmental pathways, including the 
differentiation of melanocytes of neural crest origin and neuroepithelial-derived 
RPE.  Mice with mutations at this locus display loss of pigmentation, reduced eye 
size, failure of secondary bone resorption, reduced numbers of mast cells, and 
early-onset of deafness (Hodgkinson et al., 1993). Mutations in the MITF gene, the 
human counterpart of the Mitf gene, are associated with dominantly inherited 




which are characterized by sensorineural hearing loss and abnormal pigmentation 
of the hair and skin (Tassabehji et al., 1994). Mitf belongs to the bHLH-LZ family of 
TFs and thus the basic region permits the binding to the E box motif (CANNTG), 
and the HLH-LZ region allows it to form homodimers or heterodimers with the 
related TFs TFE3, TFEB and TFEC. In mice and humans, MITF gene encodes a 
family of at least 10 distinct isoforms generated from the same gene by alternative 
promoter/exon usage (Bharti et al., 2008; Li et al., 2010b). MITF-M is specifically 
expressed in melanocytes originating from neural crest and in melanoma cells. 
Isoforms MITF-A, MITF-H and MITF-J are expressed in variable levels in different 
cell types, including the RPE. Relevantly, MITF-A is the most abundantly 
expressed in the RPE. The expression of MITF-D isoform has been found in RPE, 
macrophages, osteoclasts and mast cells, but not melanocytes and melanoma 
cells. Isoforms MITF-E and MITF-Mc are specifically expressed in mast cells, whilst 
MITF-CX has been shown to be expressed in human cervical stromal cells (Amae 
et al., 1998; Hershey and Fisher, 2005; Li et al., 2010b; Šamija et al., 2010; 
Shibahara et al., 2000). 
During the eye developmental process in the mouse, Mitf is initially expressed 
throughout the entire OV, but subsequently its expression is restricted to the dorsal 
portion and downregulated in the distal part when Vsx2 expression is initiated. 
Moreover, in Mitf mutant embryos, at least the dorsal part of the future RPE 
becomes thickened, loses expression of a number of specific TFs, gains 
expression of NR-specific genes (such as Six3, Chx10 and Crx), remains 
unpigmented and eventually transdifferentiates into a laminated second retina 
(Nguyen and Arnheiter, 2000).  As mentioned earlier on and to summarize, Mitf 
expression is downregulated by FGF signalling and Vsx2 TF, and upregulated by 
Activin, BMP and Wnt signalling pathways as well as Lhx2 TF. Moreover, Pax6 and 
Otx genes also regulate Mitf expression, in the context of OV patterning events 
(Bharti et al., 2006). 
Mitf binds and transactivates the promoter regions of genes involved in the terminal 
differentiation of the RPE, including the melanosome glycoprotein QNR17, 
melanogenic enzyme Tyrosinase and the Tyrosinase-related protein TRP-1 and 
TRP-2. This transactivation occurs through specific binding of Mitf to M-boxes and 
E-boxes containing the hexameric E-box containing motif present in the promoter 
regions of these genes (Martínez-Morales et al., 2004; Murisier et al., 2007). 
Besides cell differentiation, Mitf also plays a role in regulating cell proliferation. 




At least in melanocytes, Mitf-M isoform has been described to inhibit cell 
proliferation, through stimulation of the transcription of two negative regulators of 
the cell cycle: the CIP/KIP family member p21 and Ink4a. Aditionally, Mitf controls 
cell proliferation indirectly through the regulation of tyrosinase, which catalyzes 
DOPA synthesis and in turn, DOPA negatively regulates cell proliferation (Bharti et 
al., 2006; Nguyen and Arnheiter, 2000). 
The orthodenticle-related TF Otx1 and Otx2 are homeodomain TF with an 
essential role in anterior head formation (as described earlier for Otx2). The two 
Otx genes appear to cooperate in some aspects of vertebrate brain morphogenesis 
since a minimum level of OTX protein is required for the patterning of the anterior 
brain (Suda et al., 1999). In the vertebrate eye, both Otx1 and Otx2 are initially 
expressed throughout the OV.  Later Otx2 becomes specifically restricted to the 
presumptive RPE territory. After that regional specification of the eye is achieved, a 
second wave of Otx2 expression was found also in the NR, particularly in 
postmitotic neuroblasts committed to both neuronal and glia cell types. Studies 
involving mutant mice revealed that both Otx1 and Otx2 genes are required in a 
dose-dependent manner for the normal development of the eye. Mice deficient in 
Otx genes present clear defects in the patterning of the RPE, which is replaced by 
a NR-like territory. The expression of Mitf and Tyrosinase is largely absent and 
conversely upregulation of Pax6, Six3 and Pax2 is observed (Martinez-Morales et 
al., 2001). Furthermore, Otx2 induces a pigmented phenotype, as Mitf, when 
overexpressed in avian NR cells. Additionally, Otx2 binds specifically to a bicoid 
motif present in the promoter regions of QNR71, TRP-1, and tyrosinase genes, 
transactivating them (as is described for Mitf). Both Otx2 and Mitf co-localize in the 
nuclei of RPE cells, physically interact with each other and operate cooperatively in 
transactivating the mentioned RPE-specific promoters. Since in Mitf mutants Otx2 
is missing, and it is not possible to simply place Otx genes above Mitf genetically, 
the current hypothesis is that both TF might collaborate at the same hierarchical 
level to establish the identity of the RPE (Martínez-Morales et al., 2003a). 
As already mentioned, Pax6 plays a fundamental role in the eye developmental 
process and, if in mice Pax6 is missing entirely, OVs fail to form properly and eye 
development is aborted. Regarding differentiation of the RPE, it has shown to 
delay it (delayed or absent pigmentation) whilst not fully preventing it (Collinson et 
al., 2003). Another member of the paired box family of TF, Pax2, has also been 
implicated in some steps. Pax2 has a similar expression pattern when compared to 




entire structure, whilst Pax2 is expressed mainly in the ventral portion. Pax2, 
contrarily to Pax6, is not expressed in the lens ectoderm. At the OC stage, Pax6 is 
initially expressed in all tissues but then expression is lost in the developing RPE. 
On the other hand, Pax2 expression is restricted to the ventral NR that surrounds 
the closing optic fissure and the presumptive glia cells of the optic nerve (Baumer 
et al., 2003). Loss-of-function mutants have revealed crucial roles for Pax2 in the 
generation of the optic stalk and for Pax6 in the development of the OC, and 
results point out to the notion that the position of the OC/optic stalk boundary 
depends on Pax2 and Pax6 expression (Schwarz et al., 2000). Double null mice 
present small OV with a partial decrease on Mitf expression. It has been proposed 
a redundant function of both paired box TFs in the RPE specification, supported by 
their shared ability to bind and transactivate Mitf promoter through the same 
binding site (Baumer et al., 2003). However, Pax2 contribution has also been 
questioned and some evidence supports the idea that Pax2 may act as a negative 
regulator of RPE specification while Pax6 is a positive one (Martínez-Morales et 
al., 2004).  
 
3. Optic Cup 
The distal part of the OV makes contact with the overlying surface ectoderm, 
resulting in the specification of the lens ectoderm. Subsequently, the invagination 
of the lens placode and distal OV occurs, giving rise to a bilayered OC, which inner 
layer will develop into the NR and the outer layer into the RPE. The RPE fate that 
was initially established at the OV stage is now maintained by a concerted effort of 
multiple factors (Figure 1.14). At this point, differentiation and maturations steps 
occur: proliferation in the presumptive RPE ceases, leading to the formation of a 
single layer of cuboidal cells that become pigmented. Structural and functional 
changes take place such as formation of tight junctions, expansion of the apical 
microvilli, invagination of the basal membrane, establishment of polarity and 






Interestingly, OC folding can occur independently of the lens (but not the pre-lens 
ectoderm) or is ectopically induced by Six3 overexpression, suggesting that the 
invaginating lens may not play a role in the formation of the OC. The folding 
process may be dependent of the early specification events on OV stage and on 
the intrinsic properties of the developing epithelial cells. A study conducted in chick 
indicated that invagination was a Ca2+-dependent process. In medaka, the ojoplano 
mutant was identified displaying defects in OC folding. The mutated gene encodes 
for a transmembrane protein that localizes to the basal side of the epithelium and 
might be implicated in the establishment of focal contacts required to allow the 
transmission of contractile morphogenetic forces (Martinez-Morales and Wittbrodt, 
2009). Moreover, a recent breakthrough work reported that the complex process of 
OC formation was successfully recapitulated in 3D culture of mouse and human 
ES cells. Floating aggregates of ES cells have been cultured in medium suitable 
for retinal differentiation and containing extracellular matrix proteins. ES-cell-
derived epithelium first evaginates as vesicles and then undergoes invagination 
into the NR to form OCs. Furthermore, a multilayered NR is generated with 6 
different types of retinal cells. Therefore in homogeneous culture medium without 
Figure 1.14: Maintenance of RPE phenotype within the OC.  
Several signalling pathways, such as retinoic acid (RA), BMP, Shh and Wnt, are implicated 





external forces, positional cues or physical constraints, the formation of OCs and 
the multilayered NR occurs by self-organization, and is driven by an internal 
program that functions through local intercellular interactions. It is expected that 
these cytosystems dynamic studies will shed light in our knowledge of the 
principles by which organ architecture develops (Eiraku et al., 2011; Nakano et al., 
2012; Sasai, 2013b).  
Upon OC formation, several signalling pathways continue to exert their action 
contributing to RPE specification (Figure 1.14). The Shh signalling pathway was 
shown to be required for this step of maintenance of RPE cell fate in the ventral 
OC. In the mouse, reduced Shh signalling may not affect RPE specification but in 
further steps results in dorsal-ventral patterning defects, with loss of RPE marker 
expression and NR-into-RPE transdifferentiation (Huh et al., 1999). Dorso-ventral 
polarity of the OC is determined by BMPs dorsally and Shh ventrally, which repress 
each other’s action. Two types of TFs seem to be involved in this mutual 
repression, the T-box protein Tbx5, induced dorsally by BMP4, and the ventral 
homeodomain proteins Vax1 and Vax2, induced ventro-proximally by Shh (Bharti 
et al., 2006; Zhang and Yang, 2001; Zhao et al., 2010). BMP signalling is also 
implicated in the maintenance of the RPE in the ventral OC, since overexpression 
of BMP antagonist noggin leads to transdifferentiation of the ventral RPE (Adler 
and Belecky-Adams, 2002). Additionally retinoic acid signalling plays a role at OC 
stage since once perturbed, Pax6, Tbx5 and Bmp4 are ectopically expressed in the 
presumptive RPE, while Otx2 and Mitf are not induced, leading to a dorsal 
transdifferentiation of RPE to NR (Halilagic et al., 2007). 
Wnt/β-catenin signalling activation results in cytoplasmic stabilization of β-catenin, 
which then translocates into the nucleus and associates with TCF/LEF transcription 
factors. TCF/LEF-responsive reporters have been shown to be activated in the 
dorsal OV and in the peripheral and dorsal RPE in the OC. Conditional disruption 
of β-catenin in the mice RPE results in downregulation of Mitf and Otx2 expression 
which is replaced by that of Vsx2 and in consequent RPE-into-NR 
transdifferentiation, causing severe ocular defects such as microphthalmia.. 
Furthermore, β-catenin binds near and activates putative TCF/LEF sites in the Mitf 
and Otx2 enhancers. These results highlighted an essential role for Wnt/β-catenin 
signalling, via TCF/LEF activation, in maintaining cell fate in the developing RPE by 
the direct regulation of Mitf and Otx2 expression. Interestingly, ectopic activation of 




the RPE-like tissue alone, but is capable of doing so when in combination with 
Otx2 (Westenskow et al., 2009, 2010).  
Wnt signalling was also implicated in a regulatory loop together with Pax6 and Mitf 
controlling RPE development. A model has been proposed positioning Pax6 in the 
center of a bi-stable regulatory loop, and providing an anti-retinogenic role for Pax6 
in the developing RPE, besides its retina-promoting activity. In the RPE and 
together with Mitf or its paralog Tfec, Pax6 suppresses the expression of Fgf15 
(positive regulator of retinal development) and Dkk3 (inhibits RPE-promoting Wnt 
signalling). On the contrary, on a NR context, Pax6 promotes FGF signalling and 
inhibits canonical Wnt signalling (through Dkk3 action), thus stimulating the 
expression of retinogenic genes, including Six6 and Vsx2 (Bharti et al., 2012). 
Otx2 also interferes with the definition of RPE-NR boundaries at the OC stage, 
since it prevents the presumptive RPE region from forming the NR by repressing 
the expression of Fgf8 and Sox2, both inducers of the NR cell fate (Nishihara et al., 
2012). Regarding the differentiation and maturation steps, Otx2 cooperates with 
Mitf in the regulation of the expression of the melanogenic genes, as mentioned 
earlier, and also of another RPE-specific gene Bestrophin-1 (Masuda and Esumi, 
2010). Moreover, Otx2 has been shown to control the expression of several groups 
of genes involved in other RPE-specific functions, such as retinol metabolism, pH 
regulation and metal concentration. This regulatory action, in addition to the 
disruption of PR-RPE cell adhesion, explains the non-autonomous RPE-dependent 
origin for PR cell degeneration observed after conditional ablation of Otx2 in mice 
retinas (Béby et al., 2010; Housset et al., 2013). 
In conclusion, several molecular and signalling players work in a concerted and 
integrative way to establish RPE cells over the multistep eye developmental 
process. 
 
Degenerative disorders involving the RPE 
The retina is a complex structure constituted by several cell layers interacting with each 
other. Importantly, RPE cells are crucial for visual function providing multiple support 
roles essential to maintain PRs’ activity of sensing and transmitting visual information. 
Therefore, RPE and PR cells are considered a functional unit that interact synergistically. 
Supporting this idea, multiple diseases have been described resulting from defects on 
genes usually expressed by PRs and compromising its function, which lead to 




any of the known support functions exerted by the RPE will result in degeneration of the 
PR, and consequently loss of retina´s structure and functionality with associated vision 




For example, ABCA4 is a member of the ABCA subfamily of ATP binding cassette (ABC) 
transporters that is expressed in rod and cone PRs of the vertebrate retina. ABCA4 gene 
product was described as a retinylidene-phosphatidylethanolamine transporter that 
facilitates the removal of potentially reactive retinal derivatives from PRs following 
photoexcitation. Over 500 mutations in the gene encoding ABCA4 were described as 
associated with a spectrum of related autosomal recessive retinal degenerative diseases 
including Stargardt’s macular degeneration. Stargardt’s disease is characterized by a 
significant loss in central vision in the first or second decade of life, bilateral atrophic 
Figure 1.15: Healthy and degenerated RPE: implications for retina’s overall structure. 
(A) Healthy RPE cell layer in close interaction with Bruch’s membrane (BM) and PRs’ OS. 
(B) Degenerated RPE cells lose epithelial phenotype and become a discontinuous layer of 
cells, with loss of tight junctions between them and loss of adherence to BM. RPE 
phagosomes (Ph) may be lacking, resulting in inability to phagocytose the daily shed of OS. 
Consequently, PR cells also degenerate and the complex retina structure imperative for its 




changes in the central retina associated with degeneration of PR and underlying RPE. 
The clinical picture is of yellow flecks extending from the macula, the central posterior 
portion of the retina with the densest concentration of PR and responsible for central 
high-resolution visual acuity. These flecks correspond to abnormal accumulation of the 
toxic pigment lipofuscin in the PRs and subsequently in the RPE (Allikmets et al., 1997; 
Molday and Zhang, 2010). 
On the other hand, several retinal disorders characterized by PR and associated retinal 
circuitry degeneration have been described to result from disruption of the various 
support functions of the RPE, namely protection against photo-oxidative damage, 
transepithelial transport, visual cycle, phagocytosis of OS and secretion of growth factors 
(Strauss, 2005). Particularly, Retinitis Pigmentosa (RP) refers to a group of inherited 
retinal degenerations with a very variable clinical course, though most patients report 
problems with night blindness and progressive peripheral visual field loss, leading to 
tunnel vision, often followed by blindness. There are over 100 defined mutations that 
may lead to RP, many of each code for genes in PR (Hartong et al., 2006). However, 
many RP subtypes begin with primary failure of the RPE, as MERTK-associated 
autosomal recessive RP. MERTK is required for phagocytosis of PRs’ OS by the RPE 
and once absent, RPEs’ phagocytic ability is impaired, resulting in accumulation of 
subretinal debris and subsequent PR loss via apoptosis and retinal degeneration (Gal et 
al., 2000). 
Another example is Leber Congenital Amaurosis (LCA), a rare hereditary retinal 
degeneration caused by mutations in more than a dozen genes. LCA2 is associated with 
mutations in RPE65 gene, which is almost exclusively expressed in the RPE and 
functions as retinoid isomerase involved in the recycling all-trans-retinol to 11-cis-retinal. 
Improper functioning or absence of RPE65 results in a lack of 11-cis-retinal production 
and an inability to efficiently form the visual pigments, rhodopsin and cone opsin. 
Concomitant accumulation of large amounts of all-trans-retinyl esters in the RPE is 
thought to promote PR degeneration (Cideciyan, 2010; Moiseyev et al., 2006).  
In addition to genetic disorders, some multifactorial degenerative diseases affecting the 
retina have also been described, with underlying impairment of RPE functions. Age-
related Macular Degeneration (AMD) is a major cause of blindness worldwide. With 
ageing populations in many countries, more than 20% might have the disorder.  Damage 
to the macular region of the retina results in loss of sharp, central vision. AMD is a 
complex degenerative disorder with a polygenic hereditary component. The major risk 
factors are cigarette smoking, nutritional factors, cardiovascular diseases, and genetic 




matrix pathways. AMD arises as the result of chronic, low-grade inflammatory damage to 
the macular retina, leading to degeneration of the RPE and the Bruch’s membrane. In its 
early stage, there is formation of drusen, basal laminar and linear deposits located 
between RPE and Bruch’s membrane or inside the later, resultant of accumulation of 
metabolic end products. Over time, there is also accumulation of the toxic lysosomal 
protein lipofuscin, consequently to incomplete digestion of the OS discs by the RPE.  
Bruch’s membrane thickness increases, leading to impairment of the import of nutrients 
and export of metabolic products by the RPE cells. The late stage of AMD is divided into 
two forms: nonexudative or “dry” form and an exudative/neovascular or “wet” form. In the 
first, there are atrophic changes in the macula, with the progressive dysfunction of the 
RPE resulting in PR loss. In exsudative AMD, choroidal neovascularization is present: 
there is formation of new abnormal blood vessels in the choriocapillaries through the 
Bruch’s membrane. This neovascularisation is driven by the presence of excess VEGF 
on the apical side of the RPE, which promotes the growth of fenestrated, leaky 
capillaries that allow the build-up of fluid. These new vessels have a greater tendency of 
leakage and bleeding into the macula, ultimately leading to irreversible damage to the 
PRs if left untreated (Ehrlich et al., 2008; Lim et al., 2012).  
Moreover, Diabetic Retinopathy (DR) is another multifactorial disorder in which RPE 
dysfunction may play an important role in its pathophysiology. DR is the main cause of 
blindness in working-age adults in developed countries. It is well known that diabetes 
duration, poor glycemic control, and hypertension are the primary factors accounting for 
the risk of developing DR. Genetic factors may also influence either the onset or the 
severity of DR.  Neovascularization due to severe hypoxia is the hallmark of proliferative 
DR, which is the commonest sight-threatening lesion in type 1 diabetes. In type 2 
diabetes, the primary cause of poor visual acuity is diabetic macular edema 
characterized by vascular leakage due to the breakdown of the blood retinal barrier. 
Impairment of RPE’s functions contributes to the pathogenesis of DR, namely its 
secretion ability. Overproduction of VEGF plays an essential role in the development of 
proliferative DR. The pathogenesis of diabetic macular edema remains to be fully 
understood, but VEGF and proinflammatory cytokines have been showed to be involved 
in its development. Nonetheless, the balance between angiogenic (i.e., VEGF) and 
antiangiogenic factors (i.e., PEDF) plays a crucial role in the development of DR (Heng 






Choroideremia (CHM) is an X-linked recessive retinal dystrophy characterized by 
progressive degeneration of the PRs, the RPE and the choriocapillaries. CHM is a 
rare monogenic disease, with a described prevalence of 1 in 50000 to 1 in 100000 
(Moosajee et al., 2014). It is caused by loss-of-function mutations in CHM/REP1 
gene (Xq21.2), which encodes for Rab Escort Protein 1 (REP1), important for the 
regulation of the intracellular membrane trafficking machinery (van Bokhoven et al., 
1994; Cremers et al., 1990). 
CHM has an X-linked pattern of inheritance with affected males developing night 
blindness in their first or second decades of life. Usually visual acuity decreases 
very slowly until subjects reach the fifth decade of age, at which time the rate and 
extent of vision loss becomes significantly higher. Progressive visual field 
restrictions with loss of peripheral vision are observed, resulting in tunnel vision 
and ultimately in complete blindness (Coussa et al., 2012; Roberts et al., 2002). 
Taking advantage of ophthalmoscopy techniques, fundus autofluorescence and 
electrophysiological measurements, several studies have revealed a variability of 
disease severity, whilst some common traits are observed. Moreover, no genotype-
phenotype correlation was determined so far (Huang et al., 2012; Mura et al., 
2007; Ponjavic et al., 1995; Renner et al., 2006; Zhou et al., 2012).  
Despite the maintenance of good visual acuity in CHM patients until the 
degenerative events affect the central retina, some underlying changes in the 
retina can be identified on earlier disease stages. Typically, patchy depigmentation, 
that progressively extents to pigment loss and visibility of yellow white sclera 
through transparent retina, are observed and constitute a unique feature of CHM, 
when compared with other retinal dystrophies. Moreover, it has been described a 
thickening of the retina on earliest stages, whilst still maintaining its normally 
laminated structure. Further thickening and disorganization of the retina occurs 
subsequently to the loss of PRs, either independently or associated with RPE 
depigmentation. Finally, in the subsequent decades, a centripetal thinning of the 
dysmorphic retina is observed (Jacobson et al., 2006).  
The majority of female carriers of mutations on REP1 gene are asymptomatic, 
with no alterations on visual acuity, notwithstanding some characteristic alterations 
in fundus autofluorescence are detected (Coussa et al., 2012; Preising et al., 2009; 
Renner et al., 2009). However, fundus alterations and retina dysfunction can 
progress over time and, in some rare cases, female carriers are severely affected 




Renner et al., 2009). Mosaic distribution of abnormal retina areas was also 
observed, which was attributed to random X-chromosome inactivation leading to 
variability in the inactivated and activated gene copy in each cell (Rudolph et al., 
2003; Vajaranant et al., 2008). Disease manifestations in females may also be due 
to X-autosomal translocations involving Xq21, which lead to disruption of CHM 
gene (Lorda-Sanchez et al., 2000; Mukkamala et al., 2010). 
Loss-of-function mutations of CHM gene underlie CHM. This gene spans a 
genomic sequence of approximately 150 kb on chromosome Xq21.2, containing 15 
exons and encoding a ubiquitously expressed protein of 653 amino acids: the 
REP1 protein. REP1 plays a crucial role as a regulator of Rab GTPases’ activity. 
More than 60 different Rab proteins belonging to Ras superfamily of small 
GTPases have been described so far, functioning as regulators of intracellular 
vesicular transport and organelle dynamics. Rab GTPases regulate vesicle 
budding, vesicle tethering and fusion in vesicular transport, as well as vesicle 
motility given their role in recruiting molecular motors to organelles. Additionally, 
they coordinate intracellular signalling events with membrane traffic and define 
organelle identity through attribution of functionally distinct subdomains within a 
particular membrane (Seabra and Wasmeier, 2004; Seabra et al., 2002; Stenmark, 
2009). 
Rab GTPases act as molecular switches, cycling between an active GTP-bound 
and an inactive GDP-bound state, which correlates with phases of association and 
of dissociation with the target membrane. The GTP/GDP switch along with the 
membrane association/dissociation cycle allows both spatial and temporal control 







Rab proteins are intrinsically soluble proteins, requiring post-translation 
modifications in order to associate with cellular membranes. Rab GTPases are lipid 
modified on the C-terminus in a process termed prenylation and consisting of the 
covalent attachment, via thioether linkage, of C20 (geranylgeranyl) isoprenoid 
groups to C-terminal cysteine residues in the context of a prenylation motif. Rab 
proteins exhibit a variety of prenylation motifs at their C-termini, containing either 
one or, more frequently, two cysteine residues, both of which are modified by 
geranylgeranyl groups. This prenylation reaction is catalysed by Rab 
geranylgeranyl transferase (Rab GGTase or GGTase II), a heterodimeric enzyme 
composed of α and β subunits. However, prenylation motifs of Rab proteins are 
Figure 1.16: Rab proteins’ cycle showing membrane recruitment and activation. 
(a) Newly synthetized Rab GTPases associate with REP protein forming a stable complex 
(1), essential for the recognition of Rab proteins by heterodimeric Rab geranylgeranyl 
transferase (RabGGT or GGTase II). This enzyme is responsible for attaching 
geranylgeranyl groups to C-terminal cysteines in Rab proteins (2). Following this lipid 
transfer, REP protein is thought to deliver the prenylated Rab to the donor membrane (3) 
and then recycles to bind other nascent Rab protein (4). (b) Equivalent role is played by 
Rab GDP-dissociation inhibitor (GDI) in the case of recycling Rabs. RabGDI is thought to 
retried Rab proteins from target membranes (1) and maintain them in the cytosol in a stable 
complex (2). GDP-bound Rab is eventually delivered to the donor membrane by the 
RabGDI (3), which then recycles back to the cytosol. Both REP and RabGDI proteins 
specifically bind to the GDP-bound state of Rab proteins. After dissociation of the soluble 
regulator (REP or GDI), specific Rab guanine nucleotide exchange factors (GEF) are 
responsible for the exchange of the bound GDP for GTP, activating the Rab and stabilizing 
it on the membrane. Activated GTP-bound Rabs recruit a wide variety of downstream 
effector molecules to the membrane, which reflects the diverse functions Rabs play in 
membrane traffic. GTP hydrolysis catalyzed by a GTPase- activating protein (GAP) returns 




insufficient for GGTase II recognition, requiring prior binding of newly synthetized 
Rabs to REP protein (previously designated as component A of GGTase) (Leung 
et al., 2006; Seabra et al., 1992; Shen and Seabra, 1996). Rab:REP complex 
functions as GGTase II substrate and, after the transfer of one or two isoprenoid 
groups, the ternary complex remains associated until the binding of a new 
geranylgeranyl diphosphate (GGpp) molecule. This, in turn, stimulates the release 
of the GGTase II:REP complex. REP then escorts the prenylated Rab protein to its 
target membrane. 
Closely related to REP protein, both in sequence and structure, is Rab GDP-
dissociation inhibitor (GDI) protein. Functionally however, RabGDI protein has a 
distinctive role as an important regulator of the recycling of Rab proteins by 
mediating their reversible association with membranes. This important distinction is 
based on RabGDI inability to assist lipid modification of Rab proteins by GGTase II. 
Crystal structures of REP:GGTase II complex revealed that features observed in a 
small number of critical residues located at the interface of the two proteins are 
critical for their interaction. A highly conserved phenylalanine in REP, which is 
absent in RabGDI, is critical for the ability of REP to interact with GGTase II and 
form a complex. However, a geranylgeranyl binding site conserved in REP and 
RabGDI has been identified. Structural data of Rab7:REP complex also revealed a 
remarkable structural similarity with crystal structure of a complex between yeast 
RabGDI and Ypt1 (the yeast homologue of Rab1) (Pylypenko et al., 2003; Rak et 
al., 2004). 
In CHM, over 130 unique mutations of CHM/REP1 gene have been reported so 
far, including deletions, insertions, duplications, translocations, nonsense, splice-
site, frameshift and missense mutations. Full and partial gene deletions along with 
nonsense mutations resulting in truncated and therefore non-functional forms of 
REP1, account for 55-80% of all cases. Two missense mutations have been 
reported, being responsible for tertiary structure destabilization or inability to 
interact with GGTase II (Esposito et al., 2011; van den Hurk et al., 1997a; 
Moosajee et al., 2014; Sergeev et al., 2009). 
Notwithstanding the underlying CHM loss-of-function mutations, the molecular 
pathogenesis of CHM remains speculative. Two REP proteins are found in 
mammals, sharing 75% amino acid identity, and both are ubiquitously expressed in 
many tissues, including the several retinal layers (Keiser et al., 2005). REP2 
protein, a REP1 homolog, is encoded by autosomal CHML (CHM-like) gene. In an 




REP1 function in all cells except in the eye, thus leading to the slow-onset retinal 
degeneration characteristic of CHM and the limited nature of CHM clinical 
manifestations (Cremers et al., 1994; Seabra, 1996). However, REP2 
compensation is only partial since peripheral cells of CHM patients (like skin 
fibroblasts and monocytes) have been shown to display increased pH levels in 
lysosomes, reduced rates of proteolytic degradation and altered secretion of 
cytokines when compared to normal cells. Moreover, it has been proposed that 
these changes could be monitored and potentially correlated with disease severity 
(Strunnikova et al., 2012, 2009). 
Previous studies suggested that the molecular basis of CHM could reside in the 
existence of some Rabs that are selectively underprenylated in the absence of 
REP1. One such candidate is Rab27a, which was found to be underprenylated in 
lymphoblasts of CHM patients. Rab27a is highly expressed in the RPE and 
choroid, two cell layers usually affected in CHM (Seabra et al., 1995). Its 
underprenylated status may be due to relying only in the less efficient REP2 
prenylation reaction. Rab27a has been shown to bind equally well to both REP1 
and REP2, but with REP2-Rab27a complex displaying a lower affinity for GGTase 
II when compared with REP1-Rab27a. Moreover, Rab27a has a relatively low 
GTPase activity, resulting in a higher proportion of the inactive form of this 
molecule and concomitantly decreasing the affinity of the REP interaction in vivo 
(Larijani et al., 2003). Additionally, in CHM all prenylation reactions are provided by 
the REP-2 protein, with Rab molecules with a higher affinity for REP2 (Rab7 and 
Rab1A) competing with Rab27A for prenylation (Rak et al., 2004). However, CHM 
patients do not present absence of the pigmentation and immune system defects 
characteristic of type I Griscelli syndrome. This syndrome is caused by a defect in 
the RAB27A gene, indicating that loss of REP1 in CHM does not result in complete 
loss of Rab27a function in all tissues. Thus, it is likely that a more generalized 
effect of REP1 deficiency on multiple Rab proteins accounts for the retinal 
phenotype of CHM (Seabra et al., 2002). For instance, recent results point out to 
the possibility that impairment of Rab27b and Rab38 prenylation rate could 
contributing to CHM pathogenesis (Köhnke et al., 2013). 
Alongside with the still controversial molecular mechanism underlying CHM 
pathogenesis, it is still debatable if the degeneration of the PRs, the RPE and the 
choroid occur independently or sequentially layer-by-layer. Around the 1950s, 
McCulloch and colleagues proposed that choroid atrophic alterations resulted in 




contradictory theories were proposed: the primary cause of CHM, as suggested by 
the name itself, was a degeneration in the vasculature as supported by the finding 
of vascular endothelial cell abnormalities throughout the uveal tract, including the 
posterior choroid with loss of the RPE and NR but also the anterior uveal tract 
(Cameron et al., 1987). Contrarily, observations on a CHM carrier revealed areas 
of abnormal RPE associated with shorter or absent outer segments of the PR cells. 
Later, it was also suggested that the primary defect of CHM was at the level of the 
RPE, due to a probable impairment of its phagocytic ability (Flannery et al., 1990). 
The possibility that the primary event was a degeneration of the rod PRs was also 
raised (Syed et al., 2001).   
Upon the model of CHM disease progression, it was proposed that the early stage 
of thickened yet normally laminated retina was resultant of Müller cell activation 
and hypertrophy due to PR stress. However, it was not conclusively determined if 
this PR damage was a primary or secondary event to RPE dysfunction (Jacobson 
et al., 2006). In other studies involving young CHM patients it was observed that in 
areas where the RPE was preserved or mildly altered, retinal lamination and 
thickness remained remarkably normal. In contrast, areas of RPE and 
choriocapillaries atrophy were observed with overlying preservation of retinal 
thickness albeit with impaired lamination, suggesting that RPE changes could 
precede retinal damage (MacDonald et al., 2009; Mura et al., 2007). Recent 
studies using high-resolution retinal imaging demonstrated abnormalities of fundus 
autofluorescence, retinal layer morphology, and cone morphology and spacing in 
CHM patients and carriers. The pattern of PR degeneration is different from what is 
observed in patients with primary PR degenerations, such as Retinitis Pigmentosa. 
In CHM, both RPE and PR cells were affected, supporting the idea that these cell 
types may degenerate simultaneously (Syed et al., 2013). 
In order to provide some useful insights for understanding CHM pathogenesis, 
animal models of CHM were generated. The current hypothesis that CHM retinal 
degeneration is independent of a primary cell type or retinal layer is supported by 
data obtained from such models. Null mutations of the X-linked Chm gene in mice 
revealed to be embryonically lethal in males, and also in heterozygous females 
when the mutation is of maternal origin. Observed lethality is due to defects in 
trophoblast development and vascularization in mouse extra-embryonic tissues. In 
heterozygous females, preferential inactivation of the paternal X chromosome in 
murine extra-embryonic membranes is observed, resulting in expression of the 




males showed patchy areas of PR degeneration with normal RPE (van den Hurk et 
al., 1997b; Shi et al., 2004). In order to avoid embryonic lethality and to circumvent 
breeding problems caused by the inability to transmit the null allele from carrier 
females, a conditional mouse knockout (KO) of the Chm gene was created. Taking 
advantage of the Cre/ loxP site-specific recombination system, spatial and 
temporal control of the actual KO event was achieved. Heterozygous-null females 
exhibited characteristic hallmarks of CHM: progressive degeneration with 
diminished thickness of the PR layer, patchy depigmentation and thinning of the 
RPE cell layer, and Rab prenylation defects. By histological analysis, no correlation 
was observed between areas of RPE and/or PR degeneration (Tolmachova et al., 
2006). Furthermore, elegant experiments creating separate tissue-specific KO of 
the Chm/Rep1 gene in PR and in RPE did not result in corresponding loss of RPE 
and photoreceptors, respectively, suggesting that the degeneration of these layers 
occurs independently. However, when both PRs and RPE are impaired, PR 
functional deficit and cell death manifest much earlier, suggesting that the diseased 
RPE accelerates PR damage (Tolmachova et al., 2010). 
In zebrafish, loss of rep1 gene results in lethality at larval stages (Moosajee et al., 
2009; Starr et al., 2004). Studies in zebrafish carrying recessive nonsense 
mutations on rep1 gene lead the authors to propose a noncell-autonomous 
degeneration of PR, contrarily to results with rodent models. However, the 
zebrafish model possesses an inherent limitation for replicating the human 
condition, since the zebrafish does not have a second gene parallel to CHML to 
compensate for the lack of rep1. Nevertheless, helpful insights were withdrawn for 
these experiments since mutant RPE cells were not able to effectively eliminate PR 
outer segments, suggesting a defective phagocytosis in CHM. It was also observed 
anomalies in the maturation, size, and density of melanosomes on the RPE cell 
layer, likely reflecting the lack of rep and its role in the prenylation of Rab proteins 
involved in the trafficking of melanin into the melanosomes (Krock et al., 2007). 
Similar observations were made in the RPE-specific Chm KO mice, which 
displayed reduced numbers of melanosomes in the apical processes and delayed 
phagosome degradation. Moreover, disorganised basal infoldings of the RPE cell 
layer were also described (Tolmachova et al., 2010). In human fetal RPE cells, 
siRNA silencing of the REP1 gene lead to reduced degradation of PR outer 
segments, most likely because of the inhibition of phagosome-lysosome fusion 
events, and increased constitutive secretion of inflammatory molecules, such as 




Abnormal melanin granule distribution, absence of basal microvilli and infoldings as 
well as lack of phagocytosis of outer segments by the RPE cell layer have also 
been reported in studies with CHM patients and carriers (Bonilha et al., 2008; 
Ghosh and McCulloch, 1980; Syed et al., 2001). Additionally, inflammatory cells (T-
lymphocytes) at the active lesion have been identified, implying a local immune 
response. Altogether these data point out for striking similarities between the 
mentioned observations and some of the phenotypes reported in AMD (MacDonald 
et al., 2009). Moreover, loss of the CHM gene causes premature accumulation of 
features of aging in the RPE, suggesting that membrane traffic defects may also 
contribute to the pathogenesis of AMD (Wavre-Shapton et al., 2013). 
Current treatment options for CHM are still very limited. Periodic ophthalmologic 
examination to monitor progression of CHM is recommended. A diet rich in fresh 
fruit and leafy green vegetables, antioxidants, omega-3 fatty acids and/or vitamin A 
supplementation have been proposed (MacDonald et al., 2003). 
A more definitive intervention for the treatment of CHM is currently under study. As 
a slowly progressing monogenic disorder, CHM is potentially treatable by gene 
addition therapy. Also in the favour of this approach is the fact that nearly all 
reported cases of CHM so far have been attributed to functionally null mutations 
and the small size of the CHM protein coding sequence (1.9 kb). Preclinical studies 
had very hopeful results, with the gene therapy vector targeting both RPE and PR 
layers, the first layers to degenerate.  Earlier studies using a lentiviral vector 
showed a strong and stable expression of the human CHM/REP1 cDNA transgene 
in the RPE cells but with limited transduction of the NR cell layer (Tolmachova et 
al., 2012). Serotype 2 adeno-associated viral (AAV2) vectors have been shown to 
efficiently target RPE and PR, with no long-term retinal toxicity. They were used to 
provide strong CHM/REP1 cDNA transgene expression in CHM patient fibroblasts 
and CHM mouse RPE cells in vitro and in vivo, as well as in human PRs, with no 
observed toxic effects resulting from the REP1 overexpression (Tolmachova et al., 
2013). Gene therapy using AAV vector encoding REP1 protein is currently being 
studied in a multicentre clinical trial, which includes six male patients with CHM. 
After 6 months, the initial results of this retinal gene therapy trial were very 
optimistic and consistent with improved rod and cone function, overcoming any 






Cell-based therapies for RPE disorders 
RPE defects have a causative role in several retinal degenerative disorders, for which 
the therapeutic options are still very limited and often not curative. These disorders have 
an expected escalating burden among the overall human diseases, given the observed 
increasing longevity of the human population. The search for new therapies is thus of 
paramount importance and the potential use of cell replacement strategies have been 
extensively investigated. 
In such a regenerative medicine approach, the goal is to replace lost or abnormal cells 
(RPE cells alone and/or PR) for functional cells that would integrate properly into the 
already damaged retina structure, with corresponding increase in functionality to 
ameliorate the effects of cell loss on vision. The retina may be an ideal target for cell 
replacement therapies since the eye is easily surgical accessible, and imaging and 
functional monitoring in real time during and after intervention are facilitated by its 
intrinsic transparency. Potential improvements of visual function can be accurately and 
rapidly measured, and compared to the contralateral eye. Furthermore, the blood-retina 
barrier confers a degree of immune-privilege in the healthy eye, which may also be 
advantageous in the case of transplants in diseased eyes. The required number of cells 
may also be very small since it was estimated that 60 000 RPE cells would be sufficient 
to cover the macular region and improve visual function (Borooah et al., 2013; Ramsden 
et al., 2013). 
Proof-of-principle for the replacement of diseased RPE cells has been provided by 
experimental surgeries performed as early as the 1990’s. In the case of AMD, macular 
translocations surgeries in which the macula was moved to the non-diseased periphery 
of the retina and repositioned on top of an area of healthy RPE were performed as well 
as grafting healthy RPE cells from the periphery under the macula. Despite being 
complex and lengthy surgical procedures with high rate of complications, they provided 
evidence that such cell replacement approaches would benefit patients suffering from 
retinal degenerations (Machemer and Steinhorst, 1993; MacLaren et al., 2007). 
Replacement cells could also potentially come from endogenous progenitors. Early 
studies of retinal regeneration in amphibians have demonstrated that a small zone of 
mitotically active cells at the peripheral margin of the retina, the ciliary marginal zone 
(CMZ), responds to retinal damage by upregulating its production of new neurons. 
Additionally to this contribution by the CMZ, the RPE serves as the primary source for 
the formation of an entirely new retina by a process of transdifferentiation. In fishes and 




express embryonic retinal progenitor genes, generating all or only a few types of retinal 
neurons. However, the mammalian retina has a more limited regeneration potential with 
no significant persistent neurogenic sources in the adult CMZ, and Müller glia not 
spontaneously re-entering the mitotic cycle after retina damage. Nevertheless, despite 
the progressive decline in regenerative potential during vertebrate evolution, there are 
reasons for optimism in the possibility that such endogenous repair mechanisms can be 
stimulated in this system in higher vertebrates (Lamba et al., 2008). However, in 
genetically determined retinal degenerations, the endogenous progenitors would carry 
the same underlying genetic alteration thus probably compromising this approach. 
Recently, it was reported that a subpopulation of adult human RPE cells could be 
activated in vitro to a self-renewing cell, the RPE stem cell, with multipotent capacity to 
generate both neural and mesenchymal progeny (Salero et al., 2012). More studies to 
confirm the applicability of such cells are in order. 
Additional described cell sources for retinal replacement therapy comprise human foetal 
stem cells, umbilical tissue-derived stem cells and bone marrow-derived haematopoietic 
and mesenchymal stem cells. Subretinal or intravitreal injections of such cells on a rat 
model of AMD (RCS, Royal College of Surgeons) or a mouse model of RP have been 
performed, with observed improvement in the visual function. Since no definite evidence 
for the attainment of RPE cell morphology and/or functionality was observed in such 
cases, a paracrine rather than a replacement mechanism of repair is presumed to occur, 
with improvements on circulation and secretion of growth factors (Ramsden et al., 2013; 
Stern and Temple, 2011) . 
In recent years, pluripotent stem cells (ES cells and more recently iPS cells) have 
attracted much attention from the scientific community as a potential cell source in such 
retinal replacement therapies. The first account of the rescue of visual function by ES 
cells was that of primate ES cells-derived RPE transplanted into RCS rats. ES cells were 
differentiated into RPE cells prior to transplantation by a co-culture system with stromal 
cells (PA6) to induce neural differentiation. Large patches of polygonal pigmented cells 
expressing PAX6 and RPE-specific genes were observed (Haruta et al., 2004). 
Other approaches to obtain RPE cells from differentiation of pluripotent cells have been 
developed. Overgrowth of human stem cell colonies was observed to result in 
spontaneous differentiation of RPE cells following removal of FGF from the culture 
medium. After a few weeks, pigmented foci develop, from which the RPE-like cells were 
derived (Klimanskaya et al., 2004; Vugler et al., 2008). Later on, the same protocol was 
also successfully applied to human iPS cells (Buchholz et al., 2009; Carr et al., 2009). 




also be achieved using embryoid bodies (EB) grown in suspension that are plated out as 
adherent colonies in neural differentiation medium (Meyer et al., 2009). 
Directed differentiation protocols were also implemented with the addition of exogenous 
factors to first promote ES cells and iPS cells into neuroectodermal lineage, following by 
a step of guided differentiation into RPE-like cells. These stepwise differentiation 
methods begin with serum-free EB culture system in media containing proteins known to 
control specification of neuronal lineage, the WNT and Nodal antagonists, Dickkopf 1 
(DKK-1) and left-right determination factor (Lefty-A), respectively. A retinal precursor fate 
is induced, resulting in the expression of the early EFTFs and RPE-specific genes. Fully 
formed pigmented RPE cells arise from replated EBs after several days in culture 
(Hirami et al., 2009; Ikeda et al., 2005; Osakada et al., 2009). Alternative methods 
include sequential incubation with nicotinamide and then activin A, mimicking the TGFβ 
signalling from the extraocular mesenchyme during OV patterning and which addition 
has shown to promote the appearance of pigmented cells (Idelson et al., 2009). 
Following differentiation of pluripotent cells in RPE-like cells, a thorough step of 
characterization of the obtained cells is necessary to confirm the molecular and 
functional identity of RPE cells (a summary of these criteria was reviewed by (Bharti et 
al., 2011). ES or iPS cell-derived RPE cells have been shown to acquire a pigmented 
and polarized monolayer phenotype and to express RPE-specific genes and proteins 
with known roles on the several RPE functions. Phagocytic ability was also detected. In 
vivo functionality was also confirmed after transplantation into RCS rats or mouse 
models of RP, with observed improvement of visual function (Carr et al., 2009; Li et al., 
2012; Meyer et al., 2009). 
Delivery of the pluripotent cells-derived RPE has been attained by injection of a single-
cell suspension or alternatively, as a preformed monolayer. Preliminary results of a 
clinical trial in which single-cell suspension of human ES cells-derived RPE were very 
optimistic, reporting no evidence for teratoma formation, no vision loss and observed 
new pigmentation near the injection site (Schwartz et al., 2012). However, this delivery 
method has raised some concerns since single-cells might not develop into monolayers 
and likely will raise issues with immune rejection. In order to overcome the disorganised 
fashion in which RPE cells adhere to Bruch’s membrane when injected as a suspension, 
ES cell-derived RPE cells have also been cultured as a monolayer on a thin sheet of 
plastic polymer. This polymer was designed to act as a replacement for the aged and 
thickened Bruch’s membrane, providing an anchor for the cells as well as aiding in 





In addition to these two phase I clinical trials using ES cell-derived RPE, several others 
using different cellular sources, including iPS cells, are in earlier stages of development. 
The scientific community is actively discussing and developing guidelines related with 
tissue sourcing and GMP manufacturing in order to more efficiently and economically 
move stem cell-based therapies for retinal degenerative diseases toward the clinic 
(Bharti et al., 2014).   
In several retinal degenerations, PR loss occurs as a consequence of dysfunction of the 
diseased RPE. In late stages of such degenerative process, a dual replacement of PR 
and RPE cells is likely to be a promising therapeutic strategy. Similarly to RPE cells, 
direct differentiation of ES cells and iPS cells into PR has also been reported (Hirami et 
al., 2009; Lamba et al., 2009, 2010). Furthermore, recent developments have 
demonstrated the self-formation of entire OC from mouse and human ES cells. The 
obtained 3D structures possess a stratified neural retina and RPE which may also be a 
potential route to develop a dual RPE/PR graft that can be used in individuals at later 
stages of the disease with severe neural retina and RPE loss (Eiraku et al., 2011; 
Nakano et al., 2012).  
On the case of iPS cell-based therapies developed for monogenic diseases, gene 
defects must be corrected on iPS cells prior to differentiation and transplantation. Proof 
of principle for this approach was reported by Meyer and colleagues. Human iPS cells 
derived from a patient with gyrate atrophy, a retinal degenerative disease affecting the 
RPE, were differentiated into RPE cells exhibiting a disease-specific functional defect. 
Such phenotype was no longer observed in RPE cells derived from genetically corrected 
iPS cells (Meyer et al., 2011). This study and others, in which retinal degenerative 
disease-specific iPS cells were generated, also highlight the potential use of this 
reprogramming technology to facilitate the study of human retinal development and 






Main goals and thesis overview 
Cellular reprogramming emergent technologies have opened new opportunities for the 
establishment of novel approaches for regenerative medicine, as well as for disease 
modelling, drug discovery and toxicity assessment. Several retinal degenerative 
disorders affect millions of individuals worldwide, ultimately leading to social-impairing 
blindness. Genetic and multifactorial diseases not yet fully characterized and mostly 
without a definitive cure, with underlying defects on the RPE cell layer, cause 
degeneration of the complex retina structure with its consequent loss of function.  
Given the key advantages of prospective RPE transplantation in these pathological 
cases, and also the need for a proper model to further investigate the underlying 
molecular and pathological events, the work described in this thesis aimed at exploiting 
the potential of cellular reprogramming approaches to overcome these lacunas. 
The main goals of the work presented here are: 
 
1. Implement a methodology for obtaining iPS cells from wild-type mouse somatic 
cells, properly characterized to confirm self-renewal and pluripotency traits 
(Chapter 3). 
 
2. Obtain disease-specific iPS cells from a model of a specific retinal degeneration, 
CHM (Chapter 4). 
 
3. Differentiate pluripotent cells (WT and CHM) into RPE cells, in order to establish 
an in vitro disease model or ultimately to provide cells for prospective 
transplantation procedures (Chapter 4). 
 
4. Implement a novel methodology to directly reprogram fibroblasts into RPE cells 




















Chapter 2 : Materials and methods 
Materials 
Standard laboratory chemicals were obtained from Sigma-Aldrich, VWR and Cayman 







Table 2.1: List of antibodies used throughout this work, either for 





Wild-type (WT) animals mentioned throughout this work correspond to C57BL/6 mice, 
which were bred and maintained in the Faculdade de Ciências Médicas’ Animal House 
(Alvará de utilização de animais ao abrigo da Portaria nº 1005/92 de 23 de Outubro).  
The Chm conditional KO mouse Chmflox, MerCreMer+ that carries a tamoxifen (TM) 
responsive Cre-recombinase transgene was previously generated (Tolmachova et al., 
2006). These animals were bred and maintained at the Imperial College London’s 
Animal House. They were treated humanely in accordance with Home Office guidance 
rules under project licence 70/6176 and 70/7078, adhering to the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research.  
Non-obese diabetic/ severe combined immunodeficiency (NOD.Scid) mice were 
obtained from the Instituto Gulbenkian de Ciência Animal House Facility where they 
were also bred and housed. Animal handling was conducted according with institutional 
animal care guidelines and committee-approved protocols. 
 
Cells and cell culture conditions 
Commercially available cell lines were used when referred. However, most of the cellular 
systems employed were either primary cultures of adult somatic cells or pluripotent stem 
cell lines established under the scope of this work. 
All cell lines were maintained at a humidified cabinet at 37ºC and 5% CO2. 
 
Growth and maintenance of mammalian cell lines 
Human embryonic kidney HEK-293A and HEK-293FT were obtained from Life 
Technologies. STAR-Rdpro cells were obtained from the European Collection of Cell 
Cultures (ECACC). Mouse RPE cell line (B6-RPE07) was kindly provided by Dr. Heping 
Xu (Queen’s University Belfast, Ireland) (Chen et al., 2008). These cell lines were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Lonza) supplemented with 10% 
Fetal Bovine Serum (FBS) (Life Technologies), 100 U/mL penicillin and 100 µg/mL 
streptomycin (Pen Strep) (Life Technologies) (DMEM complete). 
Human RPE cell line ARPE19 was obtained from American Type Culture Collection 
(ATCC). This cell line was cultured in 1:1 mixture of DMEM and Ham’s F12 nutrient 
mixture (DMEM/F12) (Lonza) containing 10% FBS and Pen Strep.  
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Bl6 (Black6) Ink4a -/- Melanocytes (Melan Ink4a) (kind gift of Dr Sviderskaya, St 
Georges Hospital, London) (Sviderskaya et al, 2002) were cultured in RPMI 1640 (Life 
Technologies) supplemented with 10% FBS, 2 mM L-glutamine and Pen Strep. PMA 
(Phorbol-1,2-myristate 1,3-acetate) and cholera toxin were added fresh to the medium to 
the final concentration of 200 nM and 200 pM, respectively. 
 
Growth and maintenance of pluripotent stem cells 
Culture of pluripotent stem cells implies distinctive conditions that promote and maintain 
the self-renewal and undifferentiated phenotype in vitro. Since the first reports describing 
establishment of mouse ES cell lines (Evans and Kaufman, 1981), extensive work was 
dedicated to optimize the culture conditions of ES cells. Classically, murine ES cells are 
cultured in serum-containing media and on top of a mitotically inactivated fibroblast layer 
(“feeder cells”) to promote their proliferative and undifferentiated status. Alternatively, 
recombinant cytokine Leukemia Inhibitory Factor (LIF) can be added to the culture 
medium as a substitute of self-renewal feeders’ function (Williams et al., 1988b), given its 
capability to activate JAK-STAT signalling (Matsuda et al., 1999). 
More recently, evidence for a metastable pluripotency level has been shed into light and 
two pluripotent states have been described: a primed committed state and a naïve or 
ground state (Nichols and Smith, 2009). Culture conditions to favour naïve pluripotency 
have been optimized, involving the use of the small molecules MEK/ERK and GSK3 
signalling inhibitors (Silva et al., 2008). This so called 2i/LIF culture conditions have been 
shown to provide an optimal culture environment for mouse ES cells and to promote the 
acquisition of naïve pluripotent status when reprogramming somatic cells into iPS cells. 
Pluripotent stem cells used in this work comprise several established iPS cell lines 
(summarized in Table 2.2) and a mouse embryonic stem cell line ES-CJ7 kindly provided 
by Moises Mallo (Instituto Gulbenkian Ciência, Oeiras, Portugal). Cells were maintained 
in ES medium composed of DMEM supplemented with 15% FBS, Pen Strep, non-
essential aminoacids (Life Technologies), 0.1mM 2-mercaptoethanol (Fluka), and 1000 
U/mL of LIF (Millipore). Before use, 1 µM of MEK inhibitor PD 0325901 and 3 µM of 
GSK3 inhibitor CHIR99021 (both from Cayman Europe) were added fresh to the medium 
(2i/LIF conditions). Pluripotent stem cells were cultured in gelatin-coated dishes, with or 
without feeders (see details for preparation of feeder layer subsequently). Morphology in 
culture was observed carefully and frequently to avoid appearance of colonies with non-
defined edges and flatten structure, reminiscent of loss of undifferentiated state. Cells 




Express (Life Technologies) was used as cell dissociation agent and dilution factors 
ranged from 1:5 to 1:20. 
 
 
Table 2.2: Established iPS cell lines mentioned in this work and corresponding 
genotype, according to Chm alleles and MerCreMer transgene presence/absence. 
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To prepare gelatin-coated dishes, culture petri dishes or multiwell plates’ bottom were 
covered with 0.1% porcine gelatin in phosphate buffered saline (PBS; 137 mM NaCl, 2,7 
mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4) and incubated at 37ºC for at least 30 min. 
Before using, excess of gelatin solution was aspirated. 
 
Mouse Embryonic Fibroblast (MEF) isolation and culture 
Primary MEFs were obtained from WT or Chmflox/flox MerCreMer + pregnant female mice 
on Embryonic day 13.5 (E13.5) according to the protocol described in (Takahashi et al., 
2007b). Briefly, pregnant mice were sacrificed by cervical dislocation and uteri was 
exposed, isolated and washed with PBS twice. Embryos were separated from placenta 
and surrounding membranes and further processed in combination (WT animals) or each 
embryo individually (Chm animals). Head, visceral tissues and gonads were removed 
from isolated embryos. For Chm animals, each embryo’s head was used for genotyping 
purposes. Eventually embryonic eyes were isolated and kept for RT-PCR purposes. 
Remaining bodies were hashed out with scissors in order to provide mechanical 
dissection of the tissues. Enzymatic digestion was followed using 0.12% trypsin/0.1 mM 
Ethylenediaminetetraacetic acid (EDTA) solution (3 mL per embryo), and incubation at 
37ºC for 20 min. Additional 3 mL of same solution per embryo were added, followed by 
another 20 min incubation period. Enzymatic activity was stopped by adding 6 mL of 
DMEM complete per embryo. Cell debris were allowed to deposit for 5 min at room 
temperature (RT). Supernatant was carefully removed and centrifuged at 260 x g for 5 
min. Cell pellet was resuspended in DMEM complete and cells were plated in gelatin-
coated dished (Passage 0, P0). Medium was changed on the following day, after 
washing with PBS to remove floating/death cells. On reaching confluency, cells were 
passaged with 1:3 or 1:4 dilutions. For reprogramming experiments, MEFs were used 
within 3 or 4 passages to avoid replicative senescence. 
 
Preparation of feeder cells to culture pluripotent stem cells 
WT MEFs were used as feeder layer to culture pluripotent stem cells, after mitotic 
inactivation using mitomycin C. MEFs cultured in 10 cm petri dishes (within 5-6 
passages) were incubated with 0.012 mg/mL mitomycin C in DMEM complete medium 
for 2h30 at 37ºC, 5% CO2. Culture medium was removed and cells washed twice with 
PBS. For cell dissociation, cells were incubated with TrypLE™ Express for 5 min at 




for 5 min. The pellet was resuspended in fresh medium and the cell number was 
determined. Mitotically-inactived MEFs (feeders) were plated on gelatin-coated dishes, 
approximately 1.5x104 cells /cm2. On the following day, cells were nicely spread with little 
gaps in between and ready to be used for pluripotent stem cell culture. 
 
Mouse RPE primary cells’ isolation and culture 
Three-week old WT mice were sacrificed by cervical dislocation and eyes were collected 
in PBS. Eyes were dipped in 70% ethanol and then placed in DMEM, without serum and 
antibiotics. Eyes were then incubated in 2% dispase (Life Technologies) in DMEM for 30 
min at 37ºC for gentle dissociation of tissues. DMEM complete medium was used to stop 
enzymatic activity. Cornea, lens and vitreous were removed by piercing with the scalpel 
and cutting the front. Eye cups were subsequently incubated in DMEM complete for 8 
minutes at 37ºC, 5% CO2. Gentle pressure on the eye cup allowed detachment of NR. 
For release of RPE sheets and individual cells, eye cups were flushed with 70 µL pulses 
of DMEM complete. Medium and cells were spinned down at 260 x g for 4 min. Cell 
pellet was resuspended in DMEM supplemented with 5% FBS, Pen Strep, 50 ng/mL 
Amphotericin B and 2.5 mg/mL Gentamycin and plated in 96-well plates. Medium was 
changed after 48 h and everyday afterwards. 
 
Constructs and generation of new molecular tools 
pLenti-TetO-OSKM (#2544) and pLenti-M2rtTA (#2545) mentioned in this work were 
acquired from Addgene and correspond to TetO-FUW-OSKM plasmid 20321 and FUW-
M2rtTA plasmid 20342, respectively. pLenti-TetO-OSKM encodes for 4 genes (Oct4, 
Sox2, Klf4 and c-Myc) separated by self-cleaving 2A sequences (P2A, T2A and E2A) 
and included in a polycistronic unit. When cloned in between different cDNAs, self-
deleting 2A peptide sequences (~20 amino acids long) from the foot-and-mouth disease 
virus (FMDV) or other picornaviruses allow ribosomes to continue translating the 
downstream cistron after releasing the first protein with its carboxyl terminus fused to 2A. 
This results in the expression of almost stoichiometric amounts of each protein encoded 
by the polycistron (Radcliffe and Mitrophanous, 2004) (Figure 2.1). 
 





Expression of the 4 genes is controlled by the tetracycline operator minimal promoter 
(TetO) providing tetracycline-inducible expression when cells are co-transduced with 
Lenti-M2rtTA viral particles, which constitutively express reverse tetracycline-controllable 
transactivator (M2rtTA). DOX is used as the inducing drug. 
For generation of pAd-OSKM (#3079C2), polycistronic open reading frame encoding for 
Oct4, Klf4, Sox2 and c-Myc (OSKM) was excised from Lenti-TetO-OSKM using EcoRI 
restriction sites. The open reading frame was inserted into EcoRI-linearized pcDNA-
ENTR-BP 1848, which was prepared by removing Emerald Green Fluorescent Protein 
(EmGFP) from pcDNA™ 6.2/C-EmGFP-GW (Invitrogen) and cloning the polylinker with 
DraI/XhoI. The polylinker was generated by oligonucleotide annealing. This vector 
includes features from the Gateway® Technology (Invitrogen) which takes advantage of 
the site-specific recombination properties of bacteriophage Lambda to provide a rapid 
and efficient way to move the DNA sequence of interest into multiple vector systems. 
This universal cloning method comprises 2 recombination reactions of an entry vector 
encoding the gene of interest to create a desired destination vector. After confirmation of 
correct orientation of OSKM by Polymerase Chain Reaction (PCR) and NheI digestion, 
polycistronic expression cassette was shuttled first into Gateway® pDONR™221 vector 
and then into pAd/CMV/V5-DEST™ vector, through BP and LR recombination reactions, 
according to manufacturer’s protocols. Resulting pAd-OSKM was used to produce 
adenoviral particles as described on proper section. 
To prepare lentiviral expression vectors encoding for 10 different Eye TFs, a Gateway® 
Technology-based cloning workflow was used. First, pLenti6/V5-DEST™ Gateway® 
vector was modified to allow inducible expression of target genes. Constitutive CMV 
promoter was removed by ClaI/SpeI restriction and substituted by TetO promoter, 
prepared by PCR amplification from pLenti-TetO-OSKM using flanking primers 
containing corresponding restriction sites. Obtained pLenti6/TetO/DEST was used in 
BP/LR recombination reactions with an entry clone encoding for Green Fluorescent 
Protein (GFP) (pcDNA ENTR BP GFP, previously cloned) in order to produce lentiviral 
control plasmid pLenti-TetO-GFP (#3149C144). 
Figure 2.1: Schematic representation of Lenti-TetO-OSKM.  




Regarding cloning of the chosen 10 Eye TFs, complementary DNA (cDNA) libraries were 
produced by amplification through RT-PCR from total RNA isolated from mouse 
embryonic eye (isolated on E13.5), RAW 264.7 macrophages or Melan Ink4a cells. 
Subsequently, cDNAs encoding for the Eye TFs were PCR amplified from the cDNA 
libraries. Some of the coding sequences were PCR amplified from commercially 
available expressed sequence tags. All PCR amplifications were performed using 
Phusion polymerase (New England Biolabs) and flanking primers containing either 
EcoRI/SalI restriction sites or XhoI/KpnI. The digested products were cloned into 
adequate pcDNA ENTR BP V5 vectors, prepared with the corresponding 
endonucleases. C2 or C1 vectors were used in order to obtain entry vectors encoding for 
the Eye TFs with in frame N-terminus V5 tag sequences. Then, BP/LR reactions were 
performed using the 10 different entry vectors and pLenti6/TetO/DEST to produce 10 
inducible lentiviral plasmids, each one encoding for a V5-tagged version of the 
corresponding Eye TF. 
For the generation of lentiviral reporter systems, pLenti6/V5-DEST™ Gateway® vector 
was modified to substitute CMV promoter for RPE-specific promoters. Tyrosinase 
(monophenol monooxygenase) is the essential enzyme in melanogenesis and is 
expressed in pigmented cells, like skin melanocytes and RPE cells. Tyrosinase (Tyr) 
promoter (a 2.2kb genomic fragment containing upstream regulatory sequence of mouse 
tyrosinase gene) was obtained from pTYBS by ClaI/SpeI restriction (Yokoyama et al., 
1990). Constitutive CMV promoter of pLenti6/V5-DEST™ Gateway® vector was 
removed by ClaI/SpeI restriction digestion and substituted by the Tyr promoter. Obtained 
pLenti6/Tyr/DEST was used in BP/LR recombination reactions with an entry clone 
encoding for GFP (pcDNA ENTR BP GFP, previously cloned) in order to produce 
reporter lentiviral plasmid pLenti-Tyr-GFP (#3147C32). 
pLenti-Rpe65-GFP reporter plasmid was obtained similarly. RPE65 protein plays a 
crucial role in RPE’s visual cycle, particularly in retinal isomerization. The upstream 
region of Rpe65 gene has been shown to confer RPE-specific expression (Boulanger et 
al., 2000). A fragment containing bases -655 to +52 of the 5’ flanking region of the 
mouse Rpe65 gene was PCR amplified from mouse genomic DNA. Resulting Rpe65 
promoter was cloned in pLenti6/V5-DEST vector using ClaI/SpeI restriction sites, to 
generate pLenti6/Rpe65/DEST. pLenti-RPE65-GFP (#3681C27) was produced by 
BP/LR recombination reactions as above described. 
All generated constructs were confirmed by adequate restriction enzyme digestion and 
sequencing. See supplementary experimental procedures for information regarding 
primer sequences. 
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Transfection of HEK-293FT Cells with plasmid DNA 
Cells were transfected at 70-80% confluence in 6-well plates. Cationic lipid-based 
Lipofectamine™ 2000 (Life Technologies) was used as transfection reagent and 3 µL 
were added to 250 µL of Opti-MEM I (Life Technologies). To allow the formation of DNA-
lipid complexes, 1 µg of each plasmid to be transfected was first added to 250 µL of 
Opti-MEM I and then mixed gently with the Lipofectamine solution. Transfection mix was 
incubated for 45 min at RT. Growth medium was removed from the cells to be 
transfected prior to PBS wash and gently replaced by the transfection mix (500 µL final 
volume). Cells were incubated at 37°C 5% CO2 for 5-6h before the transfection mix was 
replaced with DMEM complete. Cells were incubated for additional 18-24h before 
harvesting. 
 
Preparation and use of lentiviral transduction particles 
For producing lentiviral particles, besides the lentiviral vector plasmid (transfer vector), 
packaging plasmid(s) and envelope plasmid are needed in order to properly assembly of 
the viral capsid to occur.  
Third Generation Packaging System plasmids (available from Addgene) pMD2.G, 
pMDLg/pRRE and pRSV-Rev can be used and co-transfected with transfer vector. 
Alternatively, STAR-Rdpro cells that stably express synthetic HIV Gag-Pol, HIV tat and 
HIV rev sequences and RD114 envelope protein can also be used. To increase 
efficiency of the viral production, both systems were used in combination. 
Star-Rdpro cells were plated the day before transfection in DMEM complete and 
transfected at 80-90% confluency. For a 10 cm petri dish, 3 µg of transfer vector, 3 µg of 
pMD2.G, 4 µg of pMDLg/pRRE and 2 µg of pRSV-Rev were mixed in 500 µL of Opti-
MEM I. Polyethylenimine (PEI) 1 µg/µL was used as transfection reagent, and 36 µg 
were added first to 500 µL of Opti-MEM I and then to plasmid DNA - Opti-MEM I mix. To 
allow formation of DNA-lipid complexes, transfection mix was incubated 45 min RT. Star-
Rdpro cells were washed with PBS twice and 3 mL Opti-MEM I was added. Then 
transfection mix was added dropwise to cells. After 6-7 h incubation at 37ºC 5% CO2, 4 
mL of DMEM without serum and antibiotics were added, followed by an overnight 
incubation. On the following day, the medium was replaced by fresh DMEM complete.  
Viral particles were harvested 72 h post-transfection. Supernatant was spun at 4000 x g 
for 10 min to remove cell debris, and used fresh for direct reprogramming experiments. 




concentrated through ultracentrifugation at 100 000 x g for 3 h at 4ºC. The resultant viral 
pellet was resuspended in DMEM complete. 
Lentiviral transductions were performed for 24 h or 48 h in the presence of 6 µg/mL 
Polybrene® (hexadimethrine bromide). This cationic polymer increases gene transfer 
efficiency through neutralization of the negative electrostatic repulsion between the cell 
surface and the virus particles, facilitating viral adsorption (Davis et al., 2004). 
For selection of lentiviral transduced cells, blasticidin was used on appropriate conditions 
for each cell line (concentration and exposure time) as optimized by a MTT-based cell 
viability assay. 
 
Preparation of adenoviral transduction particles 
Plasmid DNA of pAd-OSKM was isolated using QIAGEN Plasmid Midi kit (Qiagen) and 5 
μg of DNA were digested with PacI according to manufacturer’s protocols, followed by 
purification by phenol/chloroform extraction and isopropanol precipitation.  
On the day before transfection, HEK-293A cells were plated in T25 flasks in DMEM 
complete to reach 80% confluence on the next day. Transfection was executed as 
described previously for HEK-293FT cells, using Lipofectamine™ 2000 Reagent. Cells 
were cultured until viral production was observed by monitoring cytopathic effect with 
plaque formation and cell death (approximately 10-15 days post-transfection). The 
supernatant was collected and 3 freeze-thaw cycles were performed, followed by a 10 
min 4000 x g centrifugation to remove cell debris. A portion (500 µL approximately) of 
this initial supernatant was used to transduce confluent HEK-293A cells in a 10 cm petri 
dish. With this re-amplification step, the cytopathic effect occurs much sooner and 
collected supernatant (prepared as described) has higher viral titer. Viral aliquots were 
maintained at -80ºC for storage. 
 
Reprogramming somatic cells into pluripotency 
Generation of iPS cells was performed according to available protocols (Carey et al., 
2009; Takahashi et al., 2007b) with minor modifications. Passage 3 or 4 MEFs, either 
WT, Chmnull or Chmflox, were plated on gelatin-coated 6-well plates (1x105 cells per well). 
On the following day, 250 µL of both Lenti-TetO-OSKM and Lenti-M2rtTA freshly 
prepared lentiviral supernatants were added to each well, in the presence of Polybrene®. 
On day 1 post-transduction (dpt), 1 mg/mL DOX was added to the medium (except 
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control wells referred as “- DOX”) to induce lentiviral expression of the 4 TFs. DMEM 
complete medium was changed on 2 dpt to remove lentiviral particles (48 h of viral 
transduction). Cells were cultured in ES medium (first without 2i), with or without DOX 
accordingly, from 3 dpt and forward. Medium was changed every other day, until on 14 
dpt 1 µM of MEK inhibitor PD 0325901 and 3 µM of GSK3 inhibitor CHIR99021 were 
added (LIF/2i). These conditions were used to promote conversion of pre-iPS cells into 
fully reprogrammed cells and achievement of a naïve pluripotent state (Silva et al., 
2008). Lastly, from 21 dpt forward, DOX was removed from culture medium in all culture 
wells, to select clones that have acquired transgene independence. 
After 4 weeks of reprogramming protocol, ES cell-like colonies were manually “picked”. 
Culture medium was changed into PBS and dome-shaped colonies were aspirated using 
a P-10 micropipette. Aspirated cells were up-and-down homogenized in a 96-well plate, 
before being plated in 24-well plate wells previously prepared with a feeder layer (P0). 
From this point further iPS cells were always cultured in ES medium, in which 2i were 
added freshly. After 2-3 passages, established iPS cell lines were successfully adapted 
to feeder-free culture conditions. 
For the adenoviral-based reprogramming protocol, same conditions were employed with 
minor adjustments. Briefly, Ad-OSKM supernatant was used to transduce MEFs plated 
on the previous day. On 1 dpt, medium was changed to remove adenoviral particles. ES 
medium (without 2i) was used from 3 to 14 dpt, when 2i were added. 
 
Characterization of pluripotent stem cells 
Alkaline phosphatase staining 
Undifferentiated state of pluripotent stem cells in culture is characterized by high level of 
alkaline phosphatase (AP) expression (Pease et al., 1990). iPS cell lines and ES cells 
were plated on 6-well plates prepared with feeders with low density and allowed to grow 
for 3-4 days (small colonies are preferred to detected AP activity). AP Detection kit 
(Millipore) was used according to manufacturer’s protocol to confirm enzymatic activity of 
AP through a colorimetric reaction. ES cells were used as positive control, and feeder 





Embryoid Bodies’ differentiation assay 
EB formation followed by in vitro spontaneous differentiation is commonly used to 
confirm pluripotency capacity and differentiation potential of pluripotent stem cells 
(Kurosawa, 2007). Feeder-free cultures of iPS cell lines and ES cells were used and 
2.75x106 cells of each line were plated in bacterial-grade petri dishes (low attachment 
conditions). EB medium (DMEM supplemented with 15% KnockOut™ Serum 
Replacement (Life Technologies), non-essential amino acids, Pen Strep and 
GlutaMAX™-I (Life Technologies)) was used and cells were incubated at 37ºC 5% CO2 
for 3 days to allow formation of floating EBs. Growth medium was replaced daily. After 3 
days, EBs were spun at 100 x g for 5 min prior to being plated in gelatin-coated dishes in 
EB medium supplemented with 10% FBS. After overnight incubation to allow EBs to 
adhere, medium was changed into EB medium (without FBS). Cells were washed with 
PBS every other day and medium was changed. At day 7 and 14 of differentiation, RNA 
was collected for RT-PCR analysis. Alternatively, cells were fixed for IF staining to 
confirm the presence of endodermal, mesodermal and ectodermal markers. 
 
Teratoma formation assay 
One of the hallmarks of pluripotent stem cells is their ability to differentiate into cells from 
the three germ layers: endoderm, mesoderm and ectoderm. Besides performing in vitro 
differentiation assays, the confirmation of this property can be achieved in a more 
stringent way through an in vivo teratoma formation assay. Teratomas are benign 
tumours composed of differentiated tissues derived from all three germ layers. When 
transplanted into immunodeficient animals, pluripotent stem cells form teratoma-like 
outgrowth masses (Gropp et al., 2012). 
iPS cell lines to be tested were cultured in feeder-free conditions and subjected to a 
shorter trypsinization period in order to obtain small aggregates of cells. Single cell 
dissociation was avoided since it has been described that injection of small clusters of 
cells increases teratoma formation efficiency (Zhang et al., 2012). One million cells of 
each cell line was resuspended in 100 µL of PBS and injected subcutaneously into a 
NOD.Scid mouse. Immunodeficient mice are used to avoid immune rejection that occurs 
in non-immunocompromised animals. ES cells were also injected (positive control), as 
well as MEFs (non pluripotent cells) or PBS (negative controls). All animals were kept in 
parallel and each experimental group was composed of 2-4 animals.  Five to seven 
weeks later, mice developed tumours, which were removed, immediately rinsed with 
PBS, fixed, and embedded in paraffin. Tissue sections were cut and processed for 
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hematoxylin-eosin staining. The histological analysis was performed by a pathologist and 
a tumour was defined as a teratoma only if it contained tissues representing all three 
germ layers. 
 
Differentiation of pluripotent stem cells into retinal lineages 
Differentiation protocol adapted from Zhu et al. 
iPS cell lines and ES cells were subjected to the protocol described by (Zhu et al., 2013), 
with minor modifications. Briefly, undifferentiated cell colonies were partially lifted by 
dispase. Detached cell aggregates (diameter: 50–100 µm) from one confluent well of a 
6-well plate were embedded in 100 µL of Matrigel™ Basement Membrane Matrix (BD 
Biosciences) and plated in 24-well plates. After gelling at 37ºC for 10 min, cells 
embedded in the Matrigel layer were cultured in neural induction medium N2B27 which 
consisted of DMEM/F12+GlutaMAX (Life Technologies), neurobasal medium (Life 
Technologies), 0.5x B27 supplement (Life Technologies), 0.5x N2 supplement (Life 
Technologies), 0.1 mM 2-mercaptoethanol and 0.2 mM L-Glutamine. In separate 
experiments, IGF-1 recombinant protein was added to the medium to a final 
concentration of 10 ng/mL. 
 
Differentiation protocol adapted from Eiraku et al. and Gonzalez-Cordero et al. 
iPS cell lines and ES cells were subjected to the protocol described by (Eiraku and 
Sasai, 2012; Eiraku et al., 2011; Gonzalez-Cordero et al., 2013) with some modifications. 
Briefly, cells were dissociated to single cells with TrypLE™ Express and 2x106 cells were 
plate in bacterial-grade 10 cm petri dishes in Early retinal differentiation medium. This 
medium was composed of Glasgow minimum essential medium (GMEM) (Life 
Technologies) supplemented with 1.5% (vol/vol) KSR + 0.1 mM non-essential amino 
acids + 1 mM pyruvate + 0.1 mM 2-mercaptoethanol. Growth factor–reduced Matrigel 
(BD Biosciences) was added to the culture medium to a final concentration of 2% (v/v) 
on the following day. 
 
Differentiation protocol adapted from La Torre et al. and Osakada et al. 
iPS cell lines and ES cells were subjected to a differentiation protocol adapted from the 
reports of (Osakada et al., 2009; Torre et al., 2012). Cells were dissociated to single cells 




in Retinal induction medium. This medium was constituted of DMEM/F12+GlutaMAX, 
neurobasal medium, 0.5x B27 supplement, 0.5x N2 supplement, 0.1 mM 2-
mercaptoethanol and 0.2 mM L- Glutamine. Recombinant proteins Dkk-1, IGF-1 and 
Noggin were also added to a final concentration of 10 ng/mL each. After 3 days, on 
some experiments, floating aggregates were plated in 12-well plates coated with Growth 
factor–reduced Matrigel (P conditions). 
 
Cell viability assay 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is a 
colorimetric assay based on the reduction of MTT into formazan crystals by 
mitochondrial succinate dehydrogenase. Water soluble MTT enters cells and, in the 
mitochondria, it is reduced into an insoluble, coloured (dark purple) formazan product. 
After solubilisation with an organic solvent, the dissolved material is measured 
spectrophotometrically. Since for most cell populations the total mitochondrial activity is 
related to the number of viable cells, this assay is broadly used to measure the cell 
viability, cell proliferation or in vitro cytotoxic effects of drugs on cell lines or primary cells 
(Carmichael et al., 1987). 
MEFs were plated in a 48-well plate (1x104 cells/ well) and treated with different 
concentrations of TM, blasticidin, or lentiviral supernatants. Cell viability was assessed 
after 72 and 96 h (for TM), 48 and 72 h (for blasticidin) or 96 h (lentiviral supernatants). 
Cell culture medium was removed, 100 µL of 0.5 mg/mL MTT solution in DMEM without 
phenol red (Life Technologies) were added to the wells and samples were incubated for 
3 h at 37ºC. Removal of MTT solution preceded addition of 100 µL of acidic isopropanol 
(0.04 M HCl in absolute isopropanol) for solubilization of formazan salts. Absorbance 
was measured at 595 nm (iMark, BioRad). Percentage of cells’ survival was determined 
relative to untreated cells, after correction for the background (absorbance of the 
dissolution vehicle). For each condition, including the controls, 3 independent assays 
were carried in quadruplicates. 
For ARPE-19 cells, cell viability was assessed similarly, just adjusting cell density to 
3x104 cells/ well. 
A MTT-based cell viability assay was also used to infer proliferation and growth rates of 
iPS cell lines. For that purpose, several plating densities were tested in a 96-well plate 
format (1, 2, 5, 10 and 20x104 cells/ well). The MTT assay was performed after 24 h as 
previously described using 50 µL of MTT solution and acidic isopropanol. Subsequently, 
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cells were plated with the chosen density (1x104 cells/ well) and MTT reduction assay 
performed every day, for a total of 4 days.  
 
PCR Genotyping 
For genotyping of embryos (when isolating MEFs primary cultures), a portion of the 
embryonic head was isolated from each sample. For genotyping of cells in culture, at 
least 2x104 cells were used and pelleted after tripsinization. All samples were digested 
overnight in GNTK buffer (50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 8.5, 0.01% 
gelatin, 0.45% Nonidet P-40, 0.45% Tween-20) supplemented with 50 μg/mL proteinase 
K (Invitrogen) at 55°C. Proteinase K was heat inactivated (94ºC for 15 min) and samples 
were spun at 16000 x g for 5 min before 1–3 μL of the supernatant was used in PCR.  





RNA isolation and Reverse Transcriptase (RT) - PCR 
Total RNA was isolated from cells using an RNeasy Mini kit (Qiagen) according to 
manufacturer’s protocols. One µg of total RNA was converted into cDNA using 
SuperScript® II (Life Technologies) and random primers. cDNA was diluted 10x before 
further analysis.  
Conventional RT-PCR reactions were performed using Taq polymerase (Promega) and 
the following PCR program: 2 min initial denaturation step at 95ºC; 32 cycles of 20 
seconds denaturation step at 95ºC, 30 seconds annealing step at 58ºC and 1 min/kb at 
72ºC; 10 min final extension step at 72ºC. 




Quantitative RT-PCR reactions were performed using an ABI Prism 7900HT system 
(Applied Biosystems) using SybrGreen Master Mix. Five μl of SybrGreen, 4 μl of cDNA 
sample together with 1μl of adequate primers were used per well, in quadruplicate 
conditions. The relative transcript levels of the target genes were calculated relative to 
control wells and standardized using Gapdh as a housekeeping gene; quantification was 
performed using the delta-delta Ct method (Livak and Schmittgen, 2001). 
PCR primers used to assess gene expression levels are summarize in supplementary 
experimental procedures (Table 2.5). Ecat, Esg1, Eras, Zfp42 and Utf1 primers were 
described by (Takahashi et al., 2007b). 
 
Immunofluorescence (IF) 
Cells were seeded on gelatin-coated coverslips at appropriate cell density. When ready, 
cells were washed 2x with PBS, and fixed with 4% (v/v) paraformaldehyde (PFA) in PBS 
for 15 min at room temperature. Cells were washed 2x in PBS and permeabilized for 45 
min with 1% Bovine Serum Albumin (BSA) 0.1% Triton X-100 in PBS. Incubation with 
primary antibodies followed, diluted in the same solution, for 1 h RT or overnight at 4ºC. 
After washing 4x with PBS, samples were incubated for 1 h RT with Alexa 488-
conjugated and Alexa 547-conjugated secondary antibodies (Life Technologies, 1:1000). 
Samples were mounted using ProLong Gold Antifade Reagent with DAPI (4',6-
diamidino-2-phenylindole) (Life Technologies) and visualized either on an inverted 
microscope (Olympus IX51 U-RFL-T) or on a confocal microscope (Leica TCS SP5 
microscope, Leica Microsystems, using an 63x immersion oil lens; objective type: HCX 
PL APO CS, NA: 1.40 - 0.60). 
 
Image acquisition and analysis 
Brightfield and fluorescent images of cells in culture were acquired using an inverted 
microscope (Olympus IX51 U-RFL-T). When necessary, images were post-processed for 
overall brightness and contrast using Fiji (NIH) software.  
For determination of the percentage of cell transduction, number of Oct4 positive cells 
was counted by applying the Otsu or Moments threshold filter in each image using Fiji. 
The resulting number was divided by the corresponding number of cells, counted as the 
number of nuclei (DAPI staining). At least 1000 cells were analysed for each replicate for 
each condition. 




In order to determine lentiviral-driven GFP expression using flow cytometry, transduced 
MEFs cells were washed in 0.1% BSA in PBS once after tripsinization. Cells were then 
fixed in 0.4% PFA 0.1% BSA in PBS and kept at 4ºC until acquisition. 
Samples were analyzed using FACSCalibur ™ (BD Biosciences) or Attune® Acoustic 
Focusing Cytometer (Life Technologies) with acquisition of at least 30 000 events on 
gated population (cells). Attained results were processed using FlowJo software (Tree 
Star). Due to MEFs’ autofluorescence particularly after several days in culture, flow 
cytometry plots were analysed as FL1/BL1 versus FL2/BL2 plots to determine 
percentage of cells expressing GFP. In some cases, Median Fluorescent Intensity (MFI) 
values were also determined. 
 
Preparation of protein lysates and western blotting analysis 
Cells were seeded on 6-well plates and homogenized in RIPA buffer (50 mM Tris-HCl  
pH 7.4 containing 150 mM NaCl, 1% Triton X100, 0.1% sodium dodecyl sulphate (SDS), 
0.5% sodium deoxycholate, 1 μg/mL leupeptin and TPCK). Lysates were subsequently 
cleared by centrifugation and bicinchoninic acid (BCA) colorimetric method was used 
according to the manufacturer’s instructions (Pierce) to quantify protein content. For 
each sample, a fraction of proteins was combined with Laemmli buffer (2% SDS, 5% 2-
mercaptoehtanol, 10% glycerol, 0.002% bromophenol blue, 0.065 M Tris HCl in final 
solution) before subjected to separation based on molecular weight by SDS - 
Polyacrylamide Gel Electrophoresis (SDS-PAGE). Acrylamide gels (12.5%) were used 
and proteins were subsequently transferred to Immobilon polyvinylidine fluoride (PVDF) 
membranes (Millipore). Membranes were blocked in 4% non-fat dried milk in 0.02% 
Tween® 20 in PBS (PBST buffer) for 60 minutes at RT. Incubation with primary 
antibodies for at least 1 h RT followed, prior to incubation with appropriate Horseradish 
Peroxidase (HRP)-conjugated secondary antibodies (1:10000) for 1 h RT in 4% non-fat 
milk in PBST. Membranes were incubated with ECL Plus (GE Healthcare) and 
chemiluminescence was detected using ChemiDoc (BioRad). Western blot analysis was 
performed using Fiji software. Quantification plots show the relative density, which is 
optical density normalized to the calnexin signal in the same lane (relative density = 






Unless stated otherwise, data are presented as mean values from at least 3 independent 
experiments and error bars indicate ± SD. The results’ statistical analysis was carried out 
using the Graph Pad Prism software version 5 (GraphPad Inc., San Diego, CA, USA). 
Two-tailed Student’s t Test, one-way analysis of variance (ANOVA) or two-way ANOVA 
were used accordingly. The significance level is indicated as *** for p<0.001, ** for 
p<0.01, * for p<0.05 and NS for p>0.05. 
 
Supplementary experimental procedures 
 








Primers used for amplification of TetO promoter region: 
Forward: 5’ ATTCAATCGATAATCGGGTTTATTACAGGGACAGCAGAG 3’ (PR1493) 
Reverse: 5’ GGCGACTAGTGGGCCGCGGAGGCTGGATCGGTCCCG 3’ (PR1494) 
 
Primers used for amplification of Rpe65 promoter region 
Forward: 5’ GCATATCGATGTCTCTGAGTGCAGAACAAA 3’ (PR1949) 
Reverse: 5’ GGATACTAGTTTTCTTCCAGTGAAGATTAGAGAGAGTT 3’ (PR1950) 
 
  










Table 2.5: RT-PCR primers. 























Chapter 3 : Induced Pluripotent Stem cell technology 
Summary 
Reprogramming of somatic cells into pluripotency can be achieved using a transcription 
factor-mediated approach. Obtained iPS cells display morphology, self-renewal and 
pluripotency properties similar to ES cells. Uses for this pioneering technology are wide, 
including a better understanding of pluripotency and developmental biology, generation 
of patient- and disease–specific cell lines, drug and toxicology screenings and clinical 
applications in regenerative medicine approaches (Takahashi & Yamanaka 2013). 
Since Yamanaka’s seminal discovery in 2006 (Takahashi & Yamanaka 2006), numerous 
scientific advances were made trying to overcome major limitations of the 
reprogramming protocol, namely low efficiency, insertional mutagenesis, oncogenic 
transformation and epigenetic memory of obtained cells. 
Several methods have been described, using different initial somatic cell types, delivery 
systems and combinations of reprogramming factors. Culture conditions for the 
derivation procedure as well as the possibility of combining TFs with small molecules 
were also studied and optimized (Maherali & Hochedlinger 2008). 
Here we describe our strategy to implement iPS cell technology in the laboratory.  
Inducible lentiviral and adenoviral vectors were tested to force the expression of the 4 
classical Yamanaka factors in MEFs isolated from WT animals. Contrarily to an 
adenoviral-based approach, a lentiviral strategy was successfully implemented. Several 
iPS cell clones were isolated, expanded and characterized, displaying morphological, 
molecular and functional properties similar to ES cells, particularly in terms of self-
renewal and pluripotency. 
 
Results 
Lentiviral molecular tools efficiently transduce MEFs and allow expression of 
reprogramming factors 
Inducible polycistronic lentiviral systems can be used to reprogram somatic cells into 
pluripotency, as described by Carey and colleagues (Carey et al., 2009). In this system, 
a viral vector encodes for the 4 reprogramming genes Oct4, Sox2, Klf4 and c-Myc 
separated by 2A “self-cleaving” peptides. Therefore, efficient polycistronic expression is 




(TetO).  In the presence of DOX, cells co-transduced with the polycistronic vector (Lenti-
TetO-OSKM) and a constitutive lentivirus encoding for the tetracycline controllable 
transactivator (Lenti M2rtTA) express the 4 TFs. 
In order to implement a reprogramming protocol and to confirm the efficiency of the 
delivery system, primary cultures of MEFs isolated from E13.5 pregnant WT C57BL/6 
mice were established and transduced with viral particles of both polycistronic and 
transactivator lentiviruses. As depicted in Figure 3.1, forced expression of the 4 TFs was 
attained when cells were cultured in the presence of DOX at 4 dpt, despite some 
observed residual expression in the absence of the inducing drug justified by the 




Transduced cells were also analysed by IF in order to determine the efficiency of 
transduction (Figure 3.2). Considering the quantification of Oct4 expressing cells, 
approximately 25% of WT fibroblasts were shown to be transduced. 
 
Figure 3.1: MEFs transduced with inducible lentiviral particles express the 4 
reprogramming factors, in the presence of DOX. 
MEFs were co-transduced with Lenti-TetO-OSKM and Lenti M2rtTA viral particles and were 
cultured in the absence (-) or presence (+) of DOX. Protein expression of Oct4, Sox2, Klf4 
and c-Myc is observed in the second condition. Protein lysates collected 4 dpt were 
subjected to western blot analysis with the indicated antibodies; Canx was used as loading 
control. 





Lentiviral transduced cells display morphology and gene expression alterations during 
reprogramming protocol 
In addition to an efficient delivery system for the selected set of TFs, reprogramming to 
pluripotency is highly dependent on culture conditions, which may also to be tested and 
subjected to optimization. Standard culture conditions for the derivation and propagation 
of mouse ES cells were adopted since these conditions have been described to favour 
generation of mouse iPS cells from fibroblasts (Maherali and Hochedlinger, 2008). 
A schematic representation of the implemented protocol is depicted on Figure 3.3A.  
MEFs were co-transduced with abovementioned lentiviral particles and DOX was added 
to the culture medium on the following day, except to control wells (- DOX). At 3 dpt, cell 
culture medium was changed into an ES cell medium containing serum and LIF. On day 
14, ES cell medium was also supplemented with 1 µM of PD0325901 and 3 µM of 
CHIR99021, which inhibit MEK/ERK and GSK3 signalling, respectively. These dual 
inhibitors (2i) combined with the self-renewal cytokine LIF were described to induce a 
complete reprogramming event and promote the generation of ground state pluripotent 
cells (Silva et al., 2008). On the 4th and final week of the protocol, DOX was removed 
from culture in order to facilitate identification and isolation of fully reprogrammed cells. 
Given the inducible nature of the lentiviral delivery system, upon DOX withdrawal, cells 
that rely on exogenous expression of the pluripotent TFs are eliminated, providing a 
useful selection system. 
Figure 3.2: MEFs are transduced by the reprogramming lentiviral particles with 25% 
of efficiency.  
(A) Presence (+) of DOX induces expression of Oct4 as assessed by IF at 4 dpt; nuclei 
were counterstained with DAPI and used to quantify the total number of cells; scale bar 50 
µm. (B) Quantification of transduced cells, calculated by dividing Oct4 positive cells for the 







Figure 3.3: MEFs subjected to reprogramming protocol display typical morphological 
alterations.  
(A) Scheme representing protocol outline. (B) Initial morphology of MEFs prior to lentiviral 
transduction. (C) Representative bright-field images of transduced MEFs cultured in the 
presence (+) of DOX showing that approximately 7 dpt typical ES-like colonies start to 
appear, composed of small and compacted cells. At day 14, colonies have a more 
condensed and well defined structure in culture. In the absence (-) of DOX, transduced 
cells maintain a fibroblast-like morphology, despite becoming more confluent. Scale bar 25 
µm. 
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Several independent experiments were performed and typical morphological alterations 
were observed consistently. On 4 dpt transduced cells still display a fibroblast-like 
morphology, similar to initial cells and control cells cultured in the absence of DOX 
(Figure 3.3B and C). After approximately 7 dpt, colonies that resemble ES cells start to 
arise, with their distinctive refractive appearance. Progressively, some colonies gained 
more tight and well-defined borders, which are known to be correlated with fully 
reprogrammed iPS cell colonies (colony depicted on bottom right panel of Figure 3.3C 
for example). 
To confirm the identity and significance of the observed morphological alterations, 
expression of key pluripotency markers was analysed during the protocol time course. 
Interestingly, on 7 dpt, IF technique using antibodies against Oct4 and Sox2 revealed 
that cells corresponding to nascent ES-like colonies expressed these TFs (Figure 3.4A), 
despite exogenous (viral) or endogenous expression cannot be distinguished. 
Importantly, at 14 dpt, pluripotency TF Nanog and specific surface marker SSEA-1 were 
expressed by the arising colonies, confirming the activation of an endogenous pluripotent 
expression profile (Figure 3.4B). AP staining was also performed, with positive pink 
colonies (Figure 3.4C). In some cases, colonies were overgrown after 28 days in culture 
and cells in the middle of the colony start to die and lose their AP content, as seen on 







In order to further characterize the reprogramming events that were being observed, total 
RNA samples collected during the 28 days’ time course were analysed by quantitative 
RT-PCR. Using primers for viral specific transcripts (P2A-Sox2), robust and stable 
induction (6- to 10-fold increase) was observed in cells cultured with DOX  as compared 
to control conditions (- DOX). Of interest is to notice that viral transcripts were no longer 
expressed when inducing drug was withdrawn from culture media after day 21 (Figure 
3.5A). Additionally, Oct4 primers that cannot discriminate between viral or endogenous 
transcripts (Total Oct4) were used, showing that transduced DOX-induced MEFs 
expressed Oct4 with similar levels when compared to ES cells. Oct4 endogenous 
expression was also confirmed using a specific primer pair.  
 
Figure 3.4: Stem cell-like colonies arise during the reprogramming protocol and 
express typical pluripotency markers.  
(A) At 7 dpt, cells that start to display morphological alterations express Oct4 and Sox2. (B) 
Nanog and SSEA-1 expression is also observed in the arising colonies around 14 dpt. (A-
B) IF staining using the indicated antibodies, DAPI used to counterstain cell nuclei; scale 
bar 50 µm. (C) Cell culture dishes (6 cm) of transduced cells stained for AP 28 dpt show 
positive colonies in the presence (+) of DOX.  (D) Representative images of AP-positive 
colonies are shown; scale bar 50 µm. 




Figure 3.5: Reprogramming procedure induces consistent temporal alterations in 
terms of gene and protein expression.  
(A-C) RT-qPCR analysis of total RNA content of transduced cells reveals expression of 
P2A-Sox2 (viral transcript) when cultured in the presence of the inducing drug (DOX). Total 
Oct4 levels correlate with this result. Pluripotency genes, like endogenous Oct4, Nanog and 
Fgf4, are transcribed at detectable levels starting at day 7, 14 or 4, respectively. Gapdh is 
used as endogenous control; results are normalized to d4 (-DOX) in (A) or to ES cells (B-
C); mean ± SD, n=3. (D) Protein lysates were collected at different timepoints and 





As shown in Figure 3.5B, endogenous Oct4 was detected on day 7 and it kept increasing 
during cellular reprogramming, even after DOX withdrawal. At day 28, Total and Endo 
Oct4 levels were similar given that viral transcripts were no longer present. Nanog and 
Fgf4 transcript levels were also determined and expression of these pluripotent markers 
was also detected on day 14 or 4, respectively. It was observed that Nanog and Fgf4 
expression also increased during the protocol time course (Figure 3.5C). Importantly, 
Nanog protein expression was confirmed by western blot analysis and observed in high 
levels since day 21 (Figure 3.5D).  
At the end of the reprogramming procedure, several colonies were observed on the 
culture wells. The number of colonies emerging in each individual experiment was quite 
variable, ranging from 50 to 300 colonies arising from 1x105 initial MEFs. Given the 
determined 25% of transduction efficiency, we calculated that the reprogramming 
efficiency varied between 0.2 and 1.2%, which is in agreement with the literature (Silva 
et al., 2008). It was also observed in some experiments that colonies were present but 
with a flatter morphology and undefined borders, characteristic of partial reprogramming 
to pluripotency. These episodes, as well as experiments with lower efficiencies, could be 
related with not so freshly prepared culture media, in particular in terms of LIF, and 
variations in serum lots. Additionally, the number of arising colonies when transducing 
MEFs could be increased with higher volumes of lentiviral preparations (with expected 
increase in transduction efficiency). However, the final objective of isolating single 
colonies/clones was progressively more challenging as the colonies became closer to 
each other. Hence we decided to maintain the protocol as described. 
On each reprogramming experiment, several colonies were manually “picked” and 
further cultured in the same culture media (ES media + LIF + 2i) and in the presence of 
feeder cells (mitomycin C mitotically inactived MEFs). Some colonies didn’t survive or 
grow after subculture as expected. However the vast majority could be submitted to 
successive culture passages and expanded. Isolated iPS cell clones were now ready for 
complete characterization in terms of morphology, self-renewal and pluripotency 
attributes, which will be described later on. A diagram representing this established 
workflow is depicted on Figure 3.6.  
Despite success on generating colonies and isolated iPS clones with the lentiviral 
delivery system, alternative systems were also tested as described subsequently. 






Adenoviral molecular tools efficiently transduce MEFs and allow expression of 
reprogramming factors 
The generation of iPS cells using lentiviral vectors poses an obstacle to its potential use 
as therapeutic tools, given the integrative nature of lentivirus that can lead to insertional 
mutagenesis. Different delivery strategies were envisioned and studies describing non-
integrating viral vectors usage, such as adenovirus, for inducing pluripotency soon were 
published (Stadtfeld et al., 2008). 
Aiming at establishing an adenoviral-mediated delivery of the reprogramming factors 
whilst maintaining the same set of TFs, the polycistronic OSKM unit was subcloned into 
an adenoviral vector (Ad-OSKM) (see Chapter 2 for details). One prospective advantage 
of this approach would be to transduce all cells concomitantly with all 4 TFs, since co-
transduction with the 4 TFs in separate vectors is very inefficient, difficult to control and 
to optimize. In order to confirm the efficient delivery of the 4 TFs, cells were transduced 
with increasing quantities of adenoviral preparation and total protein content was 
Figure 3.6: Stem cell-like colonies are isolated, subcultured and expanded to 
generate iPS cell clones that will be further characterized.  




analysed by western blot technique. Results showed that all 4 TFs were expressed at 




For the sake of comparing results with the successful lentiviral protocol, several volumes 
of adenoviral preparations were used to transduce MEFs. Transduction efficiencies were 
quantified by IF as the percentage of Oct4 positive cells per total number of initial cells. 
We observed that 100 µL of viral supernatants showed to provide a transduction 
efficiency of approximately 24%, which was similar to the one obtained for the lentiviral 
co-transductions (Figure 3.8 and recall Figure 3.2). 
Figure 3.7: Adenoviral transduced cells express the 4 reprogramming factors. 
HEK-293FT cells were transduced with Ad-OSKM in increasing quantities of viral 
supernatant preparation. Protein expression of Oct4, Sox2, Klf4 and c-Myc is observed and 
is intensified with the correspondent increase in the quantity of viral particles (+). Protein 
lysates collected 1 dpt were subjected to western blot analysis with the indicated 
antibodies; Canx was used as loading control. 
 






To further characterize adenoviral forced expression of the exogenous TFs and compare 
it with the lentiviral system, western blot analysis of total protein content of transduced 
cells at 4 dpt was performed, as depicted in Figure 3.9. When comparing transduction 
conditions that provide the same level of transduction efficiency (approximately 24%), it 
was observed that Oct4 protein levels attained with 100 µL of Ad-OSKM are diminished 
than the levels promoted by the lentiviral system. Using the inducible lentiviral system, 
protein expression was only observed at this point due to the lentiviral mechanism of 
action and the use of an inducible promoter. Since adenoviral vectors do not integrate 
into the host genome, viral copies are known to diminish along with cell divisions, which 
may already have occurred at this timepoint and might explained the observed difference 
on Oct4 protein levels. However, with increasing volumes of transduction adenovirus, 
this difference was attenuated until equivalent Oct4 protein levels was attained with 250 
µL of Ad-OSKM (Figure 3.9B). 
Figure 3.8: MEFs are efficiently transduced by Ad-OSKM depending on the volume of 
transducing viral particles.  
(A) Increasing volumes of adenoviral preparation were added to MEFs and the percentage 
of transduced cells was calculated by dividing Oct4 positive cells for the total number of 
cells; mean ± SD (n=3). (B) Representative images of 100 µL of viral preparation added to 
1x10
5
 initial cells; after quantification, these conditions correspond to approximately 24% of 
transduction efficiency. IF analysis against Oct4 was performed at 1 dpt. Nuclei were 






Adenoviral transduced cells do not display typical morphological and gene expression 
alterations during reprogramming protocol 
The optimized lentiviral protocol, in terms of timeline and culture media, was applied to 
MEFs transduced with Ad-OSKM viral particles, as schematized in Figure 3.10. Cells 
were transduced with different numbers of viral copies per initial cells (termed multiplicity 
of infection, MOI). Viral volumes ranging from 25 to 500 µL per 1x105 initial cells were 
used either in a single or in several transduction events. The rationale behind this 
multiple transduction strategy was to try to overcome dilution of adenoviral intracellular 
copies due to cell division. Additionally, this strategy could allow the maintenance of high 
Figure 3.9: MEFs transduced with lentiviral and adenoviral particles used for delivery 
of reprogramming factors express Oct4 protein.   
(A) Protein lysates of transduced MEFs were collected at 4 dpt and subjected to western 
blot analysis with the mentioned antibodies. Lentiviral co-transduction was performed with 
the volumes of viral preparations used in previous section. Ad-OSKM transduction was 
performed with increasing volumes of viral supernatant. (B) Relative density of Oct4 protein 
bands using Canx as loading control, in arbitrary units (a.u.). When comparing lentiviral co-
transduction (+ DOX) and transduction with 100 µL of Ad-OSKM, the difference between 
the relative densities of Oct4 protein is statistically significant. However, no statistical 
significant difference is found when comparing with 250 µL of Ad-OSKM preparation 
(unpaired t-test, NS p>0.05, * p<0.05). Quantification of densitometry was performed using 
Image J software; mean ± SD, n=3. 
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protein levels of exogenous factors essential to promote reprogramming events and 




Several independent experiments were performed but no typical morphological 
alterations were observed, as for the lentiviral protocol executed in parallel to control for 
the proper experimental conditions. In some cases, few colonies were observed and 
manually “picked” despite not displaying fully reprogrammed morphological appearance. 
Nevertheless these cells failed to proliferate in an ES cell-like manner and no clones 
were successfully established.  
In order to dissect the absence of reprogramming events at a molecular level, 
quantitative RT-PCR analysis of total RNA of adenoviral transduced cells was performed 
during the protocol time course. A volume of 100 µL viral particles per 1x105 MEFs was 
used to obtain transduction efficiencies equivalent to the lentiviral protocol. Specific viral 
transcripts (P2A-Sox2) were detected on the first weeks after the single transduction 
event (Figure 3.11A). Similarly, Total Oct4 (viral+endogenous) levels of transduced 
MEFs were comparable to ES cells, at least on day 4 and 7, but afterwards it started to 
decrease (Figure 3.11B). No expression of endogenous pluripotency genes, like Endo 
Oct4, Nanog and Fgf4, was observed (Figure 3.11C). In a gene expression perspective, 
Figure 3.10: Timeline representing reprogramming protocol adapted for adenoviral 
delivery of reprogramming TFs.  
Transduction of MEFs with Ad-OSKM viral particles was tested using different volumes of 
viral preparation per initial number of cells (different MOIs). Single or multiple transductions 





there was no evidence of an activation of a pluripotency profile, contrarily to what was 
observed with the lentiviral delivery system.  
These gene expression results were in agreement with the observed absence of 
morphological alterations. Therefore, the objective of implementing a non-integrative 




Lentiviral iPS cell clones exhibit typical morphology in culture, self-renewal properties, and 
expression of key pluripotency markers 
Despite no success in replicating adenoviral-mediated reprogramming to pluripotency, a 
lentiviral-based protocol was efficaciously established, providing several iPS cell clones 
Figure 3.11: Protocol using adenovirus does not induce alterations of pluripotency 
genes’ expression consistent with a reprogramming event.  
(A-C) RT-qPCR analysis of total RNA content of transduced cells reveals expression of 
P2A-Sox2 (viral transcript) on the initial days but with a gradual decrease over time. Total 
Oct4 levels follow the same trend. Pluripotency genes, like endogenous Oct4, Nanog and 
Fgf4, are only expressed in residual levels. MEFs were transduced with 100 µL of 
adenoviral preparation per 1x10
5
 initial cells. Gapdh is used as endogenous control; results 
are normalized to d4 (no virus) in (A) or to ES cells (B-C); mean ± SD, n=3. 
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that were further characterized. All iPS cell lines mentioned from this point forward were 
obtained using the described lentiviral delivery system and protocol. 
Several clones from different independent experiments were established and expanded. 
To confirm that a fully reprogrammed state was achieved, iPS cell lines must first 
demonstrate morphology similar to ES cells (considered as a positive control) and 
unlimited self-renewal capacity.  The obtained representative results are shown in Figure 
3.12. Clones were established first in feeder culture conditions, but they could also be 
passaged into feeder-free cultures, maintaining colonies’ appearance and growth rates 
(Figure 3.12A). In terms of self-renewal, iPS clones were subjected to enzymatic 
passaging every 2-3 days for at least 15-20 passages, still maintaining their phenotype. 




Secondly, iPS clones must be characterized in a molecular level to confirm expression of 
key pluripotency factors. By conventional RT-PCR, iPS cell lines were analysed and 
expression of a selection of ES cell marker genes (such as Oct4, Nanog, Eras, Fgf4, 
Ecat1, Zfp42 and Esg1) was positively confirmed (Figure 3.13). Moreover, all clones 
Figure 3.12: iPS cells clones demonstrate morphology in culture and AP positive 
staining, similar to ES cells.  
(A) Three representative iPS cell lines, i2#1, j2#3 and k3#2, show a typical ES cell-like 
morphology when cultured in feeder and feeder-free conditions. (B) All clones also stain 




were negative for P2A-Sox2 viral transcript expression, confirming that they no longer 
depend on exogenous TFs’ expression. 
 
 
Furthermore, expression of Oct4 and Nanog was assessed at a protein level, as 
depicted in Figure 3.14. Three different clones are shown, all being positive for the 
expression and cellular localization of the mentioned TFs. Also, an undifferentiated ES 
cell surface antigen SSEA-1 staining was also detected in all clones. 
Figure 3.13: iPS cell lines express endogenous pluripotency markers.  
Total RNA content of 6 different clones was isolated, cDNA was produced and analysed by 
RT-PCR, using the indicated pairs of primers. iPS cell lines express pluripotency genes, in 
a transgene independent manner, since no expression of viral transcript P2A-Sox2 is 
detected. ES cells are shown as a positive control, feeders as a negative control, and 
Gapdh as endogenous control. 





Thus, isolated iPS cell clones proved to recapitulate ES cells properties, both at 
morphological and molecular levels. Subsequently, functional confirmation of attainment 
of a naïve pluripotent state was assessed. 
Figure 3.14: iPS cell lines express ES cell characteristic TFs and surface markers.  
(A) Confocal images of i2#1 cells subjected to immunostaining using mentioned antibodies 
and DAPI for nuclei counterstaining. iPS cells express Oct4, Nanog and SSEA-1, at a 
protein level and with a nuclear (Oct4 and Nanog) or cell surface localization (SSEA-1). (B) 
Same IF study is shown for 2 more clones, j2#3 and k3#2, and for ES cell as a positive 




Established iPS cell lines demonstrate a functional pluripotent capability 
Pluripotency is usually defined as the ability of germ cells to differentiate into all three 
germ layers such as endoderm, mesoderm and ectoderm. This capability of 
differentiation is regulated by a complex network of TFs and signalling pathways. 
Besides demonstrating expression of these key pluripotent TFs, one needs to prove iPS 
clones’ functional pluripotency. 
Different assays with variable levels of stringency can be used to test for iPS cell lines 
developmental potential. For that purpose, in vitro differentiation assay using EBs was 
used. Clones were grown in low attachment culture dishes to promote EB formation in 
suspension cultures. Afterwards, obtained EBs were transferred for attachment 
conditions and culture media without LIF and 2i, and allowed to differentiate 
spontaneously for 14 days in total. Results for EB assay for 3 clones and ES cells are 
depicted in Figure 3.15.  
As shown, after differentiation of all 3 clones, expression of genes from ectoderm, 
mesoderm and endoderm was detected: Pax6, Col1a1 and Gata6 respectively. In some 
cases expression was detected as soon as 7 differentiation days, while for others 14 
days were needed. Protein levels were also assessed by IF, and positive cells for Pax6 
(ectoderm), SMA (mesoderm) and AFP (endoderm) were detected for all clones (see 
representative images of one clone in Figure 3.15B). 
In order to confirm iPS clones in vivo differentiation potential, cells from i2#1, j2#3 and 
k3#2 iPS cell clones were also injected subcutaneously into immunodeficient mice. 
These cells induced teratomas, with all 3 germ layers being identified after 
histopathological analysis, therefore confirming the pluripotency of the generated iPS cell 
lines (Figure 3.16). 




Figure 3.15: iPS cell clones demonstrate their functional pluripotency in in vitro 
differentiation assay.  
(A) RT-PCR analysis of iPS cell clones in undifferentiated (UD) state or after 7 or 14 days 
of EB differentiation. ES cells were used as positive control and primers designed to 
specifically amplify transcripts from ectodermal (Pax6), mesodermal (Col1a1) and 
endodermal (Gata6) lineages. (B) Representative images of immunostaining of j2#3 cells 
after 14 days of EB differentiation assay. Protein expression of markers for the 3 lineages is 








Forced expression of defined factors can induce reprogramming of somatic cells from 
different tissues and species into a pluripotent state, generating iPS cell lines (Takahashi 
and Yamanaka, 2006; Takahashi et al., 2007a). Different technological improvements 
have been made over the years in order to increase the efficiency of the reprogramming 
Figure 3.16: Established iPS cell lines give rise to tissues from the three germ layers, 
in in vivo differentiation assay.  
iPS cell lines (i2#1, j2#3 and k3#2) were subcutaneously injected into NOD.Scid mice. 
Resultant teratomas were collected after 5 to 7 weeks and subjected to histological 
analysis after hematoxylin-eosin staining. In each teratoma, characteristic tissues from 
ectoderm (A), mesoderm (B) and endoderm (C) lineage are observed, as illustrated on 
representative images. 
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process and diminish the genomic alterations required to complete the process. The 
choice of the appropriate donor cell type, reprogramming cocktail and delivery system 
varies according to the ultimate goal of the study, for instance, basic biology studies or 
clinical applications (González et al., 2011). 
At the time that this study was initiated and until now, delivery of the 4 classical 
Yamanaka TFs (Oct4, Sox2, Klf4 and c-Myc) by an inducible lentiviral system is still the 
gold-standard procedure for the generation of iPS cells. However, the lentiviral delivery 
system raises some concerns related with lack of safety for prospective clinical 
applications. It induces genomic transgene integration, with the consequent possible 
caveat of insertional mutagenesis. Exogenous expression of a reprogramming cocktail, 
that includes the known oncogene c-Myc, contributes to the tumorigenic risk of iPS cells, 
though minimized by withdrawal of the inducing drug. Nevertheless, the efficiency, 
robustness and reproducibility of the inducible lentivirus-mediated reprogramming 
process makes it an ideal approach for the implementation of such technology in a 
laboratory for the first time (Bayart and Cohen-Haguenauer, 2013; González et al., 
2011). 
Here, we reported the generation of mouse iPS cells using a lentiviral system. MEFs 
isolated from WT animals were used and forced expression of the 4 TFs was achieved 
by transduction with an inducible lentiviral system encoding for a polycistronic OSKM. 
The polycistronic unit allows the expression of several cDNAs from the same promoter, 
thus minimizing the number of genomic insertions compared with single-factor-
expressing viruses. Additionally, the inducible nature of the lentiviral system permits the 
expression of the reprogramming factors in a controllable manner (Carey et al., 2009). 
Initially, the efficient transduction of the initial cells was confirmed, as well as the 
inducible expression of the 4 TFs. Cellular reprogramming of MEFs was attempted in 
typical ES cell culture conditions (serum and LIF), with subsequent addition of 2i to the 
culture medium in order to promote conversion of pre-iPS cells into fully reprogrammed 
cells, in a naïve pluripotent state (Silva et al., 2008). Morphological alterations of the 
initial cells were observed, with elongated fibroblasts becoming rounded and aggregated 
in small clusters characteristic of MET described to occur on early reprogramming events 
(Li et al., 2010a). Alterations on gene and protein expression were also observed with 
the reactivation of endogenous pluripotency markers, such as Oct4, Nanog, Fgf4, SSEA-
1 and AP. Such expression was maintained even when the inducing drug was withdrawn 
from the system, highlighting that reprogrammed cells were already on a transgene 




In order to establish a reprogramming protocol suitable for clinical applications, similar 
conditions (donor cell type and culture media) were employed but using a non-integrative 
viral delivery system. The same polycistronic cassette encoding for OSKM was cloned 
into an adenoviral vector, which was shown to efficiently transduce MEFs. However, the 
morphological and molecular alterations, occurring during the lentiviral protocol, were not 
observed. One possible explanation could be related with Oct4 essential role on 
reprogramming events, on a dose dependent manner. It has been shown that high 
expression of transgenic Oct4 in somatic cells and reprogramming intermediates is 
necessary for successful reprogramming, probably because Oct4 protein may assist in 
opening chromatin, increasing the chances of reactivating early pluripotency genes 
(Radzisheuskaya and Silva, 2013). Given the reduced level of Oct4 protein when 
comparing with equivalent conditions of the lentiviral system (Figure 3.9), one can 
speculate that Oct4 levels were insufficient for the initial reprogramming events. 
Additionally, an ES cell level of Oct4 must be achieved at the late stages of 
reprogramming for cells to enter the pluripotent cell state, which did not occur with the 
adenoviral system (Radzisheuskaya et al., 2013). It was observed that, on 14 dpt, Oct4 
levels were not equivalent to ES cells, contrarily to what was found for the lentiviral 
approach (Figure 3.11B and Figure 3.5B). However, increased volumes of viral 
preparations (thus with higher percentage of transduced cells) and/or multiple 
transductions (attempting a more robust expression over time) were also tested 
unsuccessfully. In some rare cases, some colonies arose in culture but could not 
successfully originate an expandable iPS cell line. Importantly, since the first reports of 
adenoviral-mediated delivery of the reprogramming factors, only a few authors claimed 
to reproduce it and with different donor cells (Fink et al., 2013). Moreover, additional and 
more appealing non-integrative approaches have been developed, such as the highly 
efficient RNA delivery (Warren et al., 2010), which will be explored in the near future. 
Contrarily to the adenoviral delivery, inducible lentiviral system efficiently allowed the 
reprogramming of MEFs into pluripotency. Emerging colonies were identified by their 
morphology, and subsequently isolated and sub-cultured, generating several iPS cell 
lines that could be expanded and characterized. Such cells must demonstrate self-
renewal and pluripotency properties similar to ES cells, in order to confirm that a 
pluripotent state has been achieved by the reprogramming process. Obtained iPS cell 
lines demonstrated unlimited propagation in vitro (self-renewal property), whilst 
displaying a typical ES cell-morphology. Molecularly, iPS cells exhibited expression of 
key pluripotency markers at a transcriptional and protein level, confirming the 
reactivation of the endogenous pluripotent program. Of particular relevance is the 
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observed expression of Oct4 and Nanog, members of the core circuitry responsible for 
activating expression of genes involved in pluripotency maintenance and inhibiting early 
lineage differentiation genes (Young, 2011). Additionally, iPS cell lines expressed other 
pluripotency factors, such as Eras, Ecat1, Esg1, Fgf4 and Zfp42 (Takahashi et al., 
2007b), were positive for AP staining and displayed characteristic SSEA-1 surface 
marker. Expression of Nanog and Zfp42 (also known as Rex1) further confirms the 
attainment of naïve pluripotency. This “ground state” has been known to be promoted by 
dual inhibition of MEK and GSK3 signalling pathways with the addition of 2i small 
molecules to the culture medium of ES cells and iPS cells. Nanog and Zfp42 are usually 
heterogeneously expressed by pluripotent cells, except in this 2i culture conditions that 
promote a more homogeneous level of expression within the cell population (Wray et al., 
2010). In accordance, Nanog protein was found to be homogeneously expressed by 
generated iPS clones (Figure 3.14).  
Another feature of naïve pluripotency is the capacity to give rise to all cell types of an 
organism except extraembryonic tissues. To confirm such property, several functional 
tests have been implemented. Generated iPS cell lines were first subjected to an in vitro 
differentiation assay, in which EB grown in suspension are plated out as adherent 
colonies and allowed to differentiate spontaneously. Expression of markers from 
ectoderm, mesoderm and endoderm lineages was observed for the tested iPS cell lines 
thus providing the first evidence for the pluripotent developmental potential. Secondly, a 
more stringent confirmation of such property was provided by an in vivo differentiation 
assay. After injection on immunodeficient mice, iPS cells formed teratomas, which were 
composed by tissues from the 3 germ layers. 
According to the requirements of the downstream goal, iPS cell lines might be more 
extensively characterized, namely in the case of prospective therapeutic application. 
Functionally, iPS cell lines can further demonstrate definite pluripotency by chimera 
formation with germline transmission and generation of entirely iPS cell-derived mice by 
tetraploid complementation (Kang et al., 2009; Okita et al., 2007). Additionally, genetic 
and epigenetic alterations have been detected on iPS cell lines, with consequent 
immunogenicity and tumorigenicity concerns, which might impair their use for cell 
replacement therapies. On such case, genome-wide sequencing, expression analysis, 
and DNA and histone modification analysis have been used for a more comprehensive 
genetic and epigenetic profiling of iPS cell lines (Liang and Zhang, 2013; Peterson and 
Loring, 2014). 
In conclusion, an inducible lentiviral approach was successfully undertaken with the 




pluripotency properties, both molecular and functionally. Importantly, in addition to 
possible therapeutic intervention on regenerative medicine field, these iPS cells can be 
used for disease modelling, drug or toxicity screening and basic biology studies. Thus, 
implementation of such Nobel awarded technology in a laboratory opens new avenues 

















Chapter 4 : Induced Pluripotent Stem cell-based applications for 
Choroideremia 
Summary 
Choroideremia (CHM) is an X-linked form of retinal degeneration of slow onset and 
progression, with affected males suffering blindness by middle age. CHM is caused by 
loss of function of REP-1, which is a regulator of Rab GTPase activity, essential for 
intracellular trafficking processes. In CHM, the RPE and other components of the retina, 
like photoreceptors and choriocapillaries, deteriorate progressively causing visual 
impairment. Using mouse models, we showed recently that the RPE plays a central role 
in the pathogenesis of CHM, suggesting that rescue of RPE function may be of great 
benefit to CHM patients (Tolmachova et al., 2013). For patients with extensive retinal 
degeneration, only regenerative approaches will enable restoration of vision. In recent 
years, this area of research has seen tremendous technological developments, which 
have offered new hope that this approach may yield results in the short term.  
iPS cells appear to be particularly attractive, given the potential to reprogram adult 
somatic cells to pluripotency, gene correction and differentiation into the desired cells, 
and therefore to generate patient-specific cells to replace damaged tissue. Alternatively, 
and more straightforwardly, iPS cells can also be used, after differentiation into a 
functional RPE, as an in vitro model of CHM to study the still unclear pathophysiological 
and molecular events that trigger retinal degeneration in this disorder. This is particularly 
relevant for CHM given the lack of proper in vitro models, namely due to limited cell 
availability of RPE primary cultures from Chm mouse model. 
Here, we report the generation and characterization of iPS cells from fibroblasts derived 
from a mouse model with conditional Chm/Rep1 KO (Tolmachova et al., 2006). MEFs 
were reprogrammed using a polycistronic lentivirus coding for Yamanaka’s transcription 
factors (Oct4, Sox2, Klf4 and c-Myc) (Carey et al., 2009; Takahashi and Yamanaka, 
2006). Several iPS cell clones were isolated and characterized in terms of morphology, 
self-renewal and expression of key pluripotency markers. In vitro and in vivo 
differentiation assays were executed to further confirm the pluripotency status of the 
obtained pluripotent cell lines. Subsequently, differentiation into RPE of iPS cell lines 
was attempted in order to provide a proof of concept of their prospective use in disease 






Chm MEFs primary cultures can be used as an in vitro model of Rep1 KO 
Conditional mouse models of Rep1 KO have been generated in order to study CHM 
pathophysiology and to test new therapeutic approaches (Tolmachova et al., 2006). Null 
mutations of Chm/Rep1 have shown to be embryonically lethal in males and 
heterozygous females that have inherited the mutation from their mothers, due to defects 
in trophoblast development and vascularization of extra-embryonic tissues (Shi et al., 
2004). Therefore conditional approaches were undertaken to circumvent this described 
lethality and breeding problems of transmitting the Chmnull allele from carrier females. 
Tamoxifen (TM)-induced conditional mouse model, which features a temporal control of 
the Cre/loxP site-specific recombination event that triggers actual Rep1 KO, can be used 
to obtain somatic cells for reprogramming experiments. These animals carry a modified 
Chm allele with its exon 4 flanked by 2 loxP sites (Chmflox), and, in some cases, also a 
MerCreMer transgene that provides TM responsiveness. 
In order to obtain Chm MEFs, a breeding scheme was established, as depicted in Figure 
4.1, with Chmflox/flox MerCreMer+ females being mated with Chmflox/Y MerCreMer- males. 
At E13.5, primary cultures of MEFs were established from each embryo separately. All 
primary cultures were characterized in terms of genotype and a representative PCR 
result is shown in Figure 4.1B. As expected, all primary cultures are Chmflox, however 
only approximately half of them possess the MerCreMer transgene (in this illustrative 
case, embryos E12, E13 and E16-19 are positive). From 10 successful matings, 68 
embryos were isolated, and 33 were positive for MerCreMer transgene. 





When Chmflox MerCreMer+ primary cultures are treated with TM, Rep1 KO is expected to 
occur. MerCreMer positive cells express Cre recombinase as a fusion protein with 2 
copies of TM-responsive estrogen receptor. Upon TM treatment, MerCreMer, usually 
sequestered in the cytoplasm, is translocated into the nucleus and catalyzes 
recombination between the 2 loxP sites flanking Rep1 exon 4. On resulting Chmnull cells, 
a frameshift mutation occurs, leading to a premature stop codon, resulting in a non-
functional Rep1 protein (Figure 4.2A).  
 
 
Figure 4.1: Breeding of Chm
flox










 males, and 
pregnant females were sacrificed for establishment of MEF primary cultures. (B) PCR 
genotyping of isolated embryos (E) 8 to 19 allows characterization in terms of MerCreMer 
transgene presence or absence (bottom panel; 510 bp). Primers to confirm Chm
flox
 





Figure 4.2: Treatment with 6 µM TM for 96 h induces genomic recombination in Chm 
MEFs without affecting cell survival.  
(A) Scheme of TM treatment of Chm
flox
 cells inducing genomic recombination between loxP 
sites (grey triangles) flanking exon 4 of Rep1 gene. A stop codon is created and Chm
null 
cells will not express functional Rep1 protein. (B) MTT assay was used to asses cell 
survival of MEFs treated with increasing concentrations of TM, for 72 or 96 h. For both 
exposure periods, 6 µM of TM can be used without affecting the percentage of survival. 
Mean ± SD, n=3. Statistically significant values relative to control for each exposure time (0 
µM) are indicated (one-way ANOVA with Dunnett’s multiple comparison test); * p<0.05, *** 
p<0.001. (C) MEFs were subjected to increasing concentrations of TM for periods of 72 h 
or 96 h, and genomic DNA was isolated and analysed by PCR. Two representative Chm
flox
 
(860 bp) cultures are shown and, in the presence of TM, genomic recombination occurs 
and Chm
null
 alleles (330 bp) are now detected. In the top panel, Chm
flox
 (860 bp) alleles are 
visible even when higher concentrations of TM were used. For 8 or 10 µM, bands are 
fainter probably due to cell death, as expected according to MTT results. 
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TM exposure conditions were optimized in terms of concentration and exposure time in 
order to maximize genomic recombination events without compromising cell viability. 
MEFs were treated with increasing concentrations of TM (ranging from 0 until 10 µM) for 
periods of 72 or 96 h. Cell viability, evaluated by MTT assay, was not affected with 
concentrations up to 6 µM, for both periods of time (Figure 4.2B). These conditions 
promoted genomic recombination with excision of exon 4 of Rep1 gene, as a shorter 
Chmnull allele was now detected by PCR (Figure 4.2C). Despite some variability between 
MEFs and presence of residual amounts of Chmflox allele in some cases, recombination 
occurred at great extent when cells were treated with TM 6 µM for 96 h. It was also 
observed that increasing TM concentration or exposure time would affect cell viability, 
without necessarily increasing recombination efficiency. Specifically, when comparing 6 
versus 8 µM treatment and 72 h versus 96 h, maintenance of residual Chmflox allele was 
observed. (Figure 4.2B and C). 
Although treating cells with 6 µM TM for 96 h was shown to be sufficient to induce 
genomic recombination, it was essential to determine expression levels of Rep1 gene to 
confirm that an efficient Rep1 KO has occurred. Therefore, all primary cultures used in 
reprogramming experiments were always characterized in terms of genotype and Rep1 
expression. In Figure 4.3A, genotyping results of 3 representative cultures are shown 
and 3 different types of cells were used throughout these studies: Chmnull (generated 
from Chmflox cells subjected to TM treatment), Chmflox (untreated) and WT primary 
cultures. The later correspond to WT MEFs as described on previous chapter (thus are 
MerCreMer-) and were used in parallel as a positive control for reprogramming events. 
In concordance with their genotypes, Rep1 expression levels of Chmnull primary cultures 
were significantly reduced when compared with Chmflox or WT MEFs, as determined by 
RT-qPCR (Figure 4.3B). Therefore, an efficient KO of Rep1 gene was successfully 
obtained in Chmnull primary cultures. Chmnull cells can be used to model Chm, directly or 
after reprogramming into a pluripotent state with the obtention of Chm iPS cells, as is 







Chm MEFs can be reprogrammed into pluripotency using a lentiviral based protocol 
Somatic cells from Chm mouse model were subjected to established lentiviral 
reprogramming protocol (see Chapter 3 for details). As WT MEFs were used to 
implement and optimize the protocol, these cells were used as a reprogramming control 
in experiments involving Chm cells.  
The first step was to assess the transduction efficiency with lentiviral reprogramming 
tools by immunostaining against Oct4 (Figure 4.4A). Co-transduction with Lenti-TetO-
OSKM and Lenti-M2rtTA was shown to promote exogenous expression of Oct4, 4 dpt, in 
the presence of DOX. This also occurred with Chmnull and Chmflox cells, with no 
significant difference in terms of percentage of transduced cells (29 and 26%, 
respectively) when comparing both cells types with each other or with WT MEFs (Figure 
4.4B). Inducible nature of lentiviral system was confirmed by western blot analysis, with 
Oct4 protein levels only being detected in the presence of DOX, in all 3 types of MEFs 
(Figure 4.4C). 
 
Figure 4.3: Primary cultures of Chm
null 
MEFs have reduced levels of Rep1 
expression.  





treated with TM) and Chm
flox 
cells. On top panel, primers 
that amplify Chm gene were used and, given the size difference, Chm
WT
 (780 bp), Chm
null
 
(330 bp) and Chm
flox
 alleles (860 bp) are distinguished. On bottom panel, PCR using 
primers that amplify MerCreMer transgene (510 bp) is shown. (B) Quantitative RT-PCR 
analysis of MEFs was performed to evaluate Rep1 expression. Chm
null
 cells exhibit at least 
80% KO of Rep1 expression when compared with WT or Chm
flox 
MEFs. Gapdh was used 
as endogenous control; mean ± SD, n=3. Statistically significant values relative to control 
are indicated (one-way ANOVA with Dunnett’s multiple comparison test); *** p<0.001. 





Transduced cells were subjected to same culture conditions as described on Chapter 3 
(schematic protocol in Figure 4.5A). The morphological alterations observed for WT cells 
also took place when reprogramming Chmnull and Chmflox cells (Figure 4.5B). Moreover, 
ES cell-like colonies emerged around 7 dpt in the presence of DOX, in both cases and 
as shown for Chmnull cells. 
 





 MEFs express Oct4, in the presence of DOX, as 
assessed by IF at 4 dpt; nuclei are counterstained with DAPI and used to quantify total 
number of cells; scale bar 50 µm. (B) Quantification of transduced cells, expressed as 
percentage of Oct4 positive cells per total number of cells, shows no statistically significant 
difference between 3 cell types (one-way ANOVA with Bonferroni’s multiple comparison 
test, NS p>0.05); mean ± SD, n=4. (C) Protein lysates were subjected to western blot 
analysis and exogenous expression of Oct4 occurs only in the presence (+) of DOX. Canx 






Several independent experiments were performed, given rise to numerous colonies from 
Chmnull and Chmflox cells that were manually “picked” and subcultured at 28 dpt (at least 
24 colonies of each cell type per experiment). As stated before for WT cells, not all 
colonies generated an expandable cell line. Nevertheless, several iPS cell lines were 




MEFs subjected to reprogramming protocol display typical 
morphological alterations.  
(A) Schematic representation of established protocol. (B) Representative brightfield images 
of transduced Chm
null
 MEFs cultured in the presence (+) of DOX showing that 
approximately 7 dpt typical ES-like colonies start to appear. At day 14, colonies have a 
more condensed and well-defined structure in culture. In the absence (-) of DOX, 
transduced cells maintain a fibroblast-like morphology. Scale bar 50 µm. 
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Chm iPS cell lines display morphology, self-renewal and pluripotency attributes 
Morphological, molecular and functional characterization of iPS cell lines is required in 
order to confirm self-renewal and pluripotency properties similar to ES cells. Established 
Chm iPS cell lines were cultured in feeder and feeder-free conditions and submitted to 
enzymatic passaging every 2-3 days during at least 15-20 subcultures, whilst 
maintaining typical ES cell-like morphology in both culture conditions. In addition to 
mentioned self-renewal capability, Chm iPS clones were also positive for AP staining. In 
Figure 4.6, representative images of ES cell-like morphological appearance and positive 
AP staining of 3 Chmnull (j5#2, j6#5, k6#10) and 3 Chmflox (j9#3, k8#6, k9#2) iPS cell 











 iPS cell clones demonstrate morphology in culture 
and AP positive staining similar to ES cells.  
(A) Three representative iPS cell lines from each genotype (Chm
null
: j5#2, j6#6, k6#10; 
Chm
flox
: j9#3, k8#6, k9#2) show a typical ES cell-like morphology when cultured in feeder 
and feeder-free conditions. (B) All iPS cell clones and ES cells stain positively for AP. Scale 
bar 50 µm. 
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At a molecular level, iPS clones were characterized by conventional RT-PCR to 
determine expression of key pluripotency markers (Figure 4.7). No expression of viral 
transcript P2A-Sox2 was observed for several Chmnull and Chmflox clones, which 
demonstrates their transgene independence. Most of Chmnull and Chmflox clones 
endogenously express all pluripotency genes tested (for Oct4, primers that specifically 




Further characterization was undertaken for 3 Chmnull (j5#2, j6#5, k6#10) and 3 Chmflox 
(j9#3, k8#6, k9#2) iPS cell clones. Expression of pluripotency markers, such as Oct4, 
Nanog and SSEA-1, was confirmed at a protein level by IF and all clones displayed 
positive staining as representatively illustrated (Figure 4.8). 
 
Figure 4.7: iPS cell lines express endogenous pluripotency markers.  
Total RNA content of 11 different Chm
null
 and 6 Chm
flox
 iPS cell clones was isolated. cDNA 
was produced and analysed by RT-PCR, using the indicated pairs of primers. iPS cell lines 
express pluripotency genes, in a transgene independent manner, since no expression of 
viral transcript P2A-Sox2 is detected. ES cells are shown as a positive control, feeders as a 






Moreover, functional pluripotency was assessed by in vitro differentiation assay, and all 
mentioned clones have demonstrated the ability to differentiate into cells from the 3 germ 
layers (Figure 4.9). After 7 or 14 days of differentiation of EB, ectodermal (Pax6), 
mesodermal (Col1a1 or SMA) and endodermal (Gata6 or AFP) markers were expressed 
as evaluated by RT-PCR and IF. 





 iPS cells were subjected to immunostaining using Oct4, Nanog and 
SSEA-1 antibodies and DAPI for nuclei counterstaining. Confocal images for two 
representative iPS clones are shown. Scale bar 20 µm. 










 iPS cell clones demonstrate their functional 
pluripotency in in vitro differentiation assay.  
(A) RT-PCR analysis of iPS cell clones in undifferentiated (UD) state or after 7 or 14 days 
of EB differentiation. Three clones from each genotype are shown as a representative 
result. Primers designed to specifically amplify transcripts from ectodermal (Pax6), 
mesodermal (Col1a1) and endodermal (Gata6) lineages were used. ES cells were used as 
positive control (B) Representative images of immunostaining of j5#2 and k8#6 iPS cell 
clones after 14 days of EB differentiation assay. Protein expression of markers for the 3 
lineages (ectoderm, mesoderm and endoderm) is observed, when the mentioned 




In a more stringent and definitive way, pluripotency was confirmed by an in vivo 
differentiation assay. Three Chmnull (j5#2, j6#5, k6#10) and 3 Chmflox (j9#3, k8#6, k9#2) 
iPS cell lines were subcutaneously injected in immunodeficient NOD.Scid mice. In all 
cases tumours arose and were collected at appropriate timepoints, followed by 





Chm iPS cell lines generated from Chmnull fibroblasts display efficient Rep1 KO 
Besides demonstrating that generated iPS cell clones display features similar to ES 
cells, characterization in terms of Chm/Rep1 gene is essential in order to establish these 





 iPS cell clones demonstrate their functional 
pluripotency in in vivo differentiation assay.  
Chm iPS cell lines were subcutaneously injected into NOD.Scid mice. Resultant teratomas 
were collected after 5 to 7 weeks and subjected to histological analysis after hematoxylin-
eosin staining. In each teratoma, characteristic tissues from ectoderm (A), mesoderm (B) 
and endoderm (C) lineage are observed, as illustrated on representative images for one 
Chm
null
 and one Chm
flox
 iPS clone. 
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Clones of both types were subjected to PCR genotyping using primers to confirm identity 
of Chm alleles and presence/absence of MerCreMer transgene (Figure 4.11A). As 
expected, iPS cells demonstrated the same genotype as the initial somatic cells: j5#2, 
j6#5 and k6#10 iPS cells are Chmnull, and j9#3, k8#6 and k9#2 iPS cells are Chmflox. All 
clones are positive for the MerCreMer transgene. 
Interestingly, all clones isolated from Chmnull MEFs submitted to reprogramming also 
maintained the same genotype as the initial cells. As mentioned before, TM treatment of 
Chmflox cells does not allow a totally efficient recombination event, as some residual 
Chmflox allele was occasionally detected, probably meaning that a small population of 
Chmflox cells is maintained (recall Figure 4.2). Nevertheless, all clonaly isolated iPS 
colonies from Chmnull MEFs have proven to be Chmnull after PCR genotype. 
In terms of Chm/Rep1 expression RT-qPCR analysis demonstrated that Chmnull iPS cells 
have reduced Rep1 expression when compared to Chmflox clones (Figure 4.11B). 
Furthermore, Rep1 KO was also confirmed at a protein level using an antibody that 
detects both Rep1 and Rep2 proteins. Concordant with the fact that only Chm/Rep1 
gene was modified and targeted for deletion in the Chm mouse model, Rep2 protein 
expression was detected on both Chmflox and Chmnull iPS cell lines. However, Rep1 
protein expression was not detected on Chmnull cells, thus confirming the applicability of 





Figure 4.11: Generated Chm
null
 iPS cell lines display an efficient KO of Rep1 gene. 
(A) gDNA of Chm
null
 (j5#2, j6#5, k6#10) and Chm
flox 
(j9#3, k8#6, k9#2) iPS cell clones was 





 (860 bp) alleles (top panel) or to confirm the presence of MerCreMer 
transgene (510 bp) (bottom panel) were used. (B) Total RNA content of same clones was 
analysed by RT-qPCR to determine Rep1 levels. Chm
null
 iPS cell lines display a reduction 
of approximately 70% of Rep1 expression when compared to Chm
flox
 iPS cell clones. 
Gapdh was used as endogenous control; mean ± SD, n=3. Statistically significant values 
relative to control are indicated (one-way ANOVA with Dunnett’s multiple comparison test); 
*** p<0.001. (C) Protein lysates from the same clones were subjected to western blot 
analysis using pan-REP (J906) antibody, which recognizes both Rep1 and Rep2 proteins. 
Rep1 protein is not detected on Chm
null
 iPS cells lysates, contrarily to Chm
flox
 iPS cell lines. 
Rep2 protein is detected on both cell lines. Canx antibody was used as loading control. 
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REP1 protein, and its ortholog REP2, are responsible for the prenylation of Rab proteins, 
a post-translational modification essential for their function as key regulators of 
intracellular trafficking. Mutations in human CHM/REP1 gene are responsible for X-linked 
disorder CHM, characterized by progressive degeneration of choroid, RPE and 
photoreceptor cells. It is assumed that CHM phenotype is restricted to the eye due to the 
presence of REP2 protein which compensates for the absence of functional REP1 
protein in all organs and tissues, except the eye (Seabra, 1996). Nevertheless, CHM 
pathogenesis remains quite unclear at the molecular level. In Saccharomyces cerevisiae, 
the REP1 homologue, MRS6, is essential for cell growth (Alory and Balch, 2000; 
Waldherr et al., 1993). Moreover, in a mutagenic screen in zebrafish, REP1 was shown 
to be essential for survival and development of hair cells in the inner ear and some cell 
types from the retina (Starr et al., 2004). 
Therefore, after establishing Chmnull and Chmflox iPS cell lines, it was pertinent to 
investigate the potential effect of Rep1 absence in survival and growth rates of 
pluripotent cells. For that purpose, an MTT assay was performed. Several plating 
densities of 3 iPS cells lines (j6#5, k6#10 and j9#3) and ES cells were tested, and MTT 
assay was performed 24 hours later. At this timepoint, cells are expected to have 
adhered and recovered from splitting, whereas not yet actively dividing. In the range 
tested, despite some variability between cell lines, absorbance measures were shown to 
have a linear relationship with the number of cells, confirming their applicability to infer 
cell number/viability (Figure 4.12A). Moreover, optimal initial seeding density was also 
determined to be 1x104 cells. 
Subsequently, all 9 extensively characterized iPS cell clones (3 of each genotype, 
including WT) and ES cells were plated and MTT assay was performed at 24, 48, 72 and 
96 h (Figure 4.12B). As expected, absorbance measures increased overtime in a 
logarithmic way up to 72 hours after plating, for all tested cells. Afterwards, cells reached 
a plateau due to increased cell density, as confirmed by microscopic observation. 
Typically, these cell lines are enzymatically splitted every 2-3 days, so consistently, 96 
hours after plating, cells were over-confluent and probably cell death was already 
occurring.  
Interestingly, there was no indication supporting the hypothesis that Rep1 absence could 
affect cell survival. All cell lines displayed different growth rates but there was no evident 
reduced value for Chmnull iPS cell lines when comparing them to Chmflox or WT ones. It is 
possible that Rep2 protein, expressed by both cell types, compensates for the lack of 






Figure 4.12: All iPS cells have equivalent growth rates, as assessed by MTT assay.  
(A) Increasing number of cells (0, 1, 2, 5, 10 and 20x10
4
) were plated and subjected to MTT 
assay after 24 h. ES cells and 3 different iPS clones were tested; n=3. Lines represent 
linear regressions for the 4 different cells. (B) MTT assay was conducted 24, 48, 72 and 96 
hours after plating 1x10
4
 cells, in order to obtain growth curves for 9 mentioned iPS clones 
(3 clones from each genotype) and ES cells. Absorbance represented in Y-axes is in log 
scale. Mean ± SD, n=3. 
iPS cell-based applications for Choroideremia 
149 
 
Chm iPS cell lines fail to differentiate into a polarized neuroepithelium when subjected to a 
protocol adapted from Zhu et al. 
Prior to use in disease modelling or cell therapy, stem cells must be differentiated into 
functional adult cells. Several protocols have been described for differentiation of ES or 
iPS cells into RPE, most of them sharing the common feature of first promoting 
conversion of stem cells into a neuroectodermal-like cell and then differentiation into 
RPE cells. Mimicry of the patterning and developmental events that occur during 
embryogenesis is achieved by changing the media composition in terms of small 
molecules and growth factors. In the mentioned protocols, factors involved in in vivo 
retinal development were used to establish a defined culture method that induces in vitro 
differentiation of stem cells into retinal progenitors and subsequently in retinal cells 
(Bharti et al., 2011). Moreover, most protocols rely in a non-adherent cell culture system 
in at least one of the differentiation steps. 
Given the panoply of published protocols with variable efficiencies, three different 
approaches were chosen and undertaken in an attempt to obtain RPE cells by 
differentiation of obtained Chm iPS cells (as well as WT). 
Recently, Zhu and colleagues established a three-dimensional (3D) epithelial cyst culture 
of human ES cells to promote the induction of a polarized neuroepithelium that could be 
converted into human RPE cells in a quantitative way (Zhu et al., 2013). The obtained 
cells could be transplanted into RCS rats without any selection or further expansion. 
Chmnull (k6#10), Chmflox (j9#3) and WT (k3#2) iPS cell lines, as well as ES cells, were 
submitted to the first step of this protocol, a 3D culture system using basement 
membrane matrix components (Matrigel) (Figure 4.13A) and their morphology was 
observed over the first 5 days (Figure 4.13B). Unlike what was described for human ES 
cells, floating aggregates were observed with different shapes and sizes, but no 






Total RNA samples were collected at day 5, cDNA was synthetized and conventional 
RT-PCR analysis was undertaken in order to characterize the occurring differentiation 
process. Consistent with a differentiation process, expression of pluripotency markers 
(Oct4, Nanog and Fgf4) at day 5 of the protocol was reduced when compared to 
undifferentiated (UD) status of pluripotent cells (Figure 4.14). Expression of Eye Field 
TFs (EFTFs; namely Pax6, Rax, Six3 and Six6) was also evaluated but, contrarily to 
what was described by Zhu and co-workers for human cells, no up-regulation was 
observed. 
Figure 4.13: iPS cell lines submitted to differentiation protocol adapted from Zhu et 
al. display morphological alterations.  
(A) Schematic representation of the protocol composed of 2 subsequent steps. At first, a 
Matrigel-based 3D culture system is used in conjunction with neuroinduction media N2B27. 
In some cases IGF-1 recombinant protein was also added (10 ng/mL). After 5 days, cells 
would be submitted to an adherent culture and RPE specific medium containing Activin A. 
(B) Representative brightfield images of iPS cells on day 2 and day 5, without IGF-1. iPS 
cell clusters observed have variable sizes and shapes. No remarkable difference on 
morphologic alterations was identified in the presence of IGF-1. Scale bar 50 µm. 





Figure 4.14: iPS cell lines submitted to differentiation protocol adapted from Zhu et 
al. have diminished levels of pluripotency markers expression but no detectable 
levels of EFTFs (except Otx2) and RPE markers at day 5.  
RT-PCR analysis of mentioned iPS cell lines and ES cells is shown for the denoted genes. 
For each cell, samples collected after 5 days of differentiation protocol in the absence (d5) 
or presence (d5+IGF-1) of IGF-1 10 ng/mL are compared with undifferentiated (UD) 
samples. Pluripotency markers (Endo Oct4, Nanog and Fgf4) have reduced expression. No 
substantial expression of EFTFs (namely Pax6, Rax, Six3 and Six6) is detected, even 




Given that it was also described that IGF-1/insulin signalling was responsible for a 
significant role in head and eye formation and for directing human iPS cells to a retinal 
progenitor identity (Lamba et al., 2006; Pera et al., 2001), differentiation protocol was 
also tested in the presence of IGF-1 recombinant protein. Morphologically, floating 
aggregates were indistinguishable of the ones obtained without IGF-1. Samples 
collected at day 5 (d5+IGF-1) were also evaluated but once again no expression of 
EFTFs was observed (Figure 4.14). 
Expression of TFs involved in RPE specification (Otx1, Otx2 and Mitf) or mature RPE 
(Tyr, Rpe65 and Rgr) genes was also assessed and, as expected for an initial step in the 
protocol, no transcripts were detected either in UD status or after differentiation, except 
for Otx2. Otx2 transcripts were detected in UD samples and after differentiation, in some 
cases with increased levels. Several studies have indicated the crucial role played by 
Otx2 in the development of anterior neuroectoderm. Also, in the eye Otx2 plays relevant 
roles in early EF and subsequent RPE specification (Beby and Lamonerie, 2013). 
Despite some increased transcriptional levels of Otx2 upon differentiation, expression of 
EFTFs was not observed and a retinal identity could not be attributed to the floating 
aggregates formed with this protocol. Therefore, subsequent steps of the described 
protocol (such as RPE specification) were not pursued.  
 
Chm iPS cell lines give rise to OV-like protusions when subjected to a differentiation 
protocol adapted from Eiraku et al. and Gonzalez-Cordero et al. 
Concomitantly, another differentiation protocol was attempted based on the work of 
Eiraku and colleagues and of Gonzalez-Cordero and co-workers (Eiraku and Sasai, 
2012; Eiraku et al., 2011; Gonzalez-Cordero et al., 2013).  
A 3D cell culture system has been shown to promote the self-formation of optic-cup 
structures, when ES cells floating aggregates are cultured under low growth factor 
conditions (serum-free floating cultures of EB-like aggregates with quick reaggregation or 
SFEBq) and supplemented with Matrigel. The details of the adapted protocol we used 
are depicted at Figure 4.15A. 
 




Figure 4.15: iPS cell lines submitted to differentiation protocol adapted from Eiraku 
et al. and Gonzalez-Cordero et al. display morphological alterations.  
(A) Schematic representation of the protocol composed of 2 subsequent steps. First, cells 
are cultured in low-adherent and serum-free conditions. Matrigel to final 2% (v/v) is added 
on day 1. After 10 days, aggregates would be transferred for another low-adherent culture 
system with culture media to promote late retinal differentiation. (B and C) Representative 
brightfield images of iPS cells on day 5. Frequently, observed iPS cell aggregates display a 
continuous neuroepithelium-like around the whole circumference. (C) Higher magnification 
of iPS cell aggregates on day 5. (D) Representative brightfield images of iPS cells on day 7 
and 10. Interestingly, on day 10 some protusions from the aggregates are observed and 





Chmnull (k6#10) and Chmflox (j9#3) iPS cell lines, as well as ES cells, were submitted to 
the Early Retinal Differentiation step in SFEBq+Matrigel conditions, and morphological 
alterations were monitored. RNA samples were collected at day 3 and 10 for later 
analysis. As described by the authors, continuous neuroepithelium-like structures were 
detected as early as day 5 of differentiation (Figure 4.15B and C). However, it was stated 
that OV-like structures containing thickened regions of the neuroepithelium that 
protruded from the iPS/ES cell aggregate were visible around day 7, followed by 
invagination of these same structures to form OC-like ones around day 9 (Gonzalez-
Cordero et al., 2013). OV-like aggregates were only detected latter (day 10) and never 
with the 50% abundance mentioned by Gonzalez-Cordero and colleagues (Figure 
4.15D).  Moreover, OC-like structures were not detected. Unfortunately, this 
differentiation protocol did not follow for longer period due to cell death. 
Regarding transcriptional modifications during differentiation protocol, as for the previous 
protocol, a set of genes was analysed (Figure 4.16).  






Figure 4.16: iPS cell lines submitted to differentiation protocol adapted from Eiraku 
et al. and Gonzalez-Cordero et al. have diminished levels of expression of 
pluripotency markers and increased expression of EFTFs.  
RT-PCR analysis of mentioned iPS cell lines and ES cells is shown for the denoted genes. 
For each cell, samples collected after 3 or 10 days of differentiation protocol (d3, d10) are 
compared with undifferentiated (UD) samples. Pluripotency markers (Endo Oct4, Nanog 
and Fgf4) show reduced expression. Pax6, Six3, Otx2 and Otx1 genes have increased 
levels of expression. No expression of RPE-specific markers is detected. Gapdh is used as 




The expression of pluripotency genes gradually diminished during the protocol for all 
tested cells, as expected for a differentiation process. It was also observed that the 
expression of EFTFs, like Pax6 and Six3, was up-regulated after 10 days of 
differentiation, in accordance with the observed OV-like structures. Regarding Rax and 
Six6 no expression was observed. As already mentioned Otx2 plays a key role in 
neuroectodermal specification. Furthermore Otx1 cooperates with Otx2, being both 
expressed simultaneously in the forming OV (Martinez-Morales et al., 2001). 
Consistently, Otx2 transcripts increased upon differentiation and Otx1 was detected at 
day 10 in at least 2 cells. Expression of RPE specific genes (namely Mitf, Tyr, Rpe65 
and Rgr) was not detected in either cell line, at day 3 or 10 of differentiation. 
Importantly, one should stress the fact that this protocol was not performed in low-
adherent 96 well-plates but using petri dishes, which can account for heterogeneity in 
formed aggregates and lack of reproducibility of the process.  
 
Chm iPS cell lines differentiate into retinal progenitor cells when subjected to a protocol 
from La Torre et al. and Osakada et al. 
Concurrently, taking into consideration growth factors and signalling molecules described 
as key regulators of the retina’s developmental process, a third approach was tackled.  
Explicitly, it has been described that inhibition of BMP and Wnt pathways are important 
for anterior neural plate patterning (del Barco Barrantes et al., 2003). Furthermore, IGF-
1/insulin signalling plays a significant role in head and eye formation (Pera et al., 2001). 
Based on work published by La Torre and others, as well as Osakada and colleagues, a 
protocol with a EB-based step, followed by a RPE specification phase, was implemented 
(Osakada et al., 2009; Torre et al., 2012).  
Initially, iPS cells [Chmnull (k6#10), Chmflox (j9#3) and WT (k3#2)] and ES cells were 
cultured in low-attachment petri dishes in Retinal Induction Media, composed of N2B27 
media supplemented with Noggin (BMP antagonist), Dkk1 (Wnt inhibitor) and IGF-1 
recombinant proteins (Figure 4.17A). All cells formed EB-like structures at day 1, as 
described. Cells were kept at these conditions for at least 10 days or, alternatively, 
floating aggregates were plated in Matrigel-coated cell culture dishes after 3 days (P 
protocol). 
 






Figure 4.17: iPS cell lines submitted to differentiation protocol adapted from La Torre 
et al. and Osakada et al. display morphological alterations.  
(A) Schematic representation of the protocol composed of 2 or 3 subsequent steps. First, 
cells were cultured in low adherent conditions in Retinal induction media (N2B27 
supplemented with Noggin, Dkk1 and IGF-1, all 10 ng/mL). Conditions were kept until day 
15 or, alternatively, cells were plated (P) in Matrigel-coated plates at day 3. A third step to 
promote RPE specification may occur later on time. (B) Representative brightfield images 
of iPS cells under floating conditions on day 5 and day 10. EB-like structures are observed. 
(C) Representative brightfield images of iPS cells on day 5, 10 and 15 after cultured in 
adherent conditions (P). (D) Higher magnification of (C) day 10P displaying epithelial-like 




Regarding morphology, EB-like aggregates kept their characteristics along the 
differentiation period, with no evident neuroepithelial-like formation as described for 
previous protocols reported on the previous sections (Figure 4.17B). Conversely, when 
these structures were plated in Matrigel after 3 days and cultured in Retinal Induction 
Media, cells acquired a neuroepithelial-like morphology in culture, resembling neural 
progenitor cells (Figure 4.17C). Cells were actively proliferating and grew into confluency 
in some areas at day 10 and 15. Moreover, hexagonal-packed epithelial patches of cells 
were visible at day 10 and 15 (Figure 4.17D). 
Gene expression was also analysed for the same set of genes as before (Figure 4.18). 
Pluripotency genes (Oct4, Nanog and Fgf4) display diminished expression levels after 
differentiation when comparing with UD status. Interestingly, at day 15P (adherent 
conditions) expression levels seemed to be augmented relative to day 10P. This fact 
may be due to proliferation of neural progenitor cells, since it has been described that 
they might also express these pluripotency markers (Lee et al., 2010). Moreover, for 
Nanog and Fgf4, a role for proliferation of neural progenitor cells has recently been 
proposed (Garg et al., 2013; Kosaka et al., 2006). 





EFTF expression was also examined and Pax6 transcripts were detected in all cells at 
day 3 and/or 10 under floating conditions, as well as at day 15P. Despite the fact that 
Rax transcripts were never detected, discrete levels of Six3 and Six6 were observed only 
for ES cells at day 10P and 15P of differentiation. Six3 was also detected at day 10 for 
Figure 4.18: iPS cell lines submitted to differentiation protocol adapted from La Torre 
et al. and Osakada et al. have diminished levels of pluripotency markers expression 
and increased expression of EFTFs.  
RT-PCR analysis of mentioned iPS cell lines and ES cells is shown for the denoted genes. 
For each cell, samples collected after 3 or 10 days of differentiation protocol (d3/d10) are 
compared with undifferentiated (UD) samples. At day 3, a fraction of each cell was plated in 
adherent conditions and samples were also analysed at day 10 and day 15 (10P and 15P). 
Pluripotency markers (Endo Oct4, Nanog and Fgf4) have reduced expression that later on 
increases for adherent conditions. Pax6, Six3, Six6, Otx2 and Otx1 genes have increased 
levels of expression. Mitf expression is observed for day 15P although no other RPE 




ES cells and j9#3. Otx2 gene was expressed in all cells either in floating or adherent 
conditions, consistent with its role in neuroectoderm specification. Its ortholog Otx1 was 
also detected in ES cells at day 10 of differentiation. Regarding RPE specific genes, Mitf 
transcripts were perceived at day 15 on adherent conditions (day 15P), even though 
some residual levels may be present earlier. Other RPE markers, like Tyr, Rpe65 and 
Rgr were not detected in these conditions. 
To summarize, three different differentiation protocols were tested and, except for the 
first case, promising results were obtained. Despite no mature RPE cells were properly 
isolated and characterized yet, significant steps towards that ultimate goal were 
undertaken, with the generation of OV-like structures in one case and the identification of 
a population of retinal progenitor cells. Subsequent RPE specification steps will be 
pursued in order to obtain the desired cell type. 
 
Discussion 
CHM is a rare monogenic disorder caused by loss-of-function mutations on CHM/REP1 
gene encoding for REP1 protein, which is responsible for the prenylation of Rab 
GTPases, key regulators of intracellular vesicular transport and organelle dynamics (van 
Bokhoven et al., 1994). It is an X-linked disorder characterized by a progressive 
degeneration of different retinal layers, namely the PRs, the RPE and the choroid. The 
pathogenesis of CHM still remains unclear, despite recent scientific advances pointing 
out to a therapeutic improvement when the RPE function is rescued (Tolmachova et al., 
2013).  
Cellular reprogramming strategies have been applied to several human diseases, 
including retinal degenerative disorders, demonstrating their potential use as therapeutic 
tools for the replacement of diseased cells or as experimental instruments to model 
disease. One can postulate that substitution of diseased RPE cells might be 
therapeutically advantageous for CHM patients in later phases of the degenerative 
process. Additionally, disease modelling studies using cells originated by reprogramming 
experiments will accelerate the characterization of the molecular events underlying CHM 
retinal degeneration. 
Here we report the generation of iPS cell lines derived from a Chm mouse model 
carrying a conditional KO of Rep1 gene. This model was previously generated by 
Tolmachova and colleagues, with heterozygous-null females exhibiting characteristic 
hallmarks of CHM: progressive degeneration of the PRs, patchy depigmentation of the 
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RPE, and Rab prenylation defects (Tolmachova et al., 2006). MEFs were isolated from 
timed matings between Chmflox/flox and Chmflox/Y mice. Established primary cultures were 
genotyped in order to select Chmflox cells carrying the MerCreMer transgene. Treatment 
of such cells with optimized conditions of TM exposure induced genomic recombination 
between the 2 loxP sites flanking exon 4 of Rep1 gene, which generates a premature 
stop codon. Resultant Chmnull cells displayed reduced levels of Rep1 gene, confirming 
the successful Rep1 KO and its utility as a Chm model. 
Taking advantage of the conditional nature of the mouse model, Chmnull and Chmflox 
MEFs were concomitantly subjected to reprogramming protocols in order to feasibly 
highlight differences derived from the Rep1 KO. Such differences were not observed in 
our system, contrarily to a few reports on different models, which suggested that 
correction of a different genetic alteration conferred a selective advantage for iPS cell 
generation and/or maintenance (Raya et al., 2009). In our study, iPS cells were 
generated from both Chmnull (Rep1 KO) and Chmflox MEFs, applying the reprogramming 
protocol optimized using WT MEFs, as described on Chapter 3. The inducible lentiviral 
system efficiently transduced Chm cells, which expressed the 4 reprogramming factors 
(OSKM) upon DOX addition. Morphological alterations, previously observed with WT 
MEFs, were also perceived for transduced Chmnull and Chmflox cells, with arising colonies 
allowing the establishment of several pluripotent cell lines. 
Generated iPS cell lines were then characterized to confirm: 1. their molecular and 
functional equivalence to ES cells; 2. their Rep1 expression status and potential usage 
as Chm model. Firstly, Chmnull and Chmflox iPS cell lines exhibited morphologic 
appearance similar to pluripotent cells. Expression of several key pluripotency markers 
was detected, such as AP, Oct4, Nanog and SSEA1. Additionally, Eras, Ecat1, Esg1, 
Fgf4 and Zfp42 expression was also detected at a transcriptional level. At this point, viral 
transcripts were not expressed confirming that the observed molecular profile was due to 
an endogenous reactivation of the pluripotent cell identity. Naïve pluripotency was 
attained with culture in 2i conditions, and in vitro and in vivo functional tests confirmed 
the ability to give rise to cells derived from the 3 germ layers. The differentiation of 
Chmnull and Chmflox iPS cell lines, either using EB bodies or after injection on an 
immunodeficient mice, generated cells and tissues with characteristic molecular and 
morphological features of ectoderm, mesoderm and endoderm. 
Subsequently to the confirmation of pluripotent state, generated iPS cell lines were 
characterized in terms of Rep1 expression. Genotyping confirmed the maintenance of 
the original Chmnull or Chmflox alleles. As expected, Chmnull iPS cell clones exhibited 




transcriptional and protein level. Aditionally, Rep1 KO seems not to be affecting cellular 
proliferation of iPS cell lines, as similar growth rates were observed for both genotypes. 
In the context of CHM disease, it was relevant to differentiate the obtained pluripotent 
cells into RPE, one of the retinal layers affected by this degenerative disorder. Several 
protocols, including directed differentiation processes, have been described over the 
years with different efficiencies and purities of obtained RPE-like cells (Bharti et al., 
2011; Borooah et al., 2013). Three protocols were tested, sharing a stepwise 
differentiation process initiated by a serum-free floating culture system promoting the 
anterior neuroepithelial fate. A subsequent phase of guided RPE-specification would 
follow. Transcriptional alterations were determined for the tested protocols and are 
summarized in Table 4.1. 
Zhu and colleagues reported a 3D system that allowed quantitative production of RPE 
cells from human ES cells within 30 days (Zhu et al., 2013). The initial step of the 
protocol was implemented with mouse iPS cells (Chmnull, Chmflox and WT) and ES cells. 
However, the aggregates of mouse pluripotent cells did not acquire the reported neural-
like tube structures nor the expression of early retinal markers, when cultured in neural 
induction media. The authors demonstrated a role for IGF1 signalling in the formation of 
the pseudostratified neuroepithelium, which lead to observed differences on the 
efficiency of the process as a consequence of variations in IGF1 levels present in the lot 
of Matrigel used to embed the floating aggregates. As an alternative to test different lots 
of Matrigel (with possible different levels of IGF1), IGF1 recombinant protein was added 
to the system to further promote the retinal fate. Nevertheless this strategy was also 
shown to be unsuccessful. In neither condition (with or without IGF-1), expression of 
EFTFs was observed. The only observed significant alterations on gene expression were 
down-regulation of pluripotency markers as well as discrete up-regulation of Otx2 levels. 
Besides its role on OV evagination and RPE specification, Otx2 is responsible for 
specifying the anterior neuroectoderm, with its expression preceding the expression of 
the early EFTFs (Hever et al., 2006). Thus, one can hypothesize that the early molecular 
events towards an anterior neuroepithelial fate had begun to take place in our system but 









Recently, groundbreaking work described the recapitulation of in vivo organogenesis in 
self-organizing aggregates of ES and iPS cells (Eiraku et al., 2011; Gonzalez-Cordero et 
al., 2013; Nakano et al., 2012). When aggregates of mouse and human pluripotent cells 
are cultured in suspension with the appropriate medium for efficient retinal differentiation, 
ES cell-derived retinal epithelia evaginate to form OV-like structures, which subsequently 
Table 4.1: Transcriptional alterations observed for tested protocols.  
Dark and light grey boxes represent strong and weak expression, respectively. White boxes 
symbolize undetectable levels of transcripts. Unless mentioned (for example, 2 out of 3 cell 




undergo an invagination step and give rise to bi-layered OC, without any external cues or 
forces. In an attempt to reproduce these results, obtained mouse iPS cells were 
submitted to SFEBq culture supplemented with Matrigel. Cell aggregates were formed in 
suspension culture and neuroepithelia surrounding the whole circumference of the EB 
was observed after 5 days.  
However, OV-like structures were observed later and less frequently than reported and 
no bilayered OCs were observed. Self-organization of the OC from pluripotent cells has 
been reported to be a size-sensitive phenomenon with retinal cell differentiation 
occurring in small aggregates of 300 mouse ES cells, but OC failing to form unless the 
number of cells reaches a critical mass of 1000-2000 cells (Eiraku et al., 2011; Nakano 
et al., 2012). Since the SFEBq culture was not performed in low-cell-adhesion 96-well 
plates, we could not control for the numbers of dissociated cells forming each cell 
aggregate. In our experiments, cell aggregates had variable sizes, probably justifying the 
lack of formation of OV and OC-like structures whilst still recapitulating some 
neuroepithelial phenotype confirmed by morphology and gene expression evaluations. 
Regarding gene expression, at day 10 of differentiation, a down-regulation of 
pluripotency markers was observed concomitantly with up-regulation of some EFTFs and 
Otx2/Otx1.  
Another differentiation protocol was tested giving promising results. Taking in 
consideration that forebrain development is dependent of IGF1 signalling and inhibition 
of both BMP and Wnt signalling, defined molecules that modulate these signalling 
pathways were employed by other groups to induce the generation of neural retinal 
progenitors from pluripotent cells (Lamba et al., 2006; Osakada et al., 2009; Torre et al., 
2012). In order to apply this protocol to our system, generated iPS cell lines and ES cells 
were cultured in low-adhesion conditions in retinal induction media containing Noggin, 
Dkk1 and IGF1. After 3 days in these conditions, expression of pluripotency genes was 
already diminished and Pax6 and Otx2 transcripts were detected. If low-adhesion culture 
conditions were continued after day 3, Six3 EFTF was also detected at day 10 as well as 
Otx2 ortholog, Otx1. Alternatively, at day 3 cells were plated in Matrigel-coated wells 
acquiring a neuroepithelial-like morphology resembling neural progenitor cells. Besides 
these actively proliferating cells, patches of cells displaying cobblestone morphology 
were also observed. Expression of EFTFs and Otx2 was detected, and also Mitf in some 
cases, possibly revealing that some cells are being specified into the RPE cell fate. A 
quantitative analysis of mRNA content and imaging techniques are needed to confirm 
the expression differences, to confirm expression at protein level and to distinguish 
whether there was nuclear or cytoplasmic expression of pluripotency factors Oct4, 
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Nanog and Fgf4 at day 15P. One possibility is that the proliferative neural progenitor 
population has a “primitive phenotype” and still share markers with ES cells (Lee et al., 
2010). Nevertheless, the observed morphologic and transcriptional alterations pointed 
out to the generation of a neural progenitor population that in some cases generated 
RPE-like hexagonal-packed cells. Since NR and RPE arise from a common embryonic 
progenitor pool, after expansion of the obtained population of cells, defined factors (such 
as Activin and Nicotinamide) can be added to the culture medium to favour RPE cell fate 
as previously reported (Buchholz et al., 2013; Idelson et al., 2009). Besides Matrigel, 
other extracellular matrix components can and should be employed to potentiate RPE 
differentiation and/or maintenance (Rowland et al., 2013). 
In summary, iPS cells were obtained from a mouse model of the retinal degenerative 
disorder Chm. Differentiation of such pluripotent cells into RPE cell fate was attempted 
with promising results. Additional systematic experiments are needed to further elucidate 
the molecular events of the differentiation process of pluripotent cells into RPE cells. A 
further protocol optimization is needed to allow the more efficient generation of RPE 
cells. These cells should be isolated from the mixed population of cells and characterized 
morphological, molecular and functionally to confirm the RPE phenotype (Bharti et al., 
2011). Concomitantly further experiments aiming at reproducing the 3D OC self-
organization will allow an alternative approach to obtain RPE cells from iPS cells, with 
the supplementary advantage of also providing NR structures (Eiraku et al., 2011). iPS 
cell-derived RPE cells are therapeutically interesting for the replacement of degenerated 
RPE. In fact, the first clinical trials exploiting iPS cell therapeutic potential were 
established for retinal degenerative disorders given the facilitated surgical accessibility 
and functional monitoring of the eye. Besides the number of cells needed for 
transplantation are quite small (Ramsden et al., 2013). Furthermore, iPS cell-derived 
RPE can be used in disease modelling studies, as already showed for several retinal 
degenerations, recently including CHM (Cereso et al., 2014; Meyer et al., 2011; Singh et 
al., 2013; Vasireddy et al., 2013). In our case, the establishment of Chm iPS cell-derived 
RPE cells will allow us to generate a proper mouse model of Chm RPE cells, 
complementary to other existing models that can be used in systematic studies to dissect 
molecular events underlying Chm pathogenesis. Interestingly, the concomitant 
generation of Chmnull and Chmflox-derived cells provides the ideal control for these 
experiments. Additionally, given the conditional nature of the Rep1 KO, this system 
allows a timely-control of the recombination event, which can help to highlight phenotypic 
differences. Moreover, the generation of Chm self-organized OCs will bring into the field 




the RPE and NR layers and their potential interaction, providing helpful insights into the 

















Chapter 5 : Direct Reprogramming of fibroblasts into RPE cells  
Summary
The developmental process in which an initial totipotent cell is progressively committed 
and differentiated into multiple cells types was for long considered to be an irreversible 
process. Initial cloning experiments placed these concepts into argue and the possibility 
to reprogram somatic cells into pluripotent counterparts finally changed the dogma in the 
field. 
Notwithstanding reprogramming into pluripotency experiments, some recent reports also 
disclosed that somatic cells can be interconverted into alternative differentiated cell 
types. These direct lineage conversion strategies, mediated by forced expression of TFs, 
occur without de-differentiation or intermediate non-differentiated states. Besides 
relevant input into developmental and disease modelling studies, these novelty 
approaches attracted much interest as an alternative way to obtain cells and tissues for 
cell replacement therapies without the use of pluripotent stem cells. 
The RPE is a polarized monolayer of pigmented cells located at the back of the eye. 
Together with choroidal vasculature and PRs, it composes the retina, a complex multi-
layered tissue responsible for vision. RPE cells are high metabolically active and 
responsible for multiple functions essential to support and maintain PR’ integrity. Primary 
RPE functions include ion and nutrient transport, light absorption, retinal recycling, 
phagocytosis of the OS of the PRs and secretion of growth factors (Strauss, 2005). 
Given its relevant role in maintaining retina functionality, not surprisingly RPE 
dysfunction is a common feature (if not a direct cause) in several retina disorders, like 
AMD, the leading cause of blindness worldwide.  
Multiple RPE in vitro systems have been developed and studied along the years, 
including immortalized cell lines, primary cultures from different species, and RPE cells 
differentiated from pluripotent stem cells (either ES or iPS cells) (Bharti et al., 2011). 
Nevertheless, current in vitro RPE cultures still display recurrent loss of key features 
(pigmentation and expression of some characteristic markers) and phenotypic instability 
and heterogeneity. Moreover, differentiation processes from pluripotent stem cells 
depend on inefficient and time-consuming protocols. 
Direct conversion of somatic cells into an active RPE will provide an alternate and more 
straightforward route to obtain RPE cells for functional and therapeutic studies. Here, we 




involved in the formation and patterning of the eye (namely Tbx3, Rax, Six3, Pax6, Lhx2, 
Six6 and Nr2e1), as well as in subsequent RPE specification steps (Pax6, Mitf, Otx1 and 
Otx2). Fibroblasts transduced with this pool of TFs gained some RPE key features, such 
as pigmentation and expression of RPE-specific markers (Mitf, Tyr, Rpe65 and Rlbp1). 
Two lentiviral reporter systems were also generated in order to optimize the TFs’ pool, 
with the purpose of increasing the direct reprogramming efficiency. These studies 
provide an experimental platform to gain insight in RPE developmental process and 
transcriptional identity, as well as prospective use for drug screening, disease modelling 
studies and regenerative medicine approaches. 
 
Results 
MEFs have different morphology and expression profiles when compared to RPE cells 
Lineage conversion strategies have been based in a deep and extensive knowledge on 
the developmental process and phenotypic characteristics of the cells aimed to be 
obtained. First and foremost, one needs to easily distinguish both somatic cell 
populations, in this case fibroblasts from RPE cells. 
MEF primary cultures obtained from WT pregnant mice displayed typical flat and 
elongated morphology and no pigmented granules were observed (Figure 5.1A). Primary 
cultures of mouse RPE cells were established from 3 week old WT mice. Besides 
contamination with a few different cell types (like choroidal melanocytes) inherent to 
isolation protocol, some RPE sheets of pigmented epithelial cells were obtained, 
maintaining characteristic features similar to RPE in situ. After enzymatic subculture of 
the RPE primary cultures however, phenotypic heterogeneity was observed, as already 
described (Burke et al., 1996). As epithelial architecture was lost, a mixed population of 
epithelioid and fusiform cells was present in RPE primary cultures (Figure 5.1A), in non-
polarized culture conditions. The typical pigment content was retained, even after cell 
passaging. 
Gene expression was also assessed for MEF and RPE primary cultures. Interestingly, 
early EFTFs, Pax6 and Rax, important for eye developmental process, were expressed 
by RPE cells from 3 week old mice, as well as by Embryonic eye, the positive control . It 
was also observed that transcripts for these 2 genes were not detected in MEFs (Figure 
5.1B).  




Figure 5.1: MEFs and RPE primary cultures display different morphology and gene 
expression profiles.  
(A) Brighfield images of representative primary cultures of MEFs and RPE. Scale bar 50 
µm. (B) RT-PCR analysis of 5 MEF primary cultures and 7 RPE primary cultures is shown 
for the denoted genes. Samples of Embryonic Eye (isolated at E13.5), a mouse RPE cell 
line (B6-RPE07 (Chen et al., 2008)) and a mouse melanocyte cell line (Melan Ink4a 




Additionally, genes important for RPE’s functional properties were analysed, and Tyr, the 
rate-limiting melanogenic enzyme essential for pigment synthesis, was found to be 
expressed by RPE cells and not MEFs. Identical expression specificity was also 
observed for Rpe65, Rgr and Rlbp1 transcripts, genes involved in the RPE’s visual cycle 
responsible for reisomerization of retinal. Contrarily, for other known to be RPE-specific 
genes, expression was observed for both RPE and MEF cells, namely for Mitf-A and 
Mertk. 
Primers designed to specifically amplify isoform A of Mitf were used in this analysis. The 
basic helix-loop-helix leucine zipper TF Mitf plays an essential role in development and 
survival of pigmented cells, like melanocytes and RPE cells. At least 9 isoforms with 
different amino termini have been identified so far, and Mitf-A has been known to 
regulate RPE development (Šamija et al., 2010; Tachibana, 2000). Mitf-A transcripts 
were observed for all cell lines and primary cultures tested, confirming previous findings 
reporting that Mitf-A mRNA is widely expressed in several cultured cells and tissues 
(Amae et al., 1998). 
Mertk has been known to play a role in POS phagocytosis, by activation of second 
messenger cascade events that trigger POS internalization by RPE cells. However, this 
receptor tyrosine kinase transduces signals from extracellular matrix in response to 
binding of several ligands. Thus it interferes with the regulation of many physiological 
processes like cell survival, migration, differentiation and phagocytosis, which may 
explain the observed expression by embryonic fibroblasts (Hafizi and Dahlbäck, 2006). 
 
Lentiviral molecular tools efficiently induce expression of TFs in transduced MEFs 
Direct lineage conversion experiments rely on forcing a high expression of TFs 
responsible for driving and/or maintaining the differentiated state to be obtained. In this 
case, it was conjectured that the gene regulatory network responsible for determining 
RPE development and specification could potentially be used to promote direct 
conversion of fibroblasts into RPE cells. With this purpose several molecular tools were 
generated. 
Inducible lentiviral systems are commonly used for forced expression of TFs in 
reprogramming experiments, either into pluripotency or for lineage conversion purposes. 
In order to facilitate extensive cloning procedures, an inducible lentiviral plasmid 
compatible with Invitrogen’s Gateway® Technology was generated (pLenti6/TetO/Dest), 
containing the tetracycline operator minimal promoter (TetO). 
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Inducible expression of the lentiviral system was first confirmed with generated control 
lentivirus, Lenti-TetO-GFP. MEFs were co-transduced with inducible lentiviral particles 
as well as Lenti-M2rtTA viral particles that drive the expression of the reverse 
transactivator M2rtTA necessary for the inducible promoter activation. Either by western 
blot analysis or by fluorescent microscopy, expression of GFP protein was observed in 




Figure 5.2: Inducible lentiviral vector allows efficient inducible expression of GFP 
protein.  
(A) MEFs were co-transduced with Lenti-TetO-GFP and Lenti-M2rtTA viral particles and 
cultured in the presence (+) or absence (-) of DOX. Protein lysates were collected 4 dpt and 
analysed by western blot with the indicated antibodies. GFP protein expression is detected 
in the presence of DOX and intensified as the volume of lentiviral supernatant increases (as 
denoted by the grey triangle). Canx was used as loading control. (B) For equivalent 




Eye morphogenesis is a multistep complex process that is initiated from a 
morphologically indistinctive early EF that evaginates to give rise to the OV. The late OV 
becomes patterned into distinct ocular tissues (NR, RPE and optic stalk) and gives rise 
to the OC after an invagination event. All these processes are tightly regulated by 
signalling pathways and a gene regulatory system extensively characterized. Initially, the 
single early EF, located centrally in the developing forebrain, is characterized molecularly 
by the expression of a core of TFs. The EFTFs include Rax (or Rx1), Pax6, Six3, Six6, 
Lhx2 and Nr2e1, as several genetic studies in mammals and lower vertebrates revealed 
(Graw, 2010). For the specification of the presumptive RPE in the OV stage, as well as 
further developmental steps in the OC, key TFs have been described to play a 
fundamental role: Mitf, Otx2 (and its orthologue Otx1) and Pax6 (Bharti et al., 2006; 
Martínez-Morales et al., 2004). 
Given their role in eye development and RPE patterning events, these 10 TFs (from now 
on designated as Eye TFs) were selected, as it was hypothesized that they could work 
as reprogramming factors to mediate the direct conversion of fibroblasts into RPE. 
cDNAs of the 10 Eye TFs were amplified and cloned into plasmid vectors, as V5-tagged 
versions to facilitate identification. By western blot analysis, expression of the 10 
individual fusion proteins was detected in transfected cells, using an anti-V5 antibody 
(Figure 5.3A). All vectors were also sequenced to confirm sequence integrity.  
All the 10 generated plasmid vectors included features to function as entry vectors in 
Gateway® system. After two recombination reactions, each V5-Eye TFs’ cDNA was 
shuttled into the pLenti/TetO/Dest, and 10 resulting inducible lentiviral plasmids were 
obtained (Lenti-TetO-V5 Eye TF) (Figure 5.3B). Inducible expression was confirmed by 
western blot analysis in MEFs co-transduced with lentiviral particles encoding for each of 
the 10 Eye TFs and Lenti-M2rtTA viral particles. Protein expression was detected in cells 
cultured in the presence of DOX, at 4 dpt (Figure 5.3C). 




Figure 5.3: V5-tagged versions of 10 TFs involved in eye and RPE developmental 
processes were successfully cloned into DOX-inducible lentiviral vectors.  
(A) HEK293FT cells were transfected with each of the 10 entry vectors expressing V5-
tagged versions of the 10 Eye TFs. Protein lysates were collected and analysed by western 
blot using anti-V5 (top panel) and anti-Calnexin (bottom panel; endogenous control) 
antibodies. NT (non transfected) cells were assayed as negative control. (B) Schematic 
representation of cloning strategy. Taking advantage of the Gateway® Technology, V5-Eye 
TF’ cDNAs were recombined from the entry vector into inducible lentiviral vectors (pLenti-
TetO). (C) MEFs were co-transduced with each resulting Lenti-TetO-V5-Eye TF and Lenti-
M2rtTA, and cultured in the presence (+) or absence (-) of DOX. Protein lysates were 
collected 4 dpt and analysed by western blot as in (A). Expression of each Eye TF is only 




Co-transduced MEFs were also subjected to IF techniques to confirm adequate nuclear 




Transduction with multiple lentiviral particles can be optimized without compromising cell 
viability 
As shown previously, transductions of MEFs with individual TF-encoding lentiviral 
particles led to an exogenous expression of the Eye TFs. However, in order to implement 
a direct reprogramming protocol, expression of multiple TFs must be induced. To this 
end, lentiviral transductions were optimized to maximize the probability of co-transducing 
fibroblasts with the chosen pool of TFs. 
Freshly produced lentiviral particles were always used since repeated freeze-thaw cycles 
may result in decrease of viral titer. In order to overcome technical restrictions related to 
Figure 5.4: Inducible lentiviral particles allow expression of 10 Eye TF in transduced 
MEFs.  
MEFs were co-transduced with each Lenti-TetO-V5-Eye TF and Lenti-M2rtTA, cultured in 
the presence of DOX and analysed by IF at 4 dpt using an anti-V5 antibody. Nuclei were 
counterstained with DAPI. Expression of the V5-TF is observed for each of the 10 lentiviral 
vectors, with nuclear localization. 
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total volume of culture wells and to increase transduction efficiency, multiple 
transductions with several lentiviral supernatants were performed after supernatant 
ultracentrifugation. 
Control vector Lenti-TetO-GFP was used for these optimization experiments, for 
simplification purposes, and increasing volumes of fresh concentrated lentiviral particles 
were used to transduce MEFs. Single transduction experiments were performed using 
from 50 to 250 µL of lentiviral preparation. Corresponding 10-fold volumes (500 to 2500 
µL) were tested in order to mimic multiple transduction of the 10 Eye TF. Lenti-M2rtTA 
virions were always co-transduced and DOX was added to the system to induce GFP 
expression. 
First, cell viability was assessed by a MTT cytotoxicity assay and results are shown in 
Figure 5.5A. Within the range of volumes tested, no significant alteration in cell viability 
was observed. 
In addition, transduced cells were also analysed by flow cytometry. Lenti-M2rtTA virions 
were added in constant amount (50 µL) or in equivalent volume (for example 1000 µL of 
Lenti-TetO-GFP would correspond to co-transduction with 100 µL of each of the 10 
different Lenti-TetO-Eye TF and 100 µL of transactivator lentivirus).  
The percentage of GFP-positive (GFP+) cells increased along the volume range, until the 
maximum value of approximately 88% (Figure 5.5B). Since it is anticipated that more 
than one TF will be necessary to reprogram fibroblasts into RPE, transduction of a single 
cell with multiple virions was desired. Thus, Median Fluorescent Intensities (MFI) were 
also analysed aiming to dissect the number of viral particles inserted in each GFP+ cell: 
the fluorescent intensity of a cell transduced with more than one copy of Lenti-TetO-GFP 
will be higher than singly transduced cells (Figure 5.5C). As expected, MFI values also 
increased along with the augment of the volumes tested, from 176 arbitrary units (a.u.) 
for 50 µL up until 681 a.u. for 2500 µL. 
Regarding Lenti-M2rtTA, no significant difference was observed for the 2 conditions 
tested in parallel, except for 2500 µL of Lenti-TetO-GFP. In this case, co-transducing 
with equivalent volume (250 µL) of transactivator yielded a higher percentage of GFP+ 
cells than using only 50 µL (Figure 5.5B). However, in the actual reprogramming 
experiments, one cannot exclude the possibility that the use of equivalent volumes of 
transactivator will increase the probability of having one single cell simultaneously 
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For a single transduction, it was observed that 150 µL of Lenti-TetO-GFP promoted 
higher percentage of transduced cells when compared to 100 µL (mean values of 31% 
versus 23%). However, further increase of Lenti-TetO-GFP volume to 200 or 250 µL did 
not generate a significant increase on the percentage of GFP+ cells. When considering 
multiple transductions with the corresponding 10-fold values, no significance was 
observed in the total number of transduced cells (Figure 5.5B). Moreover, in terms of 
MFI, values increased over the range of volumes tested but no significant differences 
were observed when comparing the abovementioned pairs of values (Figure 5.5C). 
Considering all the mentioned aspects and also the limitations due to extensive time- 
and money-consuming production of lentiviral particles, 150 µL of each individual 
lentivirus were selected for the subsequent reprogramming experiments. 
Notwithstanding the oversimplification inherent to the use of only Lenti-TetO-GFP, flow 
cytometry results showed that multiple transductions with 10-fold volume (1500 µL) 
increased not only the total number of transduced cells (mean values of 31% versus 
70%) but also the fluorescent intensity (MFI of 270 versus 527) (Figure 5.5B and C). The 
resulting population had a different histogram profile from the corresponding single 
transduction (Figure 5.6) with higher abundance of cells transduced with multiple copies 
of the lentivirus. In the subsequent reprogramming experiments, a mixed population of 
cells transduced with different combinations of the Eye TFs was expected; an event one 
cannot prevent but can account for. 
Figure 5.5: Transduction with multiple lentiviral particles can be optimized without 
compromising cell viability. 
 (A) Cell viability of MEFs transduced with increasing volumes (from 0 until 2500 µL) of 
Lenti-TetO-GFP supernatant and 50 µL of Lenti-M2rtTA was assessed by MTT assay. 
Absorbance values are normalized to NT cells, used as control. No significant alteration in 
cell viability is observed. Mean ± SD, n=3; statistical analysis using one-way ANOVA with 
Dunnett’s multiple comparison test. (B) Increasing volumes of Lenti-TetO-GFP supernatant 
and 50 µL of Lenti-M2rtTA were used to co-transduce MEFs, followed by flow cytometry 
analysis on 4 dpt. Transduction of 500 up to 2500 µL of Lenti-TetO-GFP was used to mimic 
simultaneous transduction of 10 different lentiviruses, 50 until 250 µL of each one (multiple 
TF transduction). Alternatively to constant 50 µL, equivalent volumes of Lenti-M2rtTA were 
also tested (for instance for 1500 µL of Lenti-TetO-GFP which mimic transduction of 10 
different virus 150 µL each, 150 µL of Lenti-M2rtTA were used). Percentage of transduced 
(GFP+) cells is shown. No significant difference is observed when comparing both Lenti-
M2rtTA conditions, except for 2500 µL (two-way ANOVA with Bonferroni post-test; * 
p<0.05). With 150 µL of inducible lentivirus, approximately 31% of cells were GFP
+
, which 
is significantly different from what is achieved with 100 µL (unpaired t-test, * p<0.05). Mean 
± SD, n=4. (C) For same experiments, Median Fluorescence Intensities (MFI) in arbitrary 






MEFs transduced with lentivirus encoding for 10 Eye TF gain some RPE features 
Direct reprogramming of fibroblasts into RPE cells was attempted making use of the 
generated molecular tools. MEFs were co-transduced with a pool of the 10 lentivirus 
encoding for the 10 selected Eye TF and Lenti-M2rtTA, 150 µL of each freshly prepared 
and concentrated lentiviral preparation (Figure 5.7A). DOX was added to the system at 1 
dpt to induce expression of the 10 Eye TF (except in control wells, cultured in the 
absence of DOX) and culture media was changed into DMEM 5% FBS (media used in 
RPE primary cultures) at 8 dpt. Cells were monitored for 22 days to assess potential 
morphological and gene expression alterations. In terms of morphology, a significant 
alteration was observed as soon as 8 dpt: pigmented granules were detected only in 
cells cultured in the presence of DOX (Figure 5.7B). 
Figure 5.6: Ten-fold increase of lentiviral volumes increases percentage of 
transduced cells as well as their fluorescent intensity.  
Representative flow cytometry histograms of MEFs co-transduced with Lenti-TetO-GFP 
and Lenti-M2rtTA, in the mentioned quantities. When increasing the volume of inducible 
lentivirus by 10 fold, the percentage of transduced GFP
+
 cells (FL1-H+ population) 
increases from 30.1 to 69.6%. MFI of this same population also increases from 229 to 505 
a.u. (median of the GFP
+
 population is represented as the dotted line on the right). 





Gene expression was assessed by RT-qPCR, using primers to evaluate transcriptional 
levels of TFs involved in eye and RPE development, as well as RPE-specific markers. 
Four independent experiments were performed and results showed a consistent 
increase of transcriptional levels of the analysed genes in transduced cells, when 
compared with control cells (cells at 4 dpt cultured in the absence of DOX) (Figure 5.8). 
Variability was observed between experiments, which may be explained by the technical 
difficulty in controlling co-transduction with multiple lentiviral vectors. Nevertheless, the 
trend observed over the reprogramming time was consistent between experiments and 
some conclusions may be drawn from this approach. 
Figure 5.7: MEFs transduced with pool of inducible lentivirus encoding for the 10 
Eye TFs display morphological alterations, in terms of pigmentation.  
(A) Schematic representation of protocol. Cells were co-transduced with pool of 10 
inducible lentivirus and Lenti-M2rtTA. DOX was added to culture media at 1 dpt. Media was 





Figure 5.8: MEFs transduced with pool of inducible lentivirus encoding for the 10 
Eye TFs display alterations in gene expression.  
Quantitative RT-PCR analysis of transduced MEFs revealed expression of RPE-specific 
TFs (A- Pax6, B- Rax, C- Mitf) and markers (D- Tyr, E- Rpe65 and F- Rlbp1) when cultured 
in the presence of DOX. For Mitf (C), 2 sets of primers were used. Top 4 black lines result 
from amplification with primers that do not distinguish viral from endogenous transcripts 
(Total). Primers that specifically amplify endogenous transcripts were also used (4 grey 
lines labelled as Endo). In all cases, Gapdh was used as endogenous control; results were 
normalized to d4 (-DOX). Four independent experiments were performed and displayed (4 
lines with different symbols). For all analysed genes, it is observed an increase in mRNA 
content over time, as compared with control wells (d4 –DOX). 
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Pax6 and Rax mRNA levels increased in all experiments as expected, since these key 
TFs were included in the pool of transducing lentivirus (Figure 5.8A and B) and primers 
do not distinguish viral from endogenous expression. To analyse Mitf transcriptional 
levels however, 2 sets of primers were used. Total Mitf primers amplify transcripts from 
both viral and endogenous origin, whilst Endo Mitf primers specifically amplify the later 
(Figure 5.8C). As observed for Pax6 and Rax, Total Mitf mRNA levels increase in all 
experiments since Lenti-TetO-V5-Mitf was included in the reprogramming cocktail. 
Importantly, endogenous levels of Mitf transcripts also increased in cells cultured in the 
presence of DOX, even though more discrete differences were attained. 
Besides TFs involved in eye and RPE specification, mature RPE-specific genes were 
also analysed, such as Tyr, the rate-limiting enzyme responsible for pigment synthesis. 
Tyr transcripts were detected in higher amounts along the reprogramming protocol for all 
the experiments, despite variations between them (Figure 5.8D). Interestingly, higher 
values of Tyr mRNA levels were observed for the same experiment in which higher 
values of Pax6, Rax and Total Mitf (triangle-labelled line). Mitf protein has been known to 
physically interact with Tyr gene upstream regulatory sequences and to activate 
tyrosinase promoter which can explain observed results (Murisier and Beermann, 2006). 
Visual cycle is a characteristic RPE function, essential for the recycling of retinal and for 
the maintenance of PRs’ excitability. Relative mRNA levels of genes involved in this 
process, like Rpe65 and Rlbp1, were also assessed (Figure 5.8E and F). Increased 
transcriptional levels were observed for both genes, for all the analysed time points. 
Another relevant observation was related with the temporal profile of the detected 
alterations. Expression of TFs included in the transducing pool of lentivirus increased 
almost until the maximum values within the first 4 to 8 days. Contrarily, expression of 
RPE-specific markers was almost unaltered at 4 dpt, and increased in subsequent days 
(8, 12 or even 17 dpt). These genes were not encoded by the lentivirus and alterations at 
transcriptional levels were most probably due to exogenous TFs driven activation of 
RPE-specific expression profile. Moreover, for all the genes analysed there was no 
increase in expression after 17 dpt. 
Notably, expression of Rpe65 was also confirmed at protein level by IF (Figure 5.9). At 
22 dpt, Rpe65 characteristic cytoplasmic staining was observed specifically in 







Lentiviral reporter systems drive expression of GFP protein in RPE cells 
As just demonstrated, the forced expression of 10 Eye TF on fibroblasts induced 
alterations in terms of morphology and expression of key RPE markers. However, 
despite the encouraging results, the reprogramming process was quite variable between 
experiments. In an attempt to overcome this drawback and optimize the process’ 
efficiency, a proper reporter system to better monitor cell fate conversion was desirable. 
Two lentiviral reporter systems were generated with this purpose. Upstream regulatory 
regions of Tyr gene have been studied for long and a small fragment of 270 bp has been 
shown to be sufficient to drive specific expression on pigmented cells, both melanocytes 
and RPE cells (Klüppel et al., 1991). Besides this “minimal promoter”, other regulatory 
regions were identified as regulators of Tyr expression, named initiator E-box and 
tyrosinase distal element (Aksan and Goding, 1998). A 2.2 kb promoter fragment of Tyr 
gene including all these regulatory regions was cloned into the upstream of GFP in a 
lentiviral vector (Lenti-Tyr-GFP). Upstream regions of Rpe65 gene were also 
characterized and found to promote RPE-specific expression (Boulanger et al., 2000). A 
fragment containing bases -655 to +52 of the 5’ flanking region of the mouse Rpe65 
gene was cloned into the upstream of GFP in a lentiviral vector, designated as Lenti-
Rpe65-GFP (see Chapter 2 for details). 
Figure 5.9: MEFs transduced with pool of inducible lentivirus encoding for the 10 
Eye TFs express Rpe65 protein at 22 dpt. 
IF analysis of transduced MEFs cultured in the presence (+) of DOX reveals a dotted and 
cytoplasmic staining for Rpe65 protein. Control cells (- DOX) were also analysed to exclude 
cellular auto-fluorescence due to prolonged time in culture. DAPI was used to counterstain 
nuclei. Scale bar 25 µm. 
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To test the functionality of the generated reporter systems, a human RPE cell line ARPE-
19 was transduced with lentiviral particles from both systems (Figure 5.10) (Dunn et al., 
1996). As both lentiviral vectors carry a blasticidin-resistance gene, blasticidin was 
added to the culture medium in order to select for transduced cells. First, exposure time 
and concentration of blasticidin required to kill untransduced ARPE-19 cells was 
determined by a MTT assay (Figure 5.10A). Secondly, transduced ARPE-19 cells were 
analysed by flow cytometry after selection with 16 µg/mL of blasticidin for 120 h.  ARPE-
19 cells produce pigment after long term and highly confluent cultures. However, even 
when cultured at normal confluency, GFP expressing cells were observed after 
transducing with Lenti-Tyr-GFP, as detected by flow cytometry (Figure 5.10B). A smaller 
percentage of GFP+ cells was also detected after transduction with Lenti-Rpe65-GFP 
viral particles. ARPE-19 cells express RPE65 protein so promoter activation was 
expected in transduced cells. One hypothesis to explain the obtained result is that cloned 
Rpe65 promoter drives weak expression of GFP, which was hard to specifically detect.  
Alternatively, Rpe65 expression may also be dependent on the cell confluency, and 
highly confluent cultures should be tested. Nevertheless, the 2 generated reporter 
systems were driving expression of GFP protein in the context of a RPE cell line and 






Lentiviral reporter systems can be used to optimize pool of direct reprogramming TFs 
Taking advantage of obtained lentiviral reporter systems, a protocol was established with 
the intent of optimizing direct reprogramming strategy’s efficiency.  
First, MEFs were transduced with either reporter system (Lenti-Tyr-GFP or Lenti-Rpe65-
GFP) and cultured in the presence of blasticidin to select for transduced cells. In order to 
determine appropriate exposure time and concentration of blasticidin, a MTT-based 
Figure 5.10: Human RPE cell line ARPE-19 transduced with lentiviral reporter 
systems express GFP protein.  
(A) MTT assay was used to asses cell survival of ARPE-19 cells treated with increasing 
concentrations of blasticidin, for 48 h, 72 h or 96 h. Exposure to 16 µg/mL of blasticidin for 
120 h promotes cell death of at least 90% of untransduced ARPE-19 cells. Mean value for 
these conditions is approximately 8% of cell survival and significantly different from 72 h 
exposure to the same concentration. Mean ± SD, n=3. Statistically significant values of 
relevant results from two-way ANOVA with Bonferroni posttest are shown; *** p<0.001. (B) 
ARPE-19 cells were transduced with Lenti-Tyr-GFP and Lenti-Rpe65-GFP lentiviral 
particles, cultured in the presence of blasticidin (16 µg/mL for 120 h) to select for 
transduced cells and analysed by flow cytometry to assess GFP protein expression at 7 
dpt. Representative plots are shown, including on left panel control (untransduced) cells. 
GFP
+
 cells, included in the defined gate on BL1 versus BL2 plots, are detected for both 
reporter systems: approximately 56% of GFP
+
 cells for Lenti-Tyr-GFP and 8% for Lenti-
Rpe65-GFP. 
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cytotoxic assay was used (Figure 5.11). It was observed that treatment with 6 µg/mL of 




After treatment with 6 µg/mL of blasticidin for 72 h, the blasticidin-resistant cells (which 
correspond to reporter system-transduced ones) were then co-transduced with inducible 
lentiviral particles Lenti-TetO-V5 Eye TF and reverse transactivator Lenti-M2rtTA. For 
each condition, cells cultured in the absence of DOX were kept in parallel as negative 
control, as shown in schematic protocol (Figure 5.12A). Different combinations of Eye 
TFs were tested, including the pool of 10 TFs used before. MEFs untransduced with the 
Eye TFs were also used as control. Given the relevance of Mitf, Otx2 and Pax6 in RPE 
specification (Martínez-Morales et al., 2004), these TFs were tested alone or in different 
combinations. Otx1 or Rax were also added to check if any positive interaction could 
occur (Figure 5.12B). 
Figure 5.11: Untransduced MEFs’ survival is affected by increasing concentrations 
of blasticidin. 
MTT assay was used to asses cell survival of MEFs treated with increasing concentrations 
of blasticidin, for 48 h or 72 h. Exposure to 6 µg/mL of blasticidin for 72 h promotes cell 
death of at least 95% of untransduced cells. Mean value for these conditions is 
approximately 4% of cell survival and significantly different from 48 h exposure to the same 
concentration. Mean ± SD, n=3. Statistically significant values of relevant results from two-





Figure 5.12: Direct reprogramming protocol using reporter systems to optimize 
transducing Eye TFs pool.  
(A) Schematic representation of protocol. MEFs, previously transduced with lentiviral 
reporter systems (Lenti-Tyr-GFP or Lenti-Rpe65-GFP) and selected for positively 
transduced cells using blasticidin, were co-transduced with different combinations of the 
inducible lentivirus encoding Eye TFs and Lenti-M2rtTA (150 µL each). DOX was added to 
culture media at 1 dpt, except on control wells (- DOX). At 12 and 24 dpt, GFP levels were 
assessed by flow cytometry. (B) Summary table with different combinations of transducing 
Eye TFs tested. Each column of the table represents one combination of Eye TFs tested, 
with either reporter system. Dark grey boxes indicate lentiviral particles used in each of the 
10 conditions tested.  
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For each reporter system, 10 different combinations of Eye TFs were tested in cells 
cultured in the presence of DOX, as well as in the absence of DOX (control). GFP 
expression driven by either reporter system was assessed at 12 and 24 dpt by flow 
cytometry analysis, using GFP (BL1 axis) versus auto-fluorescence (BL2 axis) to 
discriminate true GFP expression from auto-fluorescence derived from long culture 
periods. 
Regarding activation of Tyrosinase promoter, cells transduced with tested individual TFs 
cultured in the presence of DOX did not display GFP levels significantly different from 
corresponding controls (absence of DOX). However, a discrete population of GFP+ cells 
was detected for both Mitf and Otx2 (mean values for 12 dpt were approximately 1%), 
but not for Pax6 (Figure 5.13A). Additionally, combinations of 2 Eye TFs, revealed that 
Mitf and Otx2 synergistically activate Tyrosinase promoter with 4% of GFP-expressing 
cells (mean value for 12 dpt) being detected. These observations are in accordance with 
described Mitf and Otx2 ability to bind to the promoter regions of genes important for 
melanogenesis, namely Tyr, leading to their transactivation. Moreover, activation by Otx2 
has been shown to be enhanced by Mitf, with which Otx2 biochemically interacts 





(See caption on the following page) 




Combinations of 3, 4 or all 10 TFs were also tested and generated a percentage of GFP+ 
cells significantly different from corresponding controls (absence of DOX) (Figure 5.13A). 
All these combinations included the core Mitf+Otx2 mix and extra TFs. Despite some 
variability when comparing values between experiments, in all cases the 
Mitf+Otx2+Pax6+Otx1 pool of transducing lentivirus produced a bigger population of 
GFP+ cells than Mitf+Otx2 (or Mit+Otx2+Pax6) pool for the same independent 
experiment (see representative flow cytometry plots for 12 dpt in Figure 5.14). It is known 
that the homeodomain-containing TFs Otx1 and Otx2 are expressed in the OV and later 
in the presumptive RPE. Experiments with Otx1 and 2 double-deficient mice showed that 
these genes are required in a dose-dependent manner for the normal development of 
the eye, and in their absence an improperly patterned RPE differentiates into a NR-like 
structure (Martinez-Morales et al., 2001).Thus, these cooperative activity of Otx genes 
might explain the slight increase in the percentage of GFP+ cells observed when Otx1 
was added to the pool. 
Regarding the 2 experimental timepoint analysed, equivalent results were observed for 
12 dpt (Figure 5.13A) and 24 dpt (Figure 5.13B). Nevertheless the population of GFP-
expressing cells was smaller for the latter timepoint, suggesting that the observed 
alterations occur with a fast kinetics and that prolonged culture times have no advantage 
for the process. Given this observation and the mentioned Mitf key role, the ratio of GFP+ 
cells relative to Mitf alone was also determined for 12 dpt (Figure 5.13C). Combination of 
Mitf+Otx2 and also Mitf+Otx2+Pax6, Mitf+Otx2+Pax6+Otx1 or Mitf+Otx2+Pax6+Rax 
yielded a higher ratio of GFP+ cells, when comparing to control (Mitf alone), thus 
promoting a more efficient activation of Tyrosinase promoter. 
 
Figure 5.13: Different pools of transducing Eye TFs promote variable levels of 
activation of Tyrosinase promoter.  
(A) Flow cytometry analysis was used to quantify percentage of GFP
+
 cells. Different 
combinations of Eye TFs were used to transduce MEFs, previously transduced with Lenti-
Tyr-GFP reporter system. For each combination, cells were cultured either in the presence 
(+) or absence (-) of DOX. Results for 12 dpt show that 5 combinations promote GFP levels 
significantly different from corresponding control condition (- DOX) as denoted. (B) Results 
for 24 dpt show that 4 combinations promote GFP levels significantly different from 
corresponding control condition (- DOX) as indicated. Scatter dot plots with mean ± SD, 
n=4; two-way ANOVA with Bonferroni posttests. (C) For 12 dpt, ratio of GFP+ cells was 
calculated by first subtracting % of GFP+ cells obtained for control (- DOX) condition and 
then dividing by the value obtained for Mitf alone as transducing Eye TF in the 
corresponding experiment. Results point that Mitf+Otx2, Mitf+Otx2+Pax6, 
Mitf+Otx2+Pax6+Otx1 and Mitf+Otx2+Pax6+Rax combinations yield higher GFP levels 
when compared to control (Mitf alone). Scatter dot plots with mean ± SD, n=4; one-way 
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Similar experiments were performed to evaluate activation of Rpe65 promoter by 
different pools of Eye TFs. However, the percentage of GFP+ cells was not significantly 
different when comparing cells cultured in the presence of DOX (in which the Eye TF 
expression was induced) with control cells (absence of DOX). This was true for either 12 
dpt (Figure 5.15A) and 24 dpt analysis (Figure 5.15B). Nevertheless, for the pool of 10 
Eye TFs a discrete activation of Rpe65 promoter might occur since a small population of 
GFP-expressing cells was identified (Figure 5.16). This result was concordant with the 
previously shown expression of Rpe65, at a transcriptional and protein level, after 
transduction with the pool of 10 lentivirus (recall Figure 5.8E and Figure 5.9). 
Figure 5.14: Pools of transducing Eye TFs including Mitf promote variable levels of 
activation of Tyrosinase promoter.  
Representative flow cytometry plots of Lenti-Tyr-GFP-transduced MEFs at 12 dpt with 
different combinations of Lenti-TetO-V5 Eye TFs, as mentioned. Cells were cultured in the 
presence (+) or absence (-) of DOX and percentage of GFP
+
 cells was determined in BL1 







Figure 5.15: Different pools of transducing Eye TFs promote discrete levels of 
activation of Rpe65 promoter.  
(A) Flow cytometry analysis was used to quantify percentage of GFP
+
 cells. Different 
combinations of Eye TFs were used to transduce MEFs, previously transduced with Lenti-
Rpe65-GFP reporter system. For each combination, cells were cultured either in the 
presence (+) or absence (-) of DOX. Results for 12 dpt show that no combination promote 
GFP levels significantly different from corresponding control condition (- DOX) as denoted. 
Scatter dot plots with mean ± SD, n=3; two-way ANOVA with Bonferroni posttests. (B) 
Results for 24 dpt show that no combination promote GFP levels significantly different from 
corresponding control condition (- DOX) as indicated. Scatter dot plots with mean ± SD, 
n=2; two-way ANOVA with Bonferroni posttests. 





Rpe65 promoter was characterized and was shown to drive tissue-specific expression in 
the RPE, which could be valuable for gene therapy studies (Acland et al., 2005; 
Boulanger et al., 2000; Nicoletti et al., 1998). Nonetheless, its transcriptional activity was 
shown to be weak (Zhang et al., 2004). Moreover, only a few studies have addressed the 
regulatory mechanisms that regulate expression of Rpe65 gene. For instance, Otx2 and 
Lhx2 were shown to synergistically activate Rpe65 promoter, along with other factors, 
which can account for the subtle activation observed for the pool of 10 TFs (the only pool 
including Lhx2) (Masuda et al., 2014). Therefore, additional combinations of TFs can be 
tested in order to optimize Rpe65 promoter activation. Positive insight on the regulation 
of Rpe65 expression can also be drawn from such experiments. 
 
Discussion 
Cellular reprogramming experiments have highlighted the plasticity of adult somatic cells, 
providing new technologies for the generation of any desired cell types. Through the 
forced expression of TFs, it was possible to reprogram somatic cells into iPS cells that 
share pluripotency features with ES cells and can be differentiated into any adult somatic 
cell (Takahashi and Yamanaka, 2006; Takahashi et al., 2007a). Alternatively, but also 
Figure 5.16: Transduction with pool of 10 Eye TFs promotes discrete levels of 
activation of Rpe65 promoter.  
Representative flow cytometry plots of Lenti-Rpe65-GFP-transduced MEFs at 12 dpt with 
pool of 10 Lenti-TetO-V5 Eye TFs. Cells were cultured in the presence (+) or absence (-) of 
DOX and percentage of GFP
+ 
cells was determined in BL1 versus BL2 plots (notice 




using a TF-mediated approach, a somatic cell can be interconverted into another 
somatic cell type. In this direct lineage conversion methodology, no 
pluripotent/multipotent intermediate is formed (Ladewig et al., 2013). Direct lineage 
conversion has proven successful to reprogram mouse and human fibroblasts into 
several cell types, using TFs defining or specifying the target-cell identity (Huang et al., 
2011; Ieda et al., 2010; Vierbuchen et al., 2010). Here we report a set of experiments 
performed towards the goal of direct reprogramming mouse fibroblasts into functional 
RPE cells. 
Firstly, morphology and gene expression parameters were analysed using primary 
mouse RPE cultures in order to establish the criteria for the proper distinction between 
the initial fibroblastic population and the target cell to be obtained, RPE cells. Secondly, 
after a thorough literature review (see Chapter 1), a set of TFs was selected based on 
their described role on the establishment of early EF (Rax, Pax6, Six3, Six6, Lhx2, Nr2e1 
and Otx2) as well as in subsequent steps of RPE cell fate specification and maintenance 
(Mitf, Otx2, Otx1 and Pax6). Commonly used in reprogramming experiments due to the 
high efficiency and possibility to timely control the forced expression, an inducible 
lentiviral system was elected for the delivery of the 10 chosen TFs. Entry vectors 
encoding for V5-tagged versions of the 10 Eye TFs and a lentiviral plasmid containing an 
inducible promoter and recombination sites compatible with Invitrogen’s Gateway® 
Technology were generated. After the recombination reactions, 10 inducible lentiviral 
vectors encoding for V5-tagged versions of the 10 Eye TFs were generated, as well as a 
control Lenti-TetO-GFP vector. The obtained molecular tools were shown to efficiently 
transduce MEFs and to force the expression of V5-Eye TFs upon addition of DOX. 
Subsequently, the experimental conditions for multiple transductions of MEFs were 
optimized and defined using the control vector, in order to guarantee no effect on cell 
viability while maximizing the efficiency. With the adopted protocol, in single 
transductions one can anticipate approximately 31% of transduced cells, as it was 
observed for the control Lenti-TetO-GFP vector. 
Reprogramming experiments were performed using a pool containing viral particles 
encoding for the 10 Eye TFs. Transduced MEFs were monitored for alterations in 
morphology and gene expression, and pigmented cells were detected as soon as 8 dpt. 
Regarding transcriptional alterations, an expected increase on the expression of 
transduced TF was observed, concomitantly with an up-regulation of RPE-specifying TF 
Mitf and mature RPE markers (Tyr, Rpe65, Rlbp1). Rpe65 was also detected at a protein 
level on transduced cells. Interestingly, the pigmentation and gene expression alterations 
observed between 8-12 dpt revealed that reprogramming events were taking place with 
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a rapid kinetics. On described direct lineage conversion methodologies, high levels of 
expression of TFs must be capable of surmounting the genetic and epigenetic landscape 
of the original cell fate, forcing the establishment of a new program typical of the target 
cell to be obtained. Mechanistically, the reprogramming events take place in a short 
period of time after the forced expression of the set of TFs and occur in the absence of 
cellular proliferation, contrarily to what is observed for iPS cell generation (Sancho-
Martinez et al., 2012). Thus, the observed alterations occurring with a rapid kinetics are 
optimistic indicators that a reprogramming process may be taking place. 
In order to facilitate the identification/selection of the obtained RPE-like cells, as well as 
to optimize the cocktail of reprogramming TFs to provide an increased efficiency of the 
process, two lentiviral reporter systems were generated. Tyrosinase and Rpe65 
upstream regulatory regions were cloned into lentiviral vectors that elicited the 
expression of GFP protein in a RPE-specific manner, as confirmed after transducing a 
RPE cell line (Aksan and Goding, 1998; Boulanger et al., 2000). Different combinations 
of the 10 Eye TFs were used to transduce MEFs previously transduced with either 
reporter system, and resultant GFP expressing cells were quantified. For the Rpe65 
reporter system, only discrete levels of GFP expression were observed for the pool of 10 
Eye TFs, which was consistent with Rpe65 upregulation previously mentioned. 
Additional combinations of TFs should be tested in an attempt to potentiate Rpe65 
promoter activation. 
Conversely, GFP expression driven by tyrosinase promoter was specifically detected in 
transduced cells cultured in the presence of DOX for several tested combinations, 
namely the pool of 10 Eye TFs, Mitf+Otx2, Mitf+Otx2+Pax6, Mitf+Otx2+Pax6+Otx1 and 
Mitf+Otx2+Pax6+Rax. These results were in accordance with the pigmented cells 
observed for the previously tested pool of 10 Eye TFs, given that tyrosinase is the rate-
limiting enzyme responsible for melanin synthesis (Murisier and Beermann, 2006). 
Interestingly to notice, during the preparation for flow cytometry analysis, the cells’ pellet 
from some combinations of TFs were noticed to possess a more brownish appearance 
when compared with the control sample (absence of DOX), which correlates with 
pigment synthesis and tyrosinase promoter activation. Another interesting evidence was  
that Mitf and Otx2 cooperatively activate the tyrosinase promoter, as already described, 
thus confirming the functionality and applicability of the established system (Martínez-
Morales et al., 2003b; Murisier et al., 2007). All the mentioned combinations containing 
the core Mitf+Otx2 generated higher degree of tyrosinase promoter activation when 
comparing to single transduction of Mitf. Further experiments will be performed in order 




with Mitf+Otx2 (or Mitf+Otx2+Pax6) and to investigate the roles of Pax6 and Otx1. 
Relevantly, it was reported that Pax6, in cooperation with Mitf, has an anti-retinogenic 
effect in the presumptive RPE. In a Mitf mutant background, Pax6 was critical for early 
RPE development, as in heterozygous mice for a Pax6 functional null allele down-
regulation of RPE genes (including Tyr) was observed (Bharti et al., 2012). Moreover, 
more recently it was shown that Pax6 both controls the expression of an RPE isoform of 
Mitf and synergizes with Mitf to activate expression of genes involved in pigment 
biogenesis (Raviv et al., 2014). Regarding Otx1, it was shown that both Otx genes are 
required in a dose-dependent manner for the normal development of the eye and that 
once mutated the OV fails to invaginate properly and the expression of Mitf and Tyr is 
lost (Martinez-Morales et al., 2001). 
With this reporter system, we were able to minimize the pool of reprogramming TFs 
obtaining either equivalent or even higher levels of tyrosinase activation when compared 
with 10 Eye TFs pool. Average values of around 4% of GFP+ cells for Mitf+Otx2 were 
detected at 12 dpt, consistent with a desired rapid kinetics of reprogramming. A similar 
system with an antibiotic-resistance gene expression driven by the tyrosinase promoter 
can be easily employed to allow the selection of this population and further 
characterization. Moreover, one cannot exclude that other TFs would further potentiate 
the reprogramming process, which can be tested in future experiments. Explicitly, Sox9 
has been implied as a key regulator of the expression of several RPE genes, such as 
Best1 and visual cycle genes (Rpe65, Rlbp1 and Rgr) (Masuda and Esumi, 2010; 
Masuda et al., 2014). Also, the Pax-family member Pax2, which is co-expressed with 
Pax6 in the OV stage, has been shown to perform redundant activities along with Pax6. 
Together, Pax6 and Pax2 are required and sufficient to direct the early patterning of the 
RPE, probably by directly controlling the expression of RPE determinants (such as Mitf) 
(Baumer et al., 2003). Additionally, the genomic organization of Mitf gene allows 
generation of multiple mRNA (and resulting protein) isoforms with specific patterns of 
expression due to different promoter/exon usage. Besides Mitf-A isoform used in this 
study, Mitf-H, Mitf-J and Mitf-D are also expressed at OV stage in presumptive RPE and 
later on mature RPE cells, and the inclusion of such isoforms in the reprogramming 
cocktail might be advantageous (Bharti et al., 2008).   
Nevertheless further experiments to optimize and confirm the generation of RPE-like 
cells through a direct lineage conversion are in order, relevant steps were undertaken 
towards this final goal. More straightforwardly our lentiviral reporter system may allow us 
to investigate the gene regulatory network underlying RPE development and 
specification. Additionally, lineage conversion-derived RPE cells will provide new 
Direct Reprogramming of fibroblasts into RPE cells 
199 
 
opportunities for cell replacement strategies, much desired for the establishment of a 
therapeutic alternative for retinal degenerative disorders. RPE cells are also valuable 
tools for disease modelling and basic developmental studies. Recently, Zhang and 
colleagues claimed that fibroblasts were directly converted into RPE-like cells using a 
pool of retrovirus encoding for 8 TFs. This pool of TFs included 6 eye/RPE-related TFs 
but also Klf4 and c-Myc, and promoted the activation of a Bestrophin reporter system 
and some morphologic alterations. No alterations in reporter activation or morphology 
were observed with pools including only the eye/RPE-related TFs. This approach also 
comprised the addition of small molecules known to promote RPE differentiation: the 
obtained cells arose after more than 12 dpt, were actively proliferating and did not exhibit 
a molecular signature compatible with mature RPE cells. Interestingly, Tyr expression 
was not detected in these cells reported as pigmented (Zhang et al., 2013) and thus, the 
reported results still raise several questions. 
In addition to the abovementioned experiments described in this thesis, another 
promising strategy to obtain RPE cells is also been tackled as an alternative to iPS cell 
generation followed by differentiation and by direct lineage conversion. Recent reports 
stated that indirect lineage conversion has successfully generated cardiomyocytes, 
neural and mesodermal progenitor cells from fibroblasts (Efe et al., 2011; Kim et al., 
2011; Kurian et al., 2013). This plastic induction strategy relies on the transient 
expression of TFs used for iPS cell generation, promoting an “open” epigenetic 
landscape. The process occurs via de-differentiation with the generation of proliferating 
multipotent, partially reprogrammed intermediates. These unstable intermediate states 
can be subsequently committed into a differentiation state by exposure to developmental 
cues, either extracellular signals or late-identity specification TFs (Ladewig et al., 2013; 
Sancho-Martinez et al., 2012). Lineage conversion by plastic induction may be a 
possible complementary strategy to allow us to reach our final goal of efficiently 
obtaining RPE cells.  
To summarize, several molecular tools were generated and used to transduce MEFs. 
Promising outcomes were observed, such as pigmentation and up-regulation of RPE-
specific genes, suggesting that RPE transcriptional and cellular identity was successfully 
being induced. Furthermore, 2 reporter systems were also developed, allowing the 
optimization of the cocktail of reprogramming TFs and the identification of reprogrammed 
cells. Additionally, positive insights on the RPE gene regulatory mechanism were drawn 
from the described experiments and will be further examined. We are now a step closer 
to the proposed objective of obtaining RPE cells by direct conversion of fibroblasts. 




may be useful as a fast and hopefully more efficient alternative to obtain functional RPE 















Chapter 6 : Concluding remarks and future perspectives 
Cellular reprogramming strategies have profoundly changed the dogmatic concept that 
adult somatic cell identity was stably determined along the differentiation process in an 
irreversible and unidirectional way. In particular, seminal discoveries by Yamanaka and 
colleagues, demonstrating that forced expression of TFs could trigger the 
reprogramming of a somatic cell into an ES cell-like pluripotent state, inspired scientists 
in a global quest for a better mechanistic understanding, improved efficiency and broader 
applicability of this Nobel awarded finding (Takahashi and Yamanaka, 2006; Takahashi 
et al., 2007a). In addition to reprogramming into pluripotency, somatic cell can be 
successfully directly reprogrammed into a different somatic cell type through the forced 
expression of specific TFs, as was first demonstrated with lineage conversion of 
fibroblasts into functional neurons (Vierbuchen et al., 2010). 
These reprogramming discoveries have particularly contributed to the regenerative 
medicine field, as cell sources for prospective cell replacement therapies. Ophthalmic 
applications have been at the forefront of the drive for clinical translation, given the 
clinical accessibility of the visual system, its ability to be functionally monitored with 
noninvasive imaging techniques after a therapeutic intervention, and its relative isolation 
from other body systems and immune privilege (Bharti et al., 2014; Ramsden et al., 
2013). Notwithstanding retina’s complex structure, many pathological conditions affecting 
it and causing visual impairment can be attributed to the degeneration of a relatively 
simple epithelial monolayer: the RPE. RPE cells perform a multitude of support functions 
essential to maintain visual function, such as retinol recycling, light absorption, ion 
buffering, secretion of growth factors, nutrient transport and phagocytosis of the OS of 
PR cells (Sparrrow et al., 2010; Strauss, 2005). Several retinal degenerative disorders, 
namely AMD, RP and Stargardt’s disease, as well as rare disorders such as CHM, are 
characterized by an RPE degeneration underlying the pathological process and affect 
millions of people worldwide with no available curative treatment. Cell replacement of 
RPE, obtained from different sources (such as ES cells) has been shown to at least 
partially rescue visual function in such conditions (Ramsden et al., 2013). 
Despite the first evidence for the generation of disease-specific iPS cells with valuable 
therapeutic potential was established for sickle-cell anemia, one could envision such 
proof-of-concept experiments being applied in the context of retinal disorders (Figure 
6.1) (Hanna et al., 2007). In fact, in 2011 Meyer and colleagues corrected the mutation in 




were subsequently differentiated into RPE cells that no longer displayed the disease 




Furthermore, reprogramming strategies also allow the generation of valuable disease 
models which can be used to comprehensively dissect the molecular events responsible 
for the pathological condition, still mostly unknown in the case of CHM. Disease 
modelling studies also permit to investigate the therapeutic potential of new drugs and 
treatments (Bellin et al., 2012). 
In this context, the work presented in this thesis aimed at exploiting cellular 
reprogramming strategies for cell-based therapies and disease modelling studies 
focusing on retinal degenerative disorders with underlying RPE dysfunction, particularly 
in the case of CHM. Two major approaches were undertaken: first, iPS cell generation 
followed by differentiation into the desired cell type (RPE cells), using both WT and Chm 
cells; second, direct lineage conversion of fibroblasts into RPE cells. 
iPS cell technology was successfully implemented, opening new research possibilities in 
the case of the present study and also in other studies ongoing in the laboratory. WT 
Figure 6.1: Proof-of-concept experiments to confirm the therapeutic potential of iPS 
cell-based approaches in a mouse model of retinal degenerative disorder.  
Mouse fibroblasts can be reprogrammed into pluripotent iPS cells. In the case of genetic 
disorders, genetic correction is needed to provide disease-free iPS cells. Alternatively, iPS 
cells could be genetically manipulated to deliver protective molecules with therapeutic 
advantages. Pluripotent cells can then be differentiated into functional RPE cells, which can 




MEFs were subjected to a reprogramming protocol, using an inducible lentiviral system 
to provide forced expression of the 4 classic reprogramming factors (Oct4, Sox2, Klf4 
and c-Myc) (Carey et al., 2009). Morphological and gene expression alterations (up-
regulation of Endo Oct4, Nanog and Fgf4) confirmed that the reprogramming events 
were taking place. Also endogenous protein levels of Nanog and SSEA-1 were detected 
and AP positively stained arising colonies with ES cell-like morphology were observed. 
Using LIF+2i culture conditions to allow a full reprogramming process with the attainment 
of “ground-state” pluripotency (Silva et al., 2008), emerging colonies gave rise to several 
iPS cell clones, which demonstrated self-renewal properties in a transgene independent 
way. The obtained iPS cell lines also exhibited typical morphology in culture and gene 
and protein expression of key pluripotent markers, particularly confirming a naïve 
pluripotent state. Using both in vivo and in vitro differentiation assays, functional 
pluripotency was confirmed by the generation of cells from endoderm, mesoderm and 
ectoderm lineages. Non-integrative delivery system (adenovirus) of the reprogramming 
factors was also attempted, although unsuccessfully, in order to implement a strategy 
with a potential therapeutic advantage. Nevertheless, for other final purposes, such as 
disease modelling studies, the inducible lentiviral system is still widely used given its high 
efficiency and reproducibility. Additionally, albeit being an integrative method, genomic 
integration was minimized by the use of a polycistronic unit encoding for the 4 TFs 
(Carey et al., 2009). Thus, iPS cell generation was successfully attained, providing a new 
technological platform that can be explored to answer a panoply of research questions. 
The implemented reprogramming protocol was then applied to Chm cells. CHM is an X-
linked monogenic disorder caused by loss of function of CHM/REP1 gene. REP1 protein 
encoded by this gene is a key regulator of Rab GTPases activity, essential for 
intracellular trafficking events. CHM is characterized by a progressive degeneration of 
three retinal cell layers, RPE, PRs and choroid, with a complex and still largely unknown 
pathology (van Bokhoven et al., 1994; Coussa and Traboulsi, 2012). Evidence points out 
for a key role of the RPE cells in the degenerative events, with consequent therapeutic 
advantage of rescuing RPE function, eventually through cell replacement (Tolmachova 
et al., 2013). A conditional KO mouse model was used in the reprogramming 
experiments. MEFs were treated with TM to induce recombination events, with obtained 
Chmnull cells demonstrating reduced Rep1 expression. Control Chmflox cells (untreated 
with TM) express Rep1 and were used in parallel during the reprogramming events. Both 
Chmnull and Chmflox MEFs were successfully reprogrammed using the inducible lentiviral 
system encoding for OSKM. Several Chmnull and Chmflox iPS cell lines were generated, 




WT cells. Besides the confirmation of self-renewal and pluripotency attributes, Chmnull 
and Chmflox iPS cell lines were analysed in terms of Rep1 expression, at both 
transcriptional and protein levels. Chmnull iPS cell lines had reduced Rep1 expression 
when compared to Chmflox iPS cell lines, thus validating a proper Rep1 KO to be 
potentially used as a Chm model.  
Subsequently, Chmnull, Chmflox and WT iPS cell lines were subjected to three 
differentiation protocols in order to obtain RPE cells, selected from the multitude of 
protocols for differentiation of pluripotent cells (ES and/or iPS cells) currently available in 
the literature. The stepwise differentiation process described by Zhu and co-workers, 
envolving the formation of 3D neuroepithelial cysts subsequently giving rise to RPE cells 
in a quantitative way, was not properly replicated from human ES cells into our mouse 
iPS cell lines (Zhu et al., 2013). However, attempts to replicate the self-organizing 
formation of OC-like structures from mouse pluripotent cells provided more enthusiastic 
results (Eiraku and Sasai, 2012; Eiraku et al., 2011; Gonzalez-Cordero et al., 2013). iPS 
cell lines were submitted to Early Retinal Differentiation step in SFEBq+Matrigel 
conditions, with resultant down-regulation of pluripotency markers and up-regulation of 
Otx2 and some EFTFs (Pax6 and Six3). These transcriptional alterations were 
consistent with the observed appearance of neuroepithelium-like structures followed by 
OV-like protrusions of the pluripotent cell aggregates. Despite the full differentiation 
process was not completed, a positive insight was collected to facilitate further 
optimization of the protocol towards the generation of RPE cells within an OC context. 
Additionally, a third differentiation approach was tackled, based in the recapitulation of 
the signaling pathways involved in the RPE embryonic developmental process: a first 
step of EB formation in Retinal Induction Media containing Noggin, Dkk1 and IGF1 
recombinant proteins to favour neuroectodermal lineage, followed by a RPE specification 
phase (Osakada et al., 2009; Torre et al., 2012). It was observed a population of cells 
with morphology and gene expression profiles (Pax6, Six3, Otx2, and in some cases 
also Six6) resembling retinal progenitor cells. Interestingly, Mitf expression was also 
observed as well as patches of RPE-like hexagonal-packed cells. 
At this point further experiments should be undertaken in order to complete the 
differentiation protocols and obtain RPE cells, that should be properly molecular and 
functionally characterized (Bharti et al., 2011). By using the last protocol described, one 
can anticipate the generating of a proliferative progenitor population that can be 
expanded, prior to the final specification signal to induce RPE formation. On the other 
hand, the self-formation of 3D OC will allow the generation of a proper retinal structure 




functional study. This is particularly relevant in the case of CHM, since both cell layers 
are affected and there is still no definite conclusion if the degeneration process occurs in 
a sequential or simultaneous way. With our in vitro models, this question could be 
tackled as well as the still unanswered quest for the molecular events underlying CHM 
pathogenesis. Several disease-specific iPS cell based models have been generated for 
retinal degenerative disorders, including CHM, providing helpful insight into the 
pathophysiology of such conditions (Cereso et al., 2014; Jin et al., 2011; Meyer et al., 
2011; Singh et al., 2013). For CHM, the lack of a proper in vitro model possible 
contributes to the still speculative molecular pathogenesis. Thus, we postulate that our in 
vitro system of Chmnull and Chmflox iPS cell-derived RPE (either in 3D systems or in 
single layers) will be an advantageous complementary model for disease modelling 
studies. Interestingly, the conditional nature of the Rep1 KO establishes the proper 
control for such experiments, as well as providing a timely control of the KO event. This 
model could also be used to investigate age-related changes already observed in the 
Chm mouse models, with probable correlation with AMD condition (Wavre-Shapton et 
al., 2013). Finally, these in vitro models can be used to investigate the therapeutic effects 
of experimental drugs or approaches, such as gene therapy (Cereso et al., 2014; 
Tolmachova et al., 2013). 
Alternatively to the mentioned reprogramming into pluripotency experiments, direct 
lineage conversion was also attempted. It was hypothesized that the TFs involved in 
RPE developmental process could promote the conversion of fibroblasts into RPE cells. 
Ten TFs were chosen, based on their described role in establishment of the EF (Tbx3, 
Rax, Six3, Pax6, Lhx2, Six6 and Nr2e1) and subsequent RPE specification and 
maturation process (Pax6, Mitf, Otx1 and Otx2) (Fuhrmann, 2010; Graw, 2010; Martínez-
Morales et al., 2004). Extensive molecular cloning was undertaken with the successful 
generation of inducible lentivirus encoding for V5-tagged versions of the 10 Eye TFs. 
MEFs transduced with a pool of the 10 TFs acquired morphology and gene expression 
attributes characteristic of RPE cells, in a short period of time, which is consistent with a 
direct lineage conversion. In order to optimize the pool of 10 TFs and to facilitate the 
identification of reprogrammed cells, two lentiviral reporter systems were also generated. 
Equivalent or higher tyrosinase promoter activation was observed with combined pools 
containing less TFs, when comparing with the 10 TFs pool. Explicitly, the known role of 
Mitf and Otx2 in RPE specification, including their binding and transactivation of 
promoter regions of genes involved in the terminal differentiation of RPE, such as 
tyrosinase, was confirmed in our system. The possibility of a positive effect of Otx1 and 




tackled more extensively. Thus, besides contributing to the optimization of the 
reprogramming cocktail of TFs, we generated a technological system that can be used to 
investigate the molecular events responsible for RPE specification and activation and 
maintenance of RPE-specific transcriptional program. Moreover, a similar system 
although driving the expression of an antibiotic resistance gene is already being 
implemented to allow selection of the arising pigmented RPE-like cells, followed by an 
extensive characterization step. Prospectively, RPE cells generated by lineage 
conversion methodologies are important complementary tools for disease modelling 
studies and regenerative medicine application. Direct lineage conversions have some 
advantageous over the iPS cell-based strategy, which implies a longer experimental 
period, with more cellular manipulations, and a subsequent differentiation process. 
Moreover, the differentiation protocols frequently generate phenotypically unstable cells 
in an inefficiently way (Bharti et al., 2011). 
Important progress towards the applicability of cellular reprogramming strategies in RPE-
related degenerative disorders was described in this work. Nevertheless, additional, yet 
complementary, experimental approaches could also be undertaken. In the case of a 
prospective therapeutic application, a non-integrative delivery system to force the 
expression of the defined factors should be applied. In the case of iPS cells generation, 
several alternatives have been described, with the more efficient and promising 
approach being the use of modified RNAs (González et al., 2011; Yakubov et al., 2010). 
Subsequently, in the case of monogenic diseases such as CHM, the underlying gene 
defect must be genetically corrected prior to the therapeutic use. Homologous 
recombination techniques were classically applied in different models (Meyer et al., 
2011), but also non-viral plasmids harbouring scaffold/matrix attachment regions 
(S/MARs) encoding for REP1/CHM cDNA have been designed to promote effective and 
sustained long term gene delivery to the RPE (Argyros et al., 2011; Ostad-Saffari et al., 
2010). More recently, the development of zinc finger nucleases, transcription activator-
like effector nucleases and clustered regularly interspaced short palindromic 
repeat/CAS9 RNA-guided nucleases profoundly improved gene editing technologies and 
can advantageously be used for gene correction of disease-specific iPS cell lines (Li et 
al., 2014). Gene corrected iPS cells must be differentiated into RPE cells, which can be 
used in transplantation studies. Transplantation of iPS cells-derived RPE has been 
shown to improve visual function in animal models of other retinal degenerations, such 
as AMD (Carr et al., 2009). Pluripotent stem cells-derived RPE can be transplanted as 
single cell suspension or in a monolayer cultured on top of a thin sheet of polymer (Carr 




results. Nevertheless, in patients in whom  extensive degenerative process has already 
occurred, cell replacement strategies based on reprogramming strategies can be 
therapeutically advantageous (MacLaren et al., 2014). Moreover, CHM and also other 
retinal degenerative disorders could benefit from the transplantation of not only the RPE 
but also the NR layer. Protocols for differentiation of pluripotent stem cells into PRs have 
also been established, with preliminary transplantation studies confirming their 
prospective therapeutic usage (Lamba et al., 2009, 2010; Tucker et al., 2011). 
The identity of cells is defined by a network of specific TFs, which can be overexpressed 
in order to manipulate the established cell fate into a pluripotent state or another cell 
lineage. To facilitate the analysis of complex TF networks and the choice for the correct 
reprogramming cocktail, a correlation matrix of global gene expression profiles have 
recently been described. It would be interesting to confirm if the TFs predicted to be 
important for the establishment of a retinal transcriptome could be applied successfully in 
our reprogramming experiments (Yamamizu et al., 2013). Moreover, in addition to the 2 
approaches of cellular reprogramming exploited in this work, a third approach has been 
recently described to successfully reprogram fibroblasts into other cell lineages. This 
approach implies a transient overpression of the Yamanaka’s TF used to generate iPS 
cells. An “open” epigenetic state is induced, with the generation of multipotent partially 
reprogrammed intermediates, which can be forced into different cell lineages by 
manipulating culture conditions or forcing the expression of specific TFs (Ladewig et al., 
2013; Sancho-Martinez et al., 2012). This lineage conversion through plastic induction 
provides new alternatives to the retinal degenerative field. Relevantly, one can postulate 
the generation of a retinal progenitor multipotent intermediate that could be triggered into 
RPE and/or NR lineages, both being therapeutically relevant. 
In conclusion, we have exploited cellular reprogramming technologies, applying 
described protocols and also attempting to generate new approaches, with promising 
results. We focused in the application of such technologies in the retinal degenerative 
field, particularly in the case where RPE dysfunction is involved, as observed for CHM. 
Our results positively shed light into the prospective use of cellular reprogramming 
methods for therapeutic applications, drug screening, disease modelling and basic 
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Chapter 8 : Supplementary material 
Resumo alargado 
Os organismos multicelulares são formados por um conjunto de diferentes células e 
tecidos, todos derivados duma única célula inicial através dum processo de 
diferenciação. Durante muito tempo este processo de especificação progressiva dos 
diversos tipos de células foi considerado unidireccional e irreversível. Contudo, este 
conceito foi posto em causa pelas experiências inovadoras de transferência nuclear de 
células somáticas (ou clonagem) realizadas por Gurdon nos anos 60, em que o núcleo 
de uma célula do epitélio intestinal dum girino foi transferido para um oócito enucleado 
dando origem a um organismo adulto completo. Esta evidência experimental de que a 
identidade celular é plástica deu origem a um novo conceito em que as especificidades 
epigenéticas e transcricionais de uma célula somática podem ser reprogramadas de 
modo a originar outro tipo celular diferente, num processo designado de reprogramação 
celular.  
Para além da clonagem, outras tecnologias de reprogramação nuclear foram 
desenvolvidas ao longo dos anos, como a fusão celular e a reprogramação mediada por 
factores de transcrição (FT). Este último caso foi reportado pela primeira vez por 
Yamanaka e a sua equipa em 2006, causando uma verdadeira revolução na área 
científica de investigação em células estaminais. Recorrendo à expressão forçada de 4 
FT com funções conhecidas no estabelecimento e manutenção de um estado 
pluripotente, os fibroblastos foram convertidos em células com propriedades de auto-
renovação e pluripotência semelhantes às células estaminais embrionárias (CEE). 
Deste modo, Yamanaka obteve aquilo que designou por células estaminais 
pluripotentes induzidas (CEPi). Dada a relevância destas descobertas, Yamanaka e 
Gurdon receberam o Prémio Nobel da Medicina em 2012 pela “descoberta de que 
células maduras podem ser reprogramadas para um estado pluripotente”. 
A reprogramação celular de células somáticas para um estado pluripotente foi 
conseguida usando FT, técnica também utilizada na conversão directa de uma célula 
somática noutro tipo de célula (da mesma ou de diferentes linhagens). Estas inovações 
tecnológicas suscitam muito interesse em termos de aplicações em medicina 
regenerativa. Uma célula pluripotente, por definição, é capaz de dar origem aos vários 
tipos de células das 3 linhagens celulares, endoderme, mesoderme e ectoderme. Deste 
modo, e como as CEPi podem ser obtidas dos próprios doentes e diferenciadas nas 




necessidade de recorrer a embriões, contornando por isso os problemas éticos 
levantados pelas CEE. Para além disso, a possibilidade de gerar células de indivíduos 
com determinadas patologias permite obter modelos in vitro de várias doenças que 
podem ser usados para compreender melhor os mecanismos patogénicos. Ensaios para 
confirmar a eficiência e toxicidade de novos fármacos também podem ser realizados 
usando as células obtidas por reprogramação celular. Adicionalmente, estas células 
podem ser utilizadas para investigar os mecanismos reguladores da pluripotência, da 
identidade celular e dos processos de diferenciação. 
As técnicas de reprogramação celular têm sido aplicadas com sucesso a várias áreas 
da medicina regenerativa, nomeadamente em situações de degeneração da retina. A 
retina é o tecido que se encontra na zona posterior do olho, responsável pela captação 
da informação visual. Várias doenças hereditárias ou adquiridas são caracterizadas pela 
degenerescência das várias camadas celulares que constituem a retina: a neuroretina, o 
epitélio pigmentar da retina (EPR) e a coróide. Em diversas situações, o processo 
degenerativo está relacionado com a disfunção do EPR, um tecido de suporte que 
desempenha funções vitais para a manutenção da capacidade de captura e transmissão 
da informação visual dos foto-receptores da neuroretina. Nesse caso, há uma 
progressiva perda visual que pode conduzir à cegueira. A Coroideremia (CHM) é um 
dos casos em que isto acontece. Esta é uma doença hereditária ligada ao cromossoma 
X e causada por mutações que causam perda de função da proteína REP1, essencial 
para a regulação do tráfico intracelular. Esta doença é caracterizada por uma 
degenerescência progressiva da neuroretina, EPR e coróide, e leva à perda parcial de 
visão nos jovens adultos, evoluindo para cegueira total com o tempo. Apesar de os 
mecanismos moleculares subjacentes à patologia da CHM ainda serem parcialmente 
desconhecidos, existem dados que sugerem um envolvimento crucial do EPR. Terapias 
génicas com o objectivo de corrigir o defeito genético no EPR de doentes estão neste 
momento em ensaios clínicos de fase I, com resultados promissores. No entanto, em 
doentes em que a progressão dos eventos degenerativos já se encontra em fase 
avançada, apenas estratégias de substituição celular podem ser vantajosas para os 
doentes com CHM. Para além disso, existe uma lacuna nos modelos in vitro existentes, 
o que, uma vez colmatada, poderia implicar um avanço significativo na caracterização 
dos eventos degenerativos. 
Deste modo, o trabalho apresentado nesta tese foi desenhado com o objectivo principal 
de explorar as potenciais aplicações das técnicas de reprogramação celular no contexto 
das doenças degenerativas da retina com disfunção do EPR, em particular no caso da 




para a pluripotência no laboratório, de modo a ser usada no âmbito deste trabalho e 
abrindo novas portas para trabalhos subsequentes. Diversos protocolos para a obtenção 
de CEPi foram entretanto descritos, com diferentes células de origem, sistemas de 
transdução e conjunto de FT usados na reprogramação. Devido à sua alta eficiência, 
fidelidade e reprodutibilidades, foi escolhido um sistema lentiviral induzido, em que uma 
só unidade policistrónica codifica os 4 FT descritos por Yamanaka: Oct4, Sox2, Klf4 e c-
Myc. Fibroblastos de embrião de murganho (FEM) de estirpe selvagem foram 
transduzidos com as partículas lentivirais e submetidos a condições de cultura 
favoráveis às células pluripotentes. A citocina Factor Inibidor da Leucemia (LIF) e dois 
inibidores de determinadas vias de sinalização celular (2i, “dual inhibition) fazem parte 
integrante do meio de cultura, de modo a favorecer o estabelecimento dum estado de 
pluripotência naïve. Durante o processo de reprogramação, foi detectada a expressão 
de genes e proteínas características de células pluripotentes (Oct4 endógeno, Nanog, 
Fgf4, e SSEA-1). Observou-se também o aparecimento de colónias com morfologia 
semelhante às CEE e positivas para a fosfatase alcalina (AP). Estas colónias deram 
origem a diversas linhas celulares de CEPi, que demonstraram ter propriedades de 
auto-renovação mesmo quando o sistema lentiviral deixou de ser induzido, indicando 
que a activação da identidade celular pluripotente endógena foi conseguida. Para além 
disso, a morfologia e expressão de genes e proteínas característicos (Oct4, Nanog, 
SSEA-1 e AP) das células pluripotentes foi também avaliada e confirmada. Em termos 
funcionais, a pluripotência das células obtidas foi posteriormente avaliada in vitro e in 
vivo, tendo sido observado que após diferenciação as CEPi deram origem a células das 
3 linhagens germinativas em ambos os casos. Como alternativa a este protocolo, e de 
modo a obter células mais adequadas a possíveis aplicações terapêuticas, foi também 
testado um sistema de transdução adenoviral, que tem a vantagem de não integrar o 
genoma, evitando eventos de mutagénese por inserção. No entanto, não foi possível 
estabelecer linhas celulares de CEPi usando este método. Outros métodos não 
integrativos foram entretanto descritos; contudo, o sistema lentiviral continua a ser o 
mais usado e robusto no estabelecimento de modelos celulares de doença. 
Seguidamente ao estabelecimento e otimização do protocolo lentiviral de obtenção de 
CEPi, em células de estirpe selvagem, este foi aplicado a células obtidas de um modelo 
animal de Chm, em que o knockout do gene Rep1 ocorre de maneira condicional, após 
tratamento com tamoxifeno. As experiências envolveram o uso de FEM tratados e não 
tratados com a droga indutora da recombinação homóloga. Os primeiros, FEM Chmnull, 
possuem expressão reduzida de Rep1, quando comparadas com os segundos, FEM 




CEPi Chmnull e Chmflox que foram caracterizadas como referido anteriormente para as 
células de estirpe selvagem. Para além de demonstrarem propriedades de auto-
renovação e pluripotência, estas CEPi foram caracterizadas em termos de expressão de 
Rep1, tendo-se observado que as CEPi Chmnull possuem expressão reduzida quando 
comparadas com as CEPi Chmflox, confirmando a aplicabilidade das primeiras como 
modelo de Chm.  
O facto de serem pluripotentes torna as CEPi capazes de serem diferenciadas nas 
células de interesse, neste caso células do EPR. Vários protocolos estão descritos na 
literatura, e três foram testados simultaneamente em CEPi de estirpe selvagem, CEPi 
Chmnull e CEPi Chmflox. O primeiro protocolo estabelecido usando CEE humanas não foi 
reproduzido com sucesso no nosso sistema, uma vez que não se observou a formação 
das estruturas neuroepiteliais descritas, nem alterações de expressão genética 
concordantes. Pelo contrário, com o segundo protocolo, adaptado dos trabalhos 
pioneiros do grupo de Sasai, obtiveram-se resultados promissores. Em condições de 
cultura em suspensão na ausência de soro e com adição de Matrigel, a auto-formação 
de cálices ópticos tridimensionais foi reportada previamente. No nosso caso, observou-
se a formação de estruturas neuroepiteliais com protusões correspondentes a vesículas 
ópticas que, no entanto, não evoluíram para a formação dos cálices ópticos. 
Concomitantemente observou-se a expressão de FT que estabelecem primariamente e 
especificam o “eye field” (nomeadamente Otx2, Pax6 e Six3). Apesar de o processo de 
diferenciação não ter sido finalizado, obtiveram-se resultados promissores que 
facilitarão a prossecução do objectivo final de obter células do EPR, no contexto 3D dos 
cálices ópticos. Por último, foi testado um terceiro protocolo de diferenciação baseado 
nas vias de transdução de sinal que se sabem estarem implicadas no desenvolvimento 
embrionário do olho. Numa primeira fase, as células foram sujeitas a cultura em 
suspensão em meio de cultura contendo Noggin, Dkk1 e IGF-1 para favorecer a 
linhagem neuroepitelióide. Seguidamente, e já em cultura aderente, observou-se o 
aparecimento duma população celular proliferativa com morfologia e padrão de 
expressão génico (Pax6, Six3, Otx2, e em alguns caso também Six6) 
caracteristicamente observados em células retinianas progenitoras. 
Simultaneamente observou-se a expressão de Mitf e zonas com células hexagonais 
compactadas semelhantes ao EPR. Em suma, apesar de não se ter conseguido obter 
ainda uma população de EPR maduro, estas experiências abriram o caminho para a 
obtenção do mesmo, integrado numa estrutura tridimensional. Deste modo, será 
possível estudar as interações estruturais e funcionais do EPR e neuroretina, o que será 




células retinianas  progenitoras podem ser expandidas antes da aplicação do estímulo 
final de especificação do EPR, que será assim obtido de maneira mais quantitativa, 
facilitando os estudos de modelação da CHM.  
Outro objectivo explorado na presente tese, para além de implementar técnicas de 
reprogramação para a pluripotência que requerem a subsequente diferenciação em 
EPR, foi a conversão directa de fibroblastos em células do EPR. Segundo a hipótese de 
que os FT envolvidos nos processos de desenvolvimento embrionário do olho primitivo 
(Tbx3, Rax, Six3, Pax6, Lhx2, Six6 e Nr2e1) e subsequente especificação do EPR 
(Pax6, Mitf, Otx1 e Otx2) poderiam ser usados nesta conversão directa, foram criadas 
diversas ferramentas moleculares. Foram produzidos vectores lentivirais indutíveis que 
codificam para os 10 FT selecionados com base na literatura. A transdução de FEM 
com uma mistura dos 10 FT revelou o aparecimento de células pigmentadas, assim 
como o aumento da expressão de genes característicos do EPR. Para facilitar a 
identificação/isolamento das células reprogramadas e a otimização da mistura dos FT a 
usar, foram também produzidos sistemas lentivirais repórteres usando as regiões 
promotoras dos genes tirosinase e Rpe65. Nestas experiências, observou-se que a 
combinação de apenas 2 FT, Mitf e Otx2, induzia activação do promotor da tirosinase de 
maneira equivalente ao observado para o cocktail de 10 FT. Este resultado confirma 
também o funcionamento do sistema, uma vez que estes FT são conhecidos 
reguladores da expressão da tirosinase. Foi proposto também um papel para uma 
possível interacção positiva destes FT com Otx1 e/ou Pax6, contudo são necessários 
mais estudos para se poderem tirar conclusões definitivas. Pelo acima mencionado, 
estas experiências promissoras para além de permitiram optimizar uma mistura de FT 
que origina uma conversão directa mais eficiente, podem também ajudar a descobrir 
novos mecanismos moleculares que contribuem para a identidade transcricional do 
EPR. Mais ainda, está a ser implementado um sistema repórter semelhante ao já 
estabelecido, mas que permite a selecção positiva das células reprogramadas, de modo 
a futuramente se prosseguir com a caracterização molecular e funcional das mesmas e 
a confirmação da identidade de EPR. Uma vez optimizado o protocolo, este pode ser 
utilizado em células modelo de CHM para permitir estudos funcionais. 
Globalmente, os trabalhos apresentados nesta tese evidenciam as amplas 
aplicabilidades das tecnologias de reprogramação celular. Aplicando as técnicas 
descritas de reprogramação para a pluripotência, obtiveram-se CEPi de estirpes 
selvagens e Chm que, uma vez diferenciadas em EPR, constituem ferramentas 
importantes para futuros trabalhos na área da retina. No âmbito desta tese foram 




fibroblastos em EPR. No seu conjunto e a longo prazo, as células do EPR obtidas por 
reprogramação celular abrem novas possibilidades para o desenvolvimento de terapias 
de substituição celular. Por outro lado, a curto prazo, contribuem para o estabelecimento 
de modelos in vitro para estudos funcionais de doenças degenerativas da retina no 
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